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Overview 
 
This thesis focuses on the effects of pharmacological strategies on the 
development of post-traumatic stress disorders (PTSD) in the context of interpersonal 
violence. Part 1 reviews research literature examining the effects of pre-assault 
substance consumption on PTSD symptoms amongst victims of sexual assault. 
Specifically, it investigates the effects of acute substance intoxication and chronic pre-
assault problematic substance use on the severity and course of PTSD symptoms. The 
review highlights characterological self-blame and negative social reactions as 
significant mediators of PTSD recovery in the context of pre-assault substance 
consumption. 
Part 2 comprises an empirical study investigating the effects of a single dose of 
hydrocortisone on intrusive and declarative memories using the trauma film paradigm 
in a sample of female healthy participants. The findings highlight that hydrocortisone 
orally administered within the memory consolidation period can effectively reduce 
intrusive memories. Compared to the placebo group, although declarative memory was 
unaffected, the frequency and vividness of intrusive memories were significantly 
reduced in the hydrocortisone group. This research project was jointly conducted with 
another trainee from University College London (UCL) who investigated the effects 
of propranolol on intrusive and declarative memories and used the same placebo group.  
Part 3, the critical appraisal, sets out a number of reflections on the process of 
conducting the research project. The appraisal discusses personal assumptions for this 
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project and how they were challenged and modified. The implications of the current 
project for future work are also considered.  
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Impact Statement 
 
This thesis demonstrates that a single dose of hydrocortisone orally administered 
shortly after a trauma film containing interpersonal violence can rapidly reduce the 
occurrence of involuntary intrusive memories, a canonical symptom of post-traumatic 
stress disorder (PTSD), while leaving voluntary declarative memory of the event intact. 
These findings suggest that hydrocortisone might have clinical applications as 
pharmacological vaccines against PTSD by interfering with emotional memory 
consolidation or retrieval if administered within the critical period of memory 
consolidation. Hydrocortisone administration can be used as a form of early 
preventative intervention that can reduce the risk of potentially developing PTSD over 
time and associated emotional distress that otherwise may lead to reduced quality of 
life post-trauma and the development of other comorbid mental health conditions such 
as depression, anxiety and substance use disorders. Such findings shed important light 
on public service delivery in terms of developing and implementing treatment 
approaches that may combine both pharmacological and psychological interventions 
complimentarily. In addition, this thesis adds to the current literature on the effects of 
hydrocortisone, which, already known as an effective medication for a range of 
physical health conditions, may also have important clinical use in treating trauma-
related disorders and promoting public mental health.  
Furthermore, this thesis brings about more understanding of the memory 
processes and brain mechanisms under which hydrocortisone affects PTSD. It also 
identifies research areas that need more clarifications. For instance, whether the effects 
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of hydrocortisone generalise to men and other types of traumatic experiences, and to 
clinically realistic treatment timescales after a traumatic event, remains to be 
determined.  
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Part 1: Literature Review 
 
 
Post-Traumatic Stress Disorder in Victims of Sexual Assault with Pre-assault 
Substance Consumption: A Systematic Review 
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Abstract 
 
Aim 
Post-traumatic stress disorder (PTSD) and substance consumption commonly co-
occur in victims of sexual assault. Substance consumption can occur pre- and post-
assault and may lead to pre-assault intoxication, resulting in different effects on the 
development of PTSD. This review aims to give an overview of current understanding 
of the effects of pre-assault substance consumption, namely acute substance 
intoxication and chronic pre-assault problematic substance use, on symptoms of PTSD 
amongst victims of sexual assault.  
Method  
PsycINFO, EMBASE, and MEDLINE were searched using terms related to PTSD, 
sexual assault, and substance consumption. The search yielded 2004 articles, 262 of 
which were retrieved for more detailed evaluation. Thirteen articles were deemed to 
be relevant for inclusion and were appraised in detail. 
Results  
Overall, the reviewed papers support the hypothesis that acute substance 
intoxication and chronic pre-assault problematic substance use are associated with 
fewer initial PTSD symptoms but less improvement over time, resulting in slower 
overall PTSD recovery. They also highlighted post-assault characterological self-
blame and negative social reactions as mediators of recovery in the context of pre-
assault substance consumption. 
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Conclusion  
Acute substance intoxication and chronic pre-assault problematic substance use 
appear to have an impact on the development of PTSD symptoms amongst victims of 
sexual assault. The importance of developing early intervention and routine screening 
and assessment for PTSD and pre-assault substance consumption is emphasised. 
Limitations and future research directions are discussed.  
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1. Introduction 
 
1.1. Post-traumatic stress disorder (PTSD) 
Many people report experiencing or witnessing a traumatic event over the course 
of their lifetime (Benjet et al., 2016). Traumatic events, defined in the most recent 
Diagnostic and Statistical Manual of Mental Disorders as “exposure to actual or 
threatened death, serious injury, or sexual violence” (DSM-5; American Psychiatric 
Association, 2013, p. 271), include interpersonal violence, road traffic accidents, and 
exposure to aversive details of trauma through electronic and online media. Research 
suggests that a clinically significant number of people who experience traumatic 
events may go on to develop post-traumatic stress disorder (PTSD; Green, 1994). The 
lifetime prevalence rate of PTSD in the population is approximately 5-12% (Breslau 
et al., 1998; Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995; World Health 
Organisation, 2003).  
Major PTSD symptoms include re-experiencing via intrusive memories, 
flashbacks and nightmares; (hyper)arousal in the form of exaggerated startle response 
and hypervigilance; and protective reactions, including emotional numbing, avoidance, 
amnesia, and cognitive avoidance (DSM-5; 2013). In addition, PTSD commonly 
presents with various forms of negative affect, including anger, sadness and guilt. The 
severity and course of PTSD symptoms also vary across individuals, and a number of 
studies have been conducted to investigate related factors and exposure variables 
(Brewin, Andrews, & Valentine, 2000; Cougle, Resnick, & Kilpatrick, 2009; Kessler 
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et al., 1995; Kilpatrick & Saunders, 1999; Ozer, Best, Lipsey, & Weiss, 2003; Ullman, 
Filipas, Townsend, & Starzynski, 2007). 
1.2. Substance consumption and substance use disorders (SUDs) 
Substance consumption is an important public health issue that continues to result 
in substantial morbidity and significant societal economic costs (Galea, Nandi, & 
Viahov, 2004). It is associated with a wide range of negative consequences, including 
health issues, job loss, and risky and criminal behaviours (McGinnis & Foege, 1999). 
Surveys have consistently found young adults to have the highest rates of substance 
consumption (Elliott, Huizinga, & Menard, 2012). The use of substances may involve 
licit (alcohol and cigarettes, and cannabis in some jurisdictions) or illicit substances.  
In addition, frequent and excessive use of substances may result in the 
development of substance use disorders (SUDs). Individuals with SUDs show 
impaired control over their use of substances. They may experience cravings and use 
the substance in larger amounts or over a longer period despite a persistent desire to 
regulate or discontinue use. Furthermore, SUDs are usually accompanied by social 
impairment, risky use of the substance and symptoms of tolerance and withdrawal 
(DSM-5, 2013). Nationally representative surveys have demonstrated that lifetime 
prevalence rates of SUDs across countries ranged from a low of 1.3% (Italy) to a high 
of 15.0% (Ukraine), with a median of 7.0% (Demyttenaere et al., 2004; Kessler et al., 
2007). With similar diagnostic criteria to SUDs, alcohol use disorders (AUDs) involve 
problematic patterns of alcohol use leading to significant impairment or distress 
(DSM-5, 2013). The National Epidemiologic Survey on Alcohol and Related 
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Conditions in the United States showed that 12-month and lifetime prevalences of 
AUDs were 13.9% and 29.1%, respectively (Grant et al., 2015).  
Some research conducted prior to DSM-5’s revised classification scheme referred 
to substance-related problems using other terminology (e.g., substance 
misuse/abuse/dependence/use, disorder/addiction, etc.) in order to account for 
different degrees of problem severity. However, there is no such distinction in DSM-5 
which aimed for a continuum approach. Specifically, SUDs occur in a broad range of 
severity, from mild to severe, with severity based on the number of symptom criteria 
endorsed. Generally, a mild SUD is suggested by the presence of two to three 
symptoms, moderate by four to five symptoms, and severe by six or more symptoms 
(DSM-5, 2013). Therefore, for the sake of consistency, the term “SUDs” will be used 
throughout this current review wherever it is evident that publications were referring 
to a pattern of substance consumption that is consistent with the definition of SUDs as 
provided in DSM-5. 
1.3. The relationship between PTSD and SUDs 
PTSD and SUDs commonly co-occur (Kessler, Chiu, Demler, & Walters, 2005). 
Research has shown that the prevalence estimate of SUDs is high in individuals with 
PTSD, with 15.8% reporting AUDs, approximately one-third having nicotine 
dependence and 10.6% meeting criteria for SUDs of other drugs (Breslau, Davis, & 
Schultz, 2003). Similarly, 25-42% of individuals seeking treatment for SUDs meet the 
criteria for PTSD (Brady, Back, & Coffey, 2004). PTSD is comorbid with the use of 
various types of drugs, for example, heroin, cocaine, and amphetamines (Blumenthal 
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et al., 2008; Mills, Teesson, Ross, & Peters, 2006), and most commonly with alcohol 
and nicotine use (Sareen, Chartier, Paulus, & Stein, 2006; Smith, Blumenthal, Badour, 
& Feldner, 2010). In addition, patients with concurrent PTSD and SUDs show higher 
symptom severity and poorer treatment outcomes compared to patients with either 
disorder alone (Back et al., 2000; Brady, 2001).  
The relationship between PTSD and SUDs is complex and bidirectional 
(Blumenthal et al., 2008; Feldner, Babson, & Zvolensky, 2007; McFarlane, 1998). 
Extensive research has focused on delineating this relationship (McFarlane, 1998; 
Stewart, Pihl, Conrod, & Dongier, 1998; Steward & Conrod, 2003). According to the 
current literature, the following theoretical accounts of the relationship between PTSD 
and SUDs have been posited.  
1.3.1. Self-medication model  
The self-medication model proposes that trauma survivors’ excessive use of 
substance is an attempt to alleviate PTSD symptoms (Khantzian, 2003). This model 
suggests that the use of substances is maintained and reinforced due to its effect in 
temporarily reducing the negative affect and other aversive symptoms associated with 
trauma. According to this model, the use of substance functions to manage the 
emotional pain resulting from trauma in order to achieve emotional homeostasis 
(Khantzian, 1985). It posits a degree of psychopharmacological specificity in that the 
specific substance used is expected to psychophysiologically alleviate aversive affects. 
Specifically, cocaine is used to regulate low energy and depression, nicotine to remedy 
dysphoria, and alcohol to relieve anxiety (Khantzian, 1985, 1997). In PTSD, 
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furthermore, corticotropin-releasing hormone and noradrenergic systems may interact 
such that the stress response is progressively augmented. Patients may use a range of 
substances in an effort to interrupt this progressive augmentation (Koob, 1999; Post, 
Weiss, Smith, & McCann, 1997). Evidence from epidemiological and longitudinal 
studies, provides support for the self-medication model, such that young adults with 
early-life trauma tend to use drugs to self-medicate troubling trauma-associated 
memories, nightmares, or painful hyperarousal symptoms (Reed, Anthony, & Breslau, 
2007).  
1.3.2. Negative reinforcement model 
The negative reinforcement model is a general theory of problematic substance 
consumption. It suggests that withdrawal-driven negative affect is the fundamental 
motivator for the use of substances and that PTSD may lead to a greater sensitivity to 
such effects, hence indirectly augmenting an individual’s potential to develop and 
maintain ongoing problematic substance consumption (Baker, Piper, McCarthy, 
Majeskie, & Fiore, 2004). In contrast to the self-medication model, this model makes 
no prediction about psychopharmacological specificity between the substance of 
choice and the state of psychological distress. Evidence from several laboratory-based 
studies supports this model (for review, see Smith, Feldner, & Badour, 2011), 
highlighting the role of withdrawal symptoms (Feldner, Vujanovic, Gibson, & 
Zvolensky, 2008) and a lack of substance and affective specificity (Beckham et al., 
2007; McClernon et al., 2005). 
1.3.3. Mutual maintenance model  
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An extension of the self-medication model, the mutual maintenance model posits 
a reflexive relationship between SUDs and PTSD symptoms (Kaysen et al., 2011; 
McFarlane et al., 2009). This model suggests that repeated use of substances not only 
helps temporarily suppress PTSD symptoms but may also impede natural recovery 
from PTSD. For example, while exposure to trauma reminders can trigger substance 
consumption (Baker et al., 2004), withdrawal symptoms from substances, such as 
palpitations, sweating and shivering, are similar to fear responses during the traumatic 
event and can evoke traumatic memories and trigger PTSD symptoms (Jacobsen, 
Southwick, & Kosten, 2001; Stewart & Conrod, 2003). This may in turn exacerbate 
and maintain PTSD symptoms over time. Neuroendocrine research also provides some 
evidence for this model, as the acute and chronic stress in PTSD negatively affects 
hippocampal function, which can be further impaired by chronic alcohol exposure and 
especially alcohol withdrawal (Conrod & Stewart, 2003; McEwen, 2000).  
1.3.4. High-risk and susceptibility hypotheses  
The high-risk and susceptibility hypotheses are other potential pathways between 
PTSD and SUDs (Chilcoat & Breslau, 1998a, 1998b). The high-risk hypothesis 
suggests that engaging in substance consumption and related “high-risk” activities 
(e.g., being intoxicated in dangerous situations) increases the probability of 
experiencing a traumatic event, and hence of developing PTSD. The susceptibility 
hypothesis posits that excessive use of substances may play a causal role, in that 
substance users may be more susceptible to PTSD following a traumatic event due to 
impaired psychological or neurochemical systems resulting from extensive substance 
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consumption. A number of studies have demonstrated that excessive substance 
consumption contributes to rape vulnerability and increases susceptibility to the 
development of PTSD (Messman-Moore, Ward, & Brown, 2009; Testa, Livingston, 
Vanzile-Tamsen, & Frone, 2003). In addition, multiple studies with female substance 
abusers also demonstrate high rates of revictimisation in the form of partner violence, 
as well as stranger rape and physical assault in adulthood and subsequent development 
of PTSD (Classen, Palesh, & Aggarwal, 2005; Hien, Nunes, & Levin, 1995; Hien & 
Scheier, 1996; Messman-Moore et al., 2009; Ullman, Najdowski, & Filipas, 2009). 
1.3.5. Third variable model  
The third variable model postulates that concurrent PTSD and SUDs may be due 
to an unknown shared third variable, such as biological vulnerability and/or personality 
factors (Ducci et al., 2008; Haller & Chassin, 2013; Miller, Vogt, Mozley, Kaloupek, 
& Keane, 2006; Sartor et al., 2011). In addition, several research studies suggest that 
the relationship between PTSD and SUDs may be mediated by other factors, such as 
poor coping skills, self-regulatory deficits and trauma-related cognitions (Hien, Cohen, 
& Campbell, 2005; Stewart & Conrod, 2003; Thompson & Kingree, 2010). For 
example, several studies showed that high anxiety sensitivity appears to partially 
mediate the relationship between PTSD and SUDs (Lubman, Allen, Rogers, Cementon, 
& Bonomo, 2007; Stewart, Conrod, Samoluk, Pihl, & Dongier, 2000).  
1.4. The relationship between PTSD and SUDs in interpersonal violence 
Interpersonal violence refers to violence between individuals, including within 
families and between acquaintances and strangers (World Health Organisation, 2014). 
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Interpersonal violence is further differentiated into sexual and non-sexual assault. 
Non-sexual assault takes place when an individual or a group provokes and attacks a 
person physically without overt sexual contact. Non-sexual assault includes physical 
assault (i.e., physical attacks with or without the use of a weapon), threats or menacing 
and unwanted contact, such as shoving, pushing, tripping, without necessarily 
resulting in physical harm (Berenson, San Miguel, & Wilkinson, 1992). In this review, 
the term ‘sexual assault’ refers to an act in which a person sexually touches, coerces 
or physically forces a person to engage in a sexual act against their will. This broad 
category of sexual violence includes rape (forced vaginal, anal or oral penetration or 
drug-facilitated sexual assault), groping, child sexual abuse, sexual torturing, and 
sexual harassment (Berenson et al., 1992). Physical assault and sexual assault may also 
co-occur in certain situations (Sullivan, McPartland, Armeli, Jaquier, & Tennen, 2012; 
Wang, Iannotti, Luk, & Nansel, 2010). 
Many studies have demonstrated the co-occurrence of PTSD and SUDs in victims 
of interpersonal violence, including both sexual and non-sexual assaults (Griffing et 
al., 2006; Resnick, Acierno, & Kilpatrick, 1997) and focused on investigating their 
temporal relationship. Generally, these studies describe a complex temporal 
relationship between PTSD and SUDs in the context of interpersonal violence (Hedtke 
et al., 2008; Kilpatrick et al., 2003). Substance consumption can occur pre- and post-
assault and may result in peri-assault intoxication. The types of relationship are 
broadly summarised in the following three categories, which will focus on the broad 
issue of the relationship between the development of PTSD and acute intoxication, 
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chronic pre-assault problematic substance use and post-assault SUDs.  
1.4.1. The effect of acute substance intoxication on PTSD 
A number of studies have focused on the effect of acute substance intoxication on 
the development of PTSD and its recovery. Acute substance intoxication involves the 
victims’ consumption, either voluntarily or involuntarily, of psychoactive substances 
immediately or shortly before interpersonal violence, which can lead to various levels 
of intoxication and/or incapacitation prior to and during the incident (i.e., pre- and peri-
assault intoxication). Overall, inconsistent evidence has been found on the role of acute 
substance intoxication on PTSD. Some studies have suggested an increased risk of 
PTSD diagnosis and more chronic and severe course of symptoms in victims of 
interpersonal violence with acute intoxication (Abbey, Zawacki, Buck, Clinton, & 
McAuslan, 2004; Kaysen et al., 2010; Richmond & Kauder, 2000; Zatzick et al., 2002), 
whereas others indicate a protective effect of acute substance intoxication against 
PTSD (Maes, Delmeire, Mylle, & Altamura, 2001; Mellman, Ramos, David, Williams, 
& Augenstein, 1998). In addition, a number of studies have demonstrated that sexual 
assault victims with acute substance intoxication may further develop chronic 
substance use problems comorbid with PTSD and depression after an assault (Burnam 
et al., 1988; Kilpatrick, Acierno, Resnick, Saunders, & Best, 1997; Yuan et al., 2003).  
1.4.2. The effect of chronic pre-assault problematic substance use on PTSD  
The effect of chronic pre-assault problematic substance use on PTSD has also been 
investigated. This includes victims who have developed long-term SUDs and/or had 
excessive use of substances that led to negative consequences such as hangover and 
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loss of interest in activities and hobbies during the month prior to the occurrence of 
interpersonal violence. It should be noted that victims with chronic pre-assault 
problematic substance use patterns may have been either intoxicated or sober during 
the index incident of interpersonal violence. Similar to studies investigating the effect 
of acute intoxication on PTSD, findings are mixed. Some studies have suggested the 
aversive effect of chronic pre-assault problematic substance use on the development 
and maintenance of PTSD (Kaysen et al., 2006; McFarlane et al., 2009), while others 
have failed to find any relationship (Mason, Turpin, Woods, Wardrope, & Rowlands, 
2006; Zatzick et al., 2002, 2006)  
1.4.3. The relationship between PTSD and post-assault SUDs 
In addition, many studies have been conducted to investigate the relationship 
between PTSD resulting from interpersonal violence and subsequent development of 
SUDs. These studies take into consideration victims who did not have chronic 
problematic substance use or acute intoxication prior to and/or during the assault 
incident but went on to develop SUDs afterwards. Evidence regarding the onset and 
development of SUDs after assaults has been mixed. Some studies have shown that 
neither trauma exposure nor the presence of PTSD significantly predicts the onset of 
SUDs (Breslau et al., 2003; Testa, Livingston, & Hoffman, 2007), while others 
demonstrated a greater likelihood of subsequent development of SUDs in people 
meeting criteria for PTSD (Flood, McDevitt-Murphy, Weathers, Eakin, & Benson, 
2009; Kessler et al., 2005; Ray et al., 2009; Read et al., 2012). Acierno and his 
colleagues (1999) also showed that post-assault AUDs are one of the risk factors for 
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the development of PTSD following rape, but not following physical assault. 
1.5. The purpose of current review 
In sum, the relationship between PTSD and SUDs in interpersonal violence 
appears complex and inconsistent. A number of authors have suggested models to 
account for the relationship between PTSD and SUDs (McFarlane, 1998; Steward et 
al., 1998; Stewart & Conrod, 2003), but none has recently been systematically 
reviewed in the context of interpersonal violence. The current review will primarily 
focus on the effect of acute substance intoxication and chronic pre-assault problematic 
substance use on the development of PTSD symptoms specifically amongst victims of 
sexual assault occurring in adolescence and adulthood. The focus was chosen because 
many studies and reviews have been conducted to investigate the relationship between 
PTSD and post-assault SUDs (e.g., Jacobsen et al., 2001; Norman et al., 2012; Ullman, 
Relyea, Peter-Hagene, & Vasquez, 2013), but only a limited number of studies have 
focused on the effect of acute substance intoxication and chronic pre-assault 
problematic substance use on PTSD. Therefore, this needs further exploration and 
clarification. In addition, in the extant relevant research, the sample population, the 
type of substances and the type of sexual assaults differ, which in turn may contribute 
to mixed results. It is thus important to systematically review and integrate data from 
these studies to determine if any systematic pattern of results emerges.  
The current review therefore aims to provide an overview of the role of pre-assault 
substance consumption, namely acute substance intoxication and chronic pre-assault 
problematic substance use, in the development of PTSD following sexual assault and 
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to summarise the existing evidence in order to address two questions: 
1) What are the effects of acute substance intoxication and chronic pre-assault 
problematic substance use on the development of PTSD symptoms amongst 
victims of sexual assault? 
2) Which mediators have been described in the literature that might modulate the 
effects of acute substance intoxication and chronic pre-assault problematic 
substance use on PTSD symptoms amongst victims of sexual assault? 
Several past reviews have reported the effect of acute alcohol intoxication and 
chronic pre-assault problematic alcohol use on PTSD symptoms (e.g., Langdon et al., 
2017). However, this current review will be broader and cover various types of 
substances. Studies that investigate sexual assault that co-occur with physical assault 
will also be considered. In addition, the current review will include both female and 
male victims of sexual assault. The majority of past studies and reviews have targeted 
the population of female victims only (e.g., Campbell et al., 2009; Ullman, 2003; 
Langdon et al., 2017). However, there is a growing recognition of the effects of sexual 
assault in males, and it is therefore important to address the above questions with 
regards to both genders. Acute substance intoxication and chronic pre-assault 
problematic substance use are limited in victims of childhood sexual assault. Because 
of this, only sexual assault that occurred in adolescence and adulthood is included here.  
 
2. Method 
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2.1. Search strategy  
A systematic literature search was carried out using three electronic databases 
(PsycINFO, EMBASE, and MEDLINE). Search terms related to PTSD were 
combined with terms associated with substance consumption and sexual assault (see 
Figure 1 for details of search terms). The search terms selected were intentionally 
inclusive and included multiple synonyms in order to ensure that studies considering 
a wide range of outcomes would be identified. The databases were searched for articles 
published on or before 6th September 2017. 
2.2. Inclusion criteria  
Studies meeting the following inclusion criteria were included: a) the effect of 
substance consumption was being investigated; b) the study reported sexual assault in 
adolescence and adulthood (i.e., age 14 years or older); c) the study included measures 
of PTSD symptoms; d) the study assessed acute substance intoxication and chronic 
problematic substance use prior to and during sexual assault; e) the study was 
published in a peer-reviewed journal; f) the study was published in English; and g) the 
study was published after January 2000, as Ullman’s (2003) review on the link 
between substance consumption and adult sexual assault covered most relevant studies 
prior to this date. Studies meeting these criteria were subjected to formal quality and 
relevance assessment.  
Once duplicates were removed, the database search yielded 2004 unique studies. 
Titles and abstracts of these studies were retrieved for more detailed evaluation. In the 
first round of selection, if an abstract appeared to represent a relevant article 
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considering the relationship between substance consumption and PTSD, the full article 
was read to determine if the study met the inclusion criteria (n = 262). In the second 
round, 187 of the 262 references were excluded from this review because they did not 
address the impact of substance consumption on PTSD but instead focused on other 
aspects of the relationship (e.g., treatment for PTSD and SUDs; the prevalence of co-
occurrence). Of the remaining 75 articles, 52 articles were further excluded because 
they focused on the development of SUDs as a result of childhood sexual abuse. In the 
last round, 12 articles were excluded for lack of clarity as to whether they considered 
pre- or post-assault substance consumption. As a result, 11 studies remained. Two 
additional articles within the date range were identified from Campbell, Dworkin, and 
Cabral’s (2009) review, giving a total of 13 articles meeting the inclusion criteria. 
Figure 1 illustrates the selection process for the relevant articles.  
2.3. Critical appraisal of articles  
Most researchers agree that systematic reviews should take into account the quality 
of the included studies. However, methods for critically appraising studies vary 
according to the nature and methodology of the studies (Pope, Mays, & Popay, 2007). 
There is a proliferation of checklists and protocols in the literature (Katrak, 
Bialocerkowski, Massy-Westropp, Kumar, & Grimmer, 2004; Kmet, Lee, & Cook, 
2004; Sanderson, Tatt, & Higgins, 2007), meaning that researchers must determine the 
best procedure for their particular needs.   
Many tools are available to assess the quality of intervention studies and studies 
with randomised designs (e.g., Cahill, Barkham, & Stiles, 2010; Downs & Black, 
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1998), but fewer options exist for evaluating longitudinal/cohort or cross-sectional 
studies (studies included in the current review). The Newcastle-Ottawa Scale (NOS; 
Wells et al., 2011) was developed for assessing quality of non-randomised studies for 
the purpose of systematic reviews and meta-analyses. Therefore, it was chosen as the 
most appropriate scale to adapt for this review. The NOS offers a star rating system 
modified for cohort/longitudinal and cross-sectional studies respectively specific to 
this review (see Appendix 1). Using the NOS, each study is judged on multiple items, 
categorised into three groups. Firstly, ‘selection’ items refer to the representativeness 
and selection of the study groups and the ascertainment of experimental groups. 
Secondly, ‘comparability’ items examine the comparability of the study groups on the 
basis of design and/or analysis. Thirdly, ‘outcome’ items assess the determination and 
quality of outcomes. The overall rating system of quality for the current review was 
developed based on NOS star ratings. The highest quality studies are awarded up to 10 
stars for cohort/longitudinal studies and eight stars for cross-sectional studies. Studies 
earning seven or more stars were rated as “high” in both relevance and quality, studies 
scoring five to six were rated as “medium”, and studies scoring less than five were 
rated as “low”. 
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Search term 
  
PTSD: Posttraumatic Stress Disorder or PTSD or Trauma* or Imager* or (Intrus* or emotion*) 
adj5 (memor* or thought*)  
 
Substance misuse: Drug or Substance or Alcohol or SUD or AUD or ((drug* or alcohol* or 
substance*) adj5 (us* or abuse* or misuse* or consum*) adj5 (disorder* addict*) 
 
SA: rape or (sex*) adj5 (abuse* or offen* or assault* or crime* or victim* or harass* or 
coercion*) or (interperson*) adj5 (trauma* or violen*)  
 
Databases     Number of potentially relevant articles identified 
 
PsycINFO     n = 651 
MEDLINE    n = 261 
EMBASE    n = 1092 
 
Total number of articles (without duplicates)   n = 2004 
Figure 1. Flow chart for the selection of relevant articles. 
 
Did not specifically address the relationship 
between PTSD and substance consumption 
amongst the victims of sexual assault (n = 1,742) 
Articles retrieved in full for more 
detailed evaluation (n = 262) 
Did not investigate the impact of substance 
consumption on PTSD symptoms specifically (n = 
187) 
Potentially appropriate articles 
retrieved for more detailed 
information (n = 75) Articles excluded because they did not focus 
on sexual assault in adulthood (n = 52) 
Articles excluded because they did not investigate 
pre-assault substance consumption (n = 12) 
Articles added from the review by Campbell, 
Dworkin, and Cabral (2009; n =2) 
Articles with usable 
information included in the 
systematic review (n = 13).  
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3. Result 
 
3.1. Relevant articles 
Table 1a and 1b display basic details of the 13 articles retrieved by the search 
strategy described above. Twelve of these studies included only female victims, while 
one included both females and males (Blayney et al., 2016). Eleven studies examined 
sexual assault victims, and two studies investigated victims of both sexual and physical 
assault (Kaysen et al., 2010, 2011). The samples in these studies were wide ranging in 
terms of size (n = 64 to 3,001), setting (community, college, criminal justice system, 
hospital, health and human services, and victims’ service agencies), and socio-
economic status. All studies were conducted in the United States. Six studies were 
cross-sectional; seven were longitudinal. These studies utilised (semi-)structured 
and/or diagnostic interviews, surveys and questionnaires for data collection.  
Quality and relevant ratings for the 13 articles included in this review are 
summarised in Table 2. As can be seen from the table, all studies were judged to be of 
medium to high quality. In general, the ‘comparability’ item of the appraisal tool was 
consistently scored low. 
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Table 1a 
 
Details of Longitudinal/Cohort Studies Included in the Current Review  
 
Study Year N Population Age (years) 
mean (range) 
Gender Substance 
type 
Substance 
consumption 
Assault 
type  
PTSD 
measure  
Substance 
consumption 
measure  
Data 
analysis 
method 
Blayney et al. 2016 116 College students 23.04  
(18-24) 
19% 
M; 
81% F 
Alcohol Drinking frequency; 
HED; alcohol-related 
negative 
consequences; 
alcohol intoxication 
SA*⁜ PCL-Cc 
 
R-SESc; 
DDQc; 
YAACQc 
SEM 
Peter-Hagene 
& Ullman 
2015 877 Community  34.51  
(18-69) 
F Alcohol  Alcohol intoxication SA※ PDSc MSESc Cluster 
analysis 
Kaysen et al.  2010 47 Community, 
hospitals, health 
and human 
services 
35.6  
(19–53) 
F Alcohol/ 
drug  
Alcohol/drug 
intoxication; peak 
alcohol use  
SA/PA
* 
CAPSa STIa; TLFBb HLM 
Kaysen et al.  2006 108 Criminal justice 
system, 
hospitals, 
victims’ service 
agencies 
31.48  
(18–55) 
F Alcohol   Pre-assault AUDs SA/PA
* 
CAPSa SCID-NP-
III-R-AUDb 
MANOVA 
Kaysen et al.  2011 64 Community, 
hospitals, 
victims’ service 
agencies  
35.6  
(19-53) 
F Alcohol   Pre-assault AUDs; 
peak alcohol use; 
alcohol-related 
negative 
consequences 
SA/PA
※ 
CAPSa TLFBb; 
SCID-IV-
SUDb; 
DrInC-2Rc 
HLM 
Peter-Hagene 
& Ullman 
2016 1013 Community  37.89  
(18-71) 
F Alcohol Alcohol intoxication SA※ PDSc R-SESc HLM 
Note. F = female; M = male; SA = sexual assault; PA = physical assault; PTSD = post-traumatic stress disorder; AUD = alcohol use disorders; CAPS = Clinician-Administered PTSD Scale (Blake et al., 1995); PDS = Post-traumatic Stress Diagnostic 
Scale (Foa, 1995); PCL-C = PTSD Checklist-Civilian Version (Weathers, Litz, Herman, Huska, & Keane, 1993); TLFB = Timeline Follow-Back Interview (Sobell & Sobell, 1992); SCID-IV-SUD = Structured Clinical Interview for DSM-IV, 
substance use disorder module (First, Spitzer, Gibbon, & Williams, 2001); DrInC-2R = Drinker Inventory of Consequences (Project MATCH Research Group, 1997); SCID-NP-III-R-AUD = Structured Clinical Interview for DSM-III-R Non-Patient 
Version, alcohol abuse and dependence module (Spitzer, Williams, Gibbon, & First, 1989); R-SES = revised Sexual Experiences Survey (Testa, VanZile-Tamsen, Livingston, & Koss, 2004); HED = Heavy episodic drinking; DDQ = Daily Drinking 
Questionnaire (Collins, Parks, & Marlatt, 1985); YAACQ = Young Adult Alcohol Consequences Questionnaire (Read, Kahler, Strong, & Colder, 2006); MSES = Modified Sexual Experiences Survey (Messman-Moore, Walsh, & DiLillo, 2010); STI 
= Standardised Trauma Interview (Resick, Jorden, Girelli, Hutter, & Marhoefer-Dvorak, 1988); HLM = hierarchical linear model (Raudenbush & Bryk, 2002); SEM = structural equation modeling (Kline, 1996); MANOVA = multivariate analysis of 
variance. 
a Diagnostic interview. b (Semi-)structured interview. c Surveys/questionnaires 
⁜ Assault experiences during the college years were assessed. * Most recent rape experience in adulthood and adolescence was assessed. For individuals with multiple rapes, first incident of rape was assessed. ※ The most distressing assault experience 
in adulthood and adolescence was assessed. 
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Table 1b 
 
Details of Cross-sectional Studies Included in the Current Review 
 
Study Year N Population Age (years) 
mean 
(range) 
Gender Substance 
type 
Substance 
consumption 
Assault 
type  
PTSD 
measure  
Substance 
consumption 
measure  
Data 
analysis 
method 
Zinzow et al. 2012 3001 Community  46.58  
(18-76)  
F Alcohol/drug Alcohol/drug 
intoxication 
SA* NSW-
PTSDb 
REIb; NSW-
AA/DAb 
LRA 
Littleton et al. 2009 340 College 
students  
21.6  
(18–54) 
F Alcohol/drug Alcohol/drug 
intoxication; 
pre-assault 
AUDs 
SA※ PSSc ACQc; 
AUDITc 
ANOVA; 
linear 
regression 
Zinzow, Resnick, 
McCauley et al. 
2010 2000 College 
students  
20.13  F Alcohol/drug  Alcohol/drug 
intoxication 
SA* NSW-
PTSDb 
REIb LRA 
Zinzow, Resnick, 
Amstadter et al. 
2010 3001 Community  46.58  
(18-76)  
F Alcohol/drug Alcohol/drug 
intoxication 
SA* NSW-
PTSDb 
REIb LRA 
Jaffe et al. 2017 143 Community  22.00  
(18–26) 
F Alcohol  Alcohol/drug 
intoxication; 
level of 
intoxication 
SA※ PCL-Cc MSESc NBHM; 
multivariate 
models 
Brown et al. 
(Study 1) 
2009 265 College 
students 
19  
(18-22) 
F Alcohol/drug  Alcohol/drug 
intoxication 
SA※ PSSc MSESc MANOVA 
Brown et al. 
(Study 2) 
2009 244 Community  24  
(18-30) 
F Alcohol/drug Alcohol/drug 
intoxication 
SA* NSW-
PTSDc 
MSESc MANOVA 
Masters et al. 2015 667 Community  24.78  
(21-30)  
F Alcohol/drug Alcohol/drug 
intoxication; 
HED 
SA† TSIc R-SESc; HED 
questionnairec 
LCA 
Note. F = female; SA, sexual assault; PA = physical assault; PTSD = post-traumatic stress disorder; AUD = alcohol use disorders; TSI = Trauma Symptom Inventory (Briere, 1995); NSW-PTSD = National Women’s Study PTSD module (Acierno et 
al., 1999; Ruggiero et al., 2004); PSS = PTSD Symptom Scale (Foa, Riggs, Dancu, & Rothbaum, 1993); NSW-AA/DA = National Women’s Study alcohol/drug abuse module (Kilpatrick et al.; 2000; Kilpatrick et al., 1997); PCL-C = PTSD 
Checklist-Civilian Version (Weathers et al., 1993); REI = rape experience interview; TLFB, Timeline Follow-Back Interview (Sobell & Sobell, 1992); R-SES = revised Sexual Experiences Survey (Testa et al., 2004); HED = Heavy episodic drinking; 
MSES = Modified Sexual Experiences Survey (Messman-Moore et al., 2010); ACQ = Assault Characteristics Questionnaire (Littleton, Axsom, Radecki, Breitkopt, & Berenson, 2006); AUDIT = Alcohol Use Disorder Identification Test (Babor, 
Higgins-Biddle, Saunders, & Monteiro, 1992; Miles, Winstock, & Strang, 2001); NBHM = negative binomial hurdle model (Hilbe, 2011); LRA = logistic regression analyses; MANOVA, multivariate analysis of variance; ANOVA = univariate 
analyses of variance; LCA, latent class analyses (Collins & Lanza, 2010) 
a Diagnostic interview. b (Semi-)structured interview. c Surveys/questionnaires 
* Most recent rape experience in adulthood and adolescence was assessed. For individuals with multiple rapes, first incident of rape was assessed. ※ The most distressing assault experience in adulthood and adolescence was assessed. † Assault 
experiences in adolescence and adulthood (i.e., at age 14 years or older) were assessed. 
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Table 2 
 
Quality and Relevance Ratings  
 
Study Year Selection  Comparability  Outcome Overall rating  
Longitudinal/cohort studies 
 
  
    
   Blayney et al. 2016 *** * ** Medium 
   Peter-Hagene & Ullman 2015 *** * ** Medium 
   Kaysen et al. 2010 **** ** *** High 
   Kaysen et al. 2006 *** ** * Medium 
   Kaysen et al. 2011 *** * *** High 
   Peter-Hagene & Ullman 2016 *** * * Medium 
 
Cross-sectional studies 
 
     
   Zinzow et al. 2012 **** ** ** High 
   Littleton et al. 2009 ** ** ** Medium 
   Zinzow, Resnick, McCauley et al. 2010 **** * ** High 
   Zinzow, Resnick, Amstadter et al. 2010 **** * ** High 
   Brown et al. (Study 1) 2009 *** * * Medium 
   Brown et al. (Study 2) 2009 *** * ** Medium 
   Masters et al. 2015 **** ** ** High 
   Jaffe et al. 2017 *** * ** Medium 
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3.2. Synthesis of articles 
In the literature on pre-assault substance consumption, an important distinction is 
commonly made between acute substance intoxication and chronic pre-assault 
problematic substance use. In the current review, the presentation of the studies is 
therefore structured according to this distinction. Overall, 13 studies reported the 
effects of pre-assault substance consumption on PTSD symptoms amongst victims of 
sexual assault. Two studies assessed the effects of chronic pre-assault problematic 
substance use on PTSD (Kaysen et al., 2006, 2011), while 11 studies investigated the 
effects of acute substance intoxication on the development of PTSD amongst victims 
of sexual assault.  
Specifically, studies examining the effects of acute substance intoxication varied 
in their designs: four studies investigated PTSD symptoms in assault victims with and 
without acute substance intoxication (Kaysen et al., 2010; Peter-Hagene & Ullman, 
2016; Blayney et al., 2016; Jaffe et al., 2017); five studies categorised sexual assault 
experiences into types and compared their unique effects on PTSD symptoms (Brown 
et al., 2009; Littleton et al., 2009; Zinzow et al., 2012, Zinzow, Resnick, Amstadter et 
al., 2010; Zinzow, Resnick, McCauley et al., 2010); two studies used a person-centred 
approach to identify subgroups of victims based on reported sexual assault 
characteristics and compare these subgroups with one another to investigate effects on 
PTSD symptoms (Masters et al., 2015; Peter-Hagene & Ullman, 2015). The 
presentation of these 11 studies is thus structured according to their designs. Due to 
the advantages of longitudinal over cross-sectional studies in more effectively 
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examining the effect of pre-assault substance consumption on the development, 
especially the course, of PTSD symptoms, longitudinal studies are given more weight 
and hence are presented in advance of cross-sectional studies in the review. More 
emphasis is placed on studies with higher quality and relevance ratings which are 
presented in advance of studies with lower ratings. 
Of these 13 studies, in addition, three studies investigated factors mediating the 
effect of acute substance intoxication on PTSD (Blayney et al., 2016; Peter-Hagene & 
Ullman, 2015, 2016). All three studies are longitudinal, with medium quality and 
relevance ratings. They examined acute alcohol intoxication and identified two 
mediators: self-blame and social reactions, which will be subsequently elaborated in 
this review. 
3.2.1. The effects of acute substance intoxication on PTSD  
Four studies examined PTSD symptoms in assault victims with and without acute 
substance intoxication. Kaysen et al. (2010) is a longitudinal study which, out of the 
13 studies reviewed, has the highest quality and relevance rating. This study compared 
PTSD symptoms in victims of sexual or physical assault who were intoxicated as a 
result of alcohol and/or drug consumption shortly before the assault with victims who 
were unintoxicated. The PTSD symptoms were assessed at three timepoints: 2-5 weeks 
post-assault, 3 months post-assault, and 6 months post-assault. After controlling for 
victims’ perceived threat of the assault (i.e., subjective appraisal of risk and certainty 
of harm) and maximum number of drinks the victim consumed in the month prior to 
the first assessment, they found that assault victims who were unintoxicated had 
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significantly more initial intrusive symptoms at 2-5 weeks post-assault than did 
victims who were intoxicated. Over time, however, the unintoxicated assault victims 
had a significantly steeper drop-off in intrusive symptoms, suggesting a quicker 
recovery and shorter course of PTSD symptoms following the assault. There were no 
significant differences between unintoxicated and intoxicated assault victims in other 
PTSD symptoms such as avoidance and hyperarousal. This study did not differentiate 
between victims of physical and sexual assault in their PTSD symptoms.  
Similarly, Peter-Hagene and Ullman (2016) examined PTSD symptoms 
longitudinally in victims of sexual assault who had and had not consumed alcohol 
shortly before the assault. Participants were assessed annually over the course of three 
years. Overall, PTSD symptoms declined over time in both groups, indicating recovery 
from the assault. The intoxicated group had fewer and less intense PTSD symptoms 
initially, and there was no significant interaction effect between alcohol intoxication 
and time, suggesting that the differences in PTSD symptoms between intoxicated and 
unintoxicated victims did not diminish over time. Therefore, the intoxicated group 
seemed to continue to display fewer PTSD symptoms over time.  
Blayney et al. (2016) examined both cumulative and most recent sexual assault 
experiences during the college years. Cumulative sexual assault refers to the number 
of times an individual was exposed to sexual assault since starting college. Participants 
reported their sexual assault experiences, levels of acute alcohol intoxication, baseline 
PTSD symptoms and baseline drinking behaviours (i.e., drinking frequency, number 
of binge drinking and alcohol-related negative consequences for the 30 days prior to 
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the assessment) at the end of their 5th post-matriculation year. After 5 months, at the 
beginning of the 6th post-matriculation year, they were subsequently assessed on 
sexual assault revictimisation, PTSD symptoms and drinking behaviours. In 
examining cumulative experiences of sexual assault, a proportion score (number of 
assaults during intoxication out of total number of assaults) was calculated to reflect 
the extent to which alcohol intoxication was potentially implicated in the assault (i.e., 
the levels of acute alcohol intoxication). In examining the most recent experience of 
sexual assault, the number of drinks and subjective rating of intoxication at the time 
of assault were recorded to represent the levels of acute alcohol intoxication. In terms 
of both cumulative and most recent experiences of sexual assault, the findings 
suggested that greater levels of acute alcohol intoxication predicted more problematic 
post-assault drinking behaviours, but not PTSD symptoms. However, after controlling 
for participants’ baseline drinking behaviours and baseline PTSD symptoms, the 
relationship between acute alcohol intoxication and post-assault drinking behaviours 
was no longer significant.  
Jaffe et al. (2017) assessed the role of acute alcohol intoxication in relation to use 
and non-use of alcohol shortly before sexual assault, as well as in relation to the level 
of acute alcohol intoxication at the time of the assault. This cross-sectional study 
showed that intoxication at the time of the assault was associated with a greater 
probability of reporting any PTSD symptoms even after controlling for the severity of 
coercion during the assault. Unlike Blayney et al. (2016), they found a dose-dependent 
U-shaped effect of acute alcohol intoxication on PTSD symptoms. Specifically, 
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participants were asked to indicate their level of intoxication at the time of the assault: 
0 (not at all intoxicated), 1(a little), 2 (somewhat), 3 (quite), and 4 (very intoxicated). 
Results showed that when controlling for coercion severity, participants who reported 
an intoxication score of 4 had significantly greater PTSD symptoms than participants 
who reported a lower score. In addition, there was a trend that predicted PTSD severity 
was lower at scores of 1, 2 and 3 when compared to score 0, but these differences were 
not significant. Overall, this study suggested that greater levels of intoxication were 
associated with more severe PTSD symptoms, whereas low-to-moderate levels of 
intoxication were associated with less severe PTSD symptoms when compared to no 
intoxication. This dose-dependent effect of acute alcohol intoxication on PTSD was 
particularly strong for re-experiencing symptoms. 
Five cross-sectional studies categorised sexual assault experiences into types and 
compared their unique effects on PTSD symptoms. Zinzow et al. (2012) categorised 
sexual assault experiences into three different types: a) forcible rape in which the 
perpetrator used force or threat of force; b) drug-or-alcohol-facilitated/incapacitated 
rape in which victims were intoxicated and incapacitated via voluntary or involuntary 
consumption of drugs and/or alcohol during an adulthood sexual assault incident; c) 
‘combined type’ rape which is defined as sexual assault experiences in which both 
force and incapacitation were used in the same incident. PTSD outcomes of victims of 
forcible, drug-or-alcohol-facilitated/incapacitated and ‘combined type’ rape were thus 
compared with those of nonvictims who had no history of sexual assault. All types of 
sexual assault experiences were significantly related to the development of PTSD, with 
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the ‘combined type’ rape exhibiting the highest risk, followed by forcible rape and 
drug-or-alcohol-facilitated/incapacitated rape. Specifically, victims reporting 
‘combined type’ assaults were found to have over four times the likelihood of 
developing PTSD compared to nonvictims. Victims reporting drug-or-alcohol-
facilitated/incapacitated rape or forcible rape were more than two times as likely to 
develop PTSD as nonvictims.  
In the studies by Zinzow, Resnick, Amstadter, et al. (2010) and Zinzow, Resnick, 
McCauley, et al. (2010), however, sexual assault experiences were categorised 
differently: a) forcible rape in which the perpetrator used force or threat of force; b) 
incapacitated rape in which the victim was intoxicated or impaired via voluntary intake 
of drugs or alcohol; and c) drug- or alcohol-facilitated rape if the perpetrator 
deliberately attempted to produce incapacitation by administering drugs or alcohol to 
the victim. Both studies showed that forcible rape was associated with the highest risk 
of PTSD in comparison to incapacitated and drug- or alcohol-facilitated rape. 
Specifically, in Zinzow, Resnick, Amstadter, et al.’s (2010) study, victims of various 
types of sexual assault experiences were compared with nonvictims without any 
history of sexual assault. The findings revealed that women who reported forcible rape 
were over 3 times as likely as nonvictims to meet lifetime criteria for PTSD, even after 
controlling for other rape experiences and revictimisation history. Victims who 
reported drug- or alcohol-facilitated rape were almost twice as likely as nonvictims to 
meet criteria for PTSD. Victims who reported incapacitated rape, however, did not 
differ from nonvictims in terms of displaying PTSD symptoms. In addition, a statistical 
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comparison of odds ratios showed that the risk of PTSD was significantly higher for 
victims reporting forcible rape in comparison to victims reporting incapacitated rape. 
The odds ratio for victims reporting drug- or alcohol-facilitated rape did not differ from 
those reporting forcible or incapacitated rape.  
Despite these findings, Zinzow, Resnick, McCauley, et al. (2010) indicated that 
all three types of sexual assault were positively associated with PTSD. Comparisons 
were made amongst victims of sexual assault. Specifically, victims reporting a history 
of forcible rape were 4 times as likely to meet criteria for PTSD as victims without a 
history of forcible rape. Victims reporting drug- or alcohol-facilitated rape were 
associated with more than three times the likelihood of meeting PTSD criteria in 
comparison to victims without such a history. Lastly, victims reporting incapacitated 
rape were approximately two times as likely to develop PTSD as victims who had not 
experienced incapacitated rape.  
Taking a slightly different approach, Brown et al. (2009) compared forcible rape 
with incapacitated rape and with verbally coerced sexual assault experiences. Verbal 
coercion was defined as victims responding to unwanted sexual experiences because 
they were “overwhelmed by someone’s continual arguments and pressure” or because 
someone used a position of authority to coerce them. They defined incapacitated rape 
differently from the studies cited above as victims reporting that they had unwanted 
sex because they were “incapable of giving consent or resisting due to alcohol or 
drugs”. Two studies were reported in the Brown et al. (2009) article. Study 1 assessed 
the most severe unwanted sexual assault experiences in a college sample and found all 
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three groups differed significantly from one another on PTSD symptom scores. 
Consistent with the prior studies, forcible rape victims reported the highest number of 
PTSD symptoms, followed by incapacitated rape and verbal coercion victims, after 
controlling for the number of unwanted sexual assault experiences. Study 2 
investigated the most recent experiences of a more diverse community sample. Victims 
who reported experiencing multiple methods of coercion were categorised according 
to the most coercive method (e.g., victims experiencing both verbal coercion and force 
were classified as forcible rape victims). Findings showed that victims of verbal 
coercion had significantly fewer PTSD symptoms than did forcible rape victims. 
Incapacitated rape victims reported an intermediate number of PTSD symptoms that 
was not significantly different from that of either of the other groups.  
Littleton et al. (2009) investigated sexual assault experiences of impaired, 
incapacitated and nonimpaired victims. To be classified as impaired or incapacitated, 
victims needed to report impairment due at least in part to substance use. Victims who 
recounted being unconscious during the assault were classified as incapacitated, while 
those reporting less severe forms of impairment (e.g., asleep, having trouble walking) 
were classified as impaired. To be classified as nonimpaired, victims had to have 
experienced sexual assault that was not preceded by any type of impairment or 
incapacitation. No significant difference in PTSD symptoms was found amongst these 
groups. It should be noted that the lack of significant difference in this study may be 
related to its methodological weaknesses (rated as medium in quality and relevance 
rating) and relatively smaller sample size than other studies with the similar design.  
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In addition, two studies used a person-centred approach to identify subgroups of 
victims based on reported sexual assault characteristics. These subgroups were 
subsequently compared with one another to investigate effects on PTSD symptoms. 
Peter-Hagene and Ullman (2015) is a longitudinal study that used cluster analysis to 
create composite variables that encompassed both alcohol and violence information. 
They also included assault characteristics identified by previous research to be most 
relevant to (poor) recovery from PTSD, including victim and perpetrator’s use of 
alcohol, highest levels of violence and severity, victims’ perceived life threat and 
peritraumatic distress, and perpetrator identity. Three significantly different categories 
of sexual assault emerged from the data: a) alcohol-related assaults (cluster 
encompassing alcohol-related assault and moderate levels of violence, fear and 
distress); b) high-violence assaults (cluster with the most violent experiences and 
severe assaults); and c) moderate sexual-severity assaults (cluster containing the 
lowest levels of sexual assault severity and physical violence). Peter-Hagene and 
Ullman (2015) subsequently used these resultant clusters to predict a range of post-
assault outcomes, including PTSD symptoms. These outcomes were assessed at a one-
year interval, and findings indicated a significant difference amongst three clusters in 
post-assault PTSD symptoms. Alcohol-related assault victims experienced lower 
PTSD symptoms than high-violence assault victims but more severe symptoms than 
moderate-severity assault victims. However, the difference between high-violence and 
alcohol-related assault victims in PTSD symptoms decreased over time, resulting in 
no significant difference one year later. 
47 
Masters et al. (2015), on the other hand, is a cross-sectional study that used latent 
class analyses (LCA) to identify subgroups of sexual assault victims based on multiple 
characteristics of their assault experiences. The subgroup structure was subsequently 
validated in a second cohort recruited in an identical manner to the first cohort. They 
identified three substantially different subgroups: a) contact or attempted assault 
(victims of contact sexual assault or attempted rape, with no act of victimisation by 
penetration); b) incapacitated assault (victims of rape reporting prior incapacitation by 
a substance); and c) forceful severe assault (victims of completed rape who were not 
incapacitated reporting force as the predominant characteristic of the assault). The 
results indicated that in terms of post-assault psychological distress, women in the 
forceful severe assault subgroup, compared with the other two subgroups, had 
significantly higher levels of symptoms of various mental health issues, including 
PTSD symptoms (e.g., intrusive thoughts and defensive avoidance) over the past six 
months. Moreover, victims in this group also reported more episodes of binge drinking 
in the past year than did victims in the incapacitated group.  
3.2.2. The effects of chronic pre-assault problematic substance use on PTSD  
Kaysen et al. (2011) examined longitudinally the effects of AUDs, self-reported 
maximum number of drinks and alcohol-related negative consequences for 30 days 
prior to the assault on different clusters of PTSD symptoms respectively. The victims 
of sexual or physical assault were assessed within 5 weeks of the assault as well as 3 
months and 6 months post-assault. Alcohol-related negative consequences were 
divided into two variables: a) severity of baseline drinking consequences experienced 
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during the 30 days prior to the assault; and b) changes in consequences from baseline 
to 3 months and from baseline to 6 months. Findings suggested that AUDs and alcohol-
related negative consequences (e.g., hangover, loss of interest due to drinking) were 
associated with significantly lower reports of PTSD symptoms immediately post-
trauma exposure, even after controlling for demographics, trauma and psychological 
variables. There was no significant decrease in PTSD symptoms over time amongst 
victims with AUDs. Likewise, changes in alcohol-related negative consequences over 
time did not significantly interact with changes in PTSD symptoms. For those 
reporting high levels of alcohol-related negative consequences during the 30 days pre-
assault, their PTSD symptoms did not decrease significantly over time. It was also 
shown that no individual cluster of PTSD symptoms accounted for this association, 
and the association of PTSD symptoms with maximum number of drinks was not 
significant. Similar to the previous study, this study did not differentiate between 
victims of physical and sexual assault in their PTSD symptoms. 
In addition, Kaysen et al. (2006) assessed victims’ PTSD symptoms 2-4 weeks 
and 3 months after the experience of sexual or physical assault longitudinally. They 
reported that victims with pre-assault AUDs showed significantly worse intrusion and 
avoidance symptoms of PTSD, but not hyperarousal symptoms, than those without 
pre-assault AUDs. They also found that victims who had pre-assault AUDs continued 
to have higher PTSD symptoms over time than victims without such histories, thus 
experiencing less symptom improvement over time. This interactive effect between 
pre-assault AUDs and time was only significant for hyperarousal symptoms, not for 
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avoidance or intrusion symptoms, suggesting that only hyperarousal symptoms 
improved over time in victims with pre-assault AUDs. This study did not differentiate 
between victims of physical and sexual assault in their PTSD symptoms.  
3.2.3. Mediators of the relationship between acute alcohol intoxication and PTSD: 
Self-blame 
Three longitudinal studies examined the mediating role of post-assault self-blame 
in the relationship between acute alcohol intoxication and PTSD symptoms. Peter-
Hagene and Ullman (2015) measured self-blame using the Self-Blame Attribution 
Questionnaire (Frazier, 2003), which is composed of two 5-item subscales assessing 
both characterological and behavioural self-blame. Characterological self-blame 
attributions are dispositional beliefs about one’s own character, reflecting beliefs that 
the assault was a result of who the victim was as a person or that the assault was 
deserved. Behavioural self-blame attributions, on the other hand, are situational, 
specific beliefs about one’s actions (e.g., drinking) before the assault. This study 
showed that although assault characteristics predicted both behavioural and 
characterological self-blame, high-violence and alcohol-related assault types were 
related to increased PTSD via characterological self-blame as a mediator. Overall, 
characterological self-blame was positively related to PTSD, and its indirect effect on 
the difference in PTSD symptoms between alcohol-related and moderate-severity 
types was significant.  
In a similar vein, Peter-Hagene and Ullman (2016) found that victims who were 
intoxicated as a result of pre-assault drinking tended to report more behavioural and 
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characterological self-blame than those who were not. Although the effect of drinking 
on characterological self-blame was less strong than its effect on behavioural self-
blame, it was more consistent over time and was maintained over time. The effect of 
behavioural self-blame, however, has been demonstrated to diminish over time. 
Although the total effect of acute alcohol intoxication on PTSD was negative (i.e., 
acute alcohol intoxication was associated with fewer PTSD symptoms), the overall 
findings suggested a positive indirect effect of acute alcohol intoxication on PTSD via 
characterological self-blame, but not behavioural self-blame (i.e., intoxicated victims 
with characterological self-blame reported increased PTSD symptoms).  
In contrast, Blayney et al. (2016) reported inconsistent findings. They examined 
post-assault cognitions on three scales: a) self; b) world; and c) self-blame. The “self” 
scale includes cognitions about one’s character, such as “I am inadequate” and “I have 
permanently changed for the worse”. The “world” scale represents beliefs about the 
external world, such as “I can’t rely on others” and “I have to be on guard at all times”. 
The “self-blame” scale includes beliefs that one is responsible for the assault, for 
example, “the event happened because of the way that I acted”. All three scales were 
tested as potential mediators for the association between acute alcohol intoxication and 
PTSD symptoms in relation to both cumulative sexual assault experiences since the 
start of college and the most recent experience during the college years. Results 
indicated a lack of significant indirect effect of these cognitions on the relationship 
between acute alcohol intoxication at the time of the assault and PTSD symptoms.  
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3.2.4. Mediators of the relationship between acute alcohol intoxication and PTSD: 
Social reactions 
One longitudinal study examined the mediating role of post-assault social reactions. 
Peter-Hagene and Ullman (2015) used the Social Reaction Questionnaire (SRQ: 
Ullman, 2000) to measure how often victims received positive and/or negative social 
reactions since the assault on a rating scale ranging from 0 (never) to 4 (always). This 
questionnaire further separated negative social reactions into acknowledgement-
without-support social reactions (i.e., acknowledging the assault happened, but failing 
to give adequate support; misplaced efforts to control the victim’s decisions) and 
turning-against social reactions (i.e., blaming the victim, not believing her story) based 
on confirmatory factor analyses (Relyea & Ullman, 2015). The findings indicated that 
high-violence and alcohol-related assault types were related to increased PTSD via 
turning-against social reactions specifically. Namely, turning-against social reactions 
mediated the difference in PTSD symptoms between high-violence and alcohol-related 
versus moderate-sexual-severity assaults.  
 
4. Discussion 
 
4.1. Summary 
The purpose of this review was to provide an overview of the effects of acute 
substance intoxication and chronic pre-assault problematic substance use on the 
development of PTSD symptoms in the context of sexual assault. In total, seven studies 
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showed initial lower levels of PTSD symptoms in intoxicated victims compared to 
unintoxicated victims (Kaysen et al., 2010; Masters et al., 2015; Peter-Hagene & 
Ullman, 2015, 2016; Zinzow et al., 2012; Zinzow, Resnick, Amstadter, et al., 2010; 
Zinzow, Resnick, McCauley, et al., 2010). Two of these studies further showed a more 
chronic course of PTSD symptoms with less improvement over time in intoxicated 
victims than unintoxicated ones (Kaysen et al., 2010; Peter-Hagene & Ullman, 2015). 
One study indicated a dose-dependent effect of acute substance intoxication, showing 
its positive association with PTSD severity only at high levels of intoxication (Jaffe et 
al., 2017). All of these studies showed that the effects of acute substance intoxication 
were particularly strong for re-experiencing PTSD symptoms such as intrusive 
memories. Three studies found no evidence of effects of acute substance intoxication 
on PTSD (Blayney et al., 2016; Brown et al., 2016; Littleton et al., 2009).  
In addition, two studies showed a more chronic course of PTSD in victims with 
chronic pre-assault problematic substance use, such as pre-assault AUDs, one of which 
showed initial lower levels of PTSD symptoms (Kaysen et al., 2016), whereas the other 
showed initial higher levels (Kaysen et al., 2011). Two studies identified 
characterological self-blame as a significant mediator of the effect of acute substance 
intoxication on PTSD (Peter-Hagene & Ullman, 2015, 2016), and one of them also 
suggested negative post-assault social reactions as a significant mediator (Peter-
Hagene & Ullman; 2015). One study, however, failed to find any mediator (Blayney 
et al., 2016).   
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4.2. Interpretation of findings  
Based on the results from the current review, it appears that overall acute substance 
intoxication is associated with initially decreased PTSD symptoms but a more chronic 
course of residual symptoms. The initial lower level of PTSD symptoms may be 
because acute substance administration can dampen stress responses and impair 
acquisition of fear memories (Faingold, N’Gouemo, & Riaz, 1998; Nomura & Matsuki, 
2008), which may in turn result in lower perceived severity of the assault and less 
posttraumatic distress (Abbey, Clinton-Sherrod, McAuslan, Zawacki, & Buck, 2003). 
However, in more severe sexual assaults, psychoactive drugs are unlikely to have an 
appreciable stress dampening effect (Brown et al., 2009; Kahn, Jackson, Kully, Badger, 
& Halvorsen, 2003; Layman, Gidycz, & Lynn, 1996; Peter-Hagene & Ullman, 2015). 
Therefore, it is unsurprising that higher levels of PTSD symptoms were found in 
forcible sexual assaults compared to substance-involved sexual assaults. 
In addition, the effects on PTSD symptoms may be attributed to the impact of 
acute substance intoxication on memory and extinction learning. For instance, research 
suggested that alcohol may elicit retrograde facilitation and anterograde impairment 
for emotional materials, such that it may facilitate memory for the events occurring 
prior to but impair memory for the events after its administration, which in this case is 
the memory for the incident of sexual assault. Therefore, information about sexual 
assault might not be well-recalled after alcohol consumption, resulting in less 
psychological distress and an initial decrease in PTSD symptoms (Knowles & Duka, 
2004). Furthermore, both human and animal studies showed that extinction learning 
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under alcohol is slower, weaker and less context-specific, possibly resulting in 
persistent distress and fear following sexual assault during alcohol intoxication (Bisby 
et al., 2015; Lattal, 2007; Normura & Matsuki, 2008). Therefore, alcohol may be 
associated with reduced extinction of the learned associations over time (Stephens et 
al., 2005), resulting in greater chronicity of PTSD symptoms. However, it should be 
noted that it is unclear whether effects seen with alcohol can generalise to other drugs, 
such as cannabis, benzodiazepines or GHB, that have similar amnestic effects (the 
latter two are commonly used in the case of “date rape”; Elsohly, Lee, Holzhauer, & 
Salamone, 2001). 
However, the particularly strong effect of acute substance intoxication on re-
experiencing and intrusive memories, cardinal symptoms of PTSD, may be explained 
by the dual representation theory (DRT; Brewin, Dalgleish, & Joseph, 1996; Brewin, 
Gregory, Lipton, & Burgess, 2010). According to DRT, memory for an event is 
supported by contextual and sensation-based memory systems. Contextual memory 
representations (C-reps) are the basis for narrative memory, can be voluntarily 
retrieved, and are contextually bound. Sensory memory representations (S-reps) 
include low-level, sensation-based information pertaining to sensory and affective 
experiences. Typical memory encoding involves interconnected and equally salient C-
reps and S-reps, whereas pathological encoding may occur during traumatic events, 
resulting in salient and enduring S-reps that are disconnected from corresponding C-
reps without contextualising sensory memories (Brewin et al., 2010). As a result, the 
reactivation of S-reps (e.g., through reminders) can trigger perceptual re-experiencing 
55 
of the event without information regarding the encoding context (e.g., intrusive 
memories and flashbacks). Research has found that substance intoxication, such as in 
the case of alcohol, may selectively impair contextual memories (Söderlund, Parker, 
Schwartz, & Tulving, 2005), so that intoxication at the time of sexual assault may 
intensify re-experiencing and intrusion symptoms by further increasing the 
disconnection between C-reps and S-reps. In turn, more frequent intrusive memories 
and re-experiencing symptoms may foster a sense that the world is unsafe, potentially 
increasing hyperarousal or avoidance symptoms (Jaffe et al., 2017), further hindering 
recovery (Brewin et al., 2010).  
In addition, research evidence suggests that substances, such as alcohol and 
benzodiazepine (Manconi et al., 2017; Roehrs & Roth, 2001), can lead to disturbances 
in rapid eye moment (REM) sleep, which, in turn, can suppress memory consolidation 
via dreaming and result in a long-term impact on PTSD symptoms (Mellman, 
Bustamante, Fins, Pigeon, & Nolan, 2002). Insufficient memory consolidation may 
lead the traumatic memory trace to stay primarily located in subcortical and primary 
perceptual areas (S-reps), leaving it tightly coupled to its autonomic and perceptual 
markers, without appropriately integrating in autobiographical, cortical memory 
networks (C-reps). Exposure to a trauma trigger subsequently results in the involuntary 
retrieval of traumatic memory that is not contextualised and that is fragmented in time 
(i.e., intrusive memories), consisting of primary sensory information (images, smell, 
sounds) that is linked to physiological fear symptoms (Brewin, 2011; van Marle, 2015).  
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The U-shape dose-dependent effect of acute alcohol intoxication shown in Jaffe 
et al.’s (2017) study might be related to the effect of amnesia resulting from high levels 
of acute intoxication. A number of research studies show that the consumption of high-
level amnesic substances can sometimes result in amnesia for trauma, especially in 
some cases of involuntary intoxication. Due to the lack of recall of the traumatic 
experience, victims with amnesia tend to wonder about what has happened and 
imagine the worst-case scenario, which, in turn, can lead to negative interpretations of 
the assault and hence various anxiety and PTSD symptoms, including fear, avoidance, 
nightmares and intrusive thoughts (McNeil, 1996; Mechanic, Resick, & Griffin, 1998). 
In addition, despite alcohol-related memory impairment at high levels of intoxication, 
victims are likely to retain memory from before and after the trauma (Ehlers et al., 
2002) that also contributed to the development of intrusive memories. However, Jaffe 
et al.’s findings differs from those of Bisby and his colleagues (2009). They conducted 
experimental studies examining the effects of acute alcohol intoxication on intrusive 
memories following trauma video scenarios relating to road traffic accidents rather 
than interpersonal violence. They found an inverted U-shape effect of alcohol on 
intrusive memories, with a low dose increasing memory intrusions and a high dose 
decreasing intrusive symptoms. Differences in study methodology and sample likely 
contributed to these differing results. For instance, it is likely that the levels of 
intoxication achieved in the controlled laboratory environment are lower than those 
that would be experienced personally in a real-world setting.  
The reviewed studies assessing mediating factors showed that characterological, 
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but not behavioural, self-blame, mediated the effects of acute substance intoxication, 
contributing to the chronic course of PTSD symptoms over time. Previous studies have 
reported similar findings that characterological self-blame is related to poorer recovery 
outcomes (Frazier, 2003; Koss, Figueredo, & Prince, 2002; Ullman, Filipas, Townsend, 
& Starzynski, 2007). Blame that is related to one’s behaviour (e.g., drinking or taking 
drugs) might not have the same degree of detrimental effect on recovery as blame that 
is generalised to one’s character (e.g., “I am a bad person”; “it’s my fault”), which is 
more inherent and less modifiable (Macy, Nurius, & Norris, 2007). Although the use 
of substances is a specific behaviour, its links to characterological self-blame might be 
driven by strong societal stereotypes about the use of alcohol and drugs, especially 
among women who tend to be viewed as more sexual, “loose,” or “bad”, and deserving 
punishment (George, Cue, Lopez, Crowe, & Norris, 1995; Norris & Cubbins, 1992). 
As a result, individuals tend to blame themselves for the assault and identify with these 
societal stereotypes if they had been drinking or taking drugs, resulting in 
characterological self-blame, which is more strongly related to PTSD over time. 
Post-assault social reactions also play a role in the chronicity of PTSD symptoms. 
Sexual assault victims with acute substance intoxication tended to experience more 
blame and disbelief from others and hence receive more negative social support than 
victims without intoxication (Ullman & Filipas, 2001; Ullman & Najdowski, 2011). 
There is ample evidence that negative social reactions contribute to PTSD symptoms 
(Littleton, 2010; Ullman et al., 2007), although positive social support does not appear 
to protect against PTSD (Elklit & Christiansen, 2013; Littleton, 2010; Peter-Hagene & 
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Ullman, 2014; Ullman & Peter-Hagene, 2016). In addition, due to the aversive social 
responses, these victims are less likely to seek help or talk about the assault with others, 
leading to more maladaptive individual and social coping strategies, such as avoidance, 
denial and social withdrawal. This, in turn, hinders the recovery of PTSD symptoms 
(Relyea & Ullman, 2015). 
Due to the limited number of studies and inconsistent findings (Kaysen et al., 2016; 
Kaysen et al., 2011), it is difficult to draw any conclusion regarding the effects of 
chronic pre-assault problematic substance use on PTSD symptoms. The inconsistent 
findings may be attributed to the different sample sizes (both relatively small) and the 
course and onset of pre-assault substance problems. The time for the follow-up PTSD 
assessments also varies between studies, and PTSD symptoms were examined either 
in clusters or as a whole, which may lead to differential outcomes. In addition, two 
studies examining the effects of chronic pre-assault problematic substance use 
included both physical and sexual assault victims, so the outcomes may not be 
generalisable to studies with sexual assault victims only. Lastly, these two studies both 
investigated AUDs, possibly leading to different results from the effects of other drugs.  
4.3. Limitations  
The limitations of this review should be kept in mind when considering the 
findings. Although the review was designed to include both male and female sexual 
assault victims, there was only one study comprising both genders (with only 19% 
male college victims in a total sample of 116; Blayney et al., 2016). Previous research 
suggested gender differences in that women appear more vulnerable to alcohol-related 
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consequences at lower levels of alcohol exposure than men (Nolen-Hoeksema, 2004). 
In general, women tend to have more fatty tissue than men as a percentage of their 
body weight. Fat is inversely related to body water. As alcohol is more soluble in water 
than in fat, it is distributed throughout a lower water volume, resulting in less alcohol 
dilution in women. In addition, women usually have lower gastric dehydrogenase 
activity in the stomach to metabolise alcohol, so that after an equivalent dose of alcohol, 
women have higher blood ethanol levels than men and hence greater vulnerability to 
the consequences of drinking alcohol (Jones & Jones, 1976; Lieber, 1997). Therefore, 
the findings in this current review, which mostly consisted of female victims, may not 
be generalisable to male victims.  
In addition, most reviewed studies reported the impact of pre-assault alcohol 
consumption, whereas there was little extant information on the impact of other types 
of substances, limiting the generalisability of these findings. Research also highlighted 
that the vast majority of victims who use drugs also consume alcohol (Wood & Sher, 
2002), so the co-occurrence may bring challenges in separating the outcomes. In 
addition, the reviewed studies did not report the type of drugs involved in the assault. 
Research studies show that stimulant drugs (e.g., nicotine, cocaine, methamphetamine) 
and depressant drugs (e.g., heroin, GHB, benzodiazepine) affect the body and brain 
functions differently (e.g., Hindmarch, 2004; Meyer & Quenzer, 2013) and may result 
in different effects on the development of PTSD symptoms.  
The inclusion of diverse designs (cross-sectional and longitudinal) might be 
considered a limitation of the current review. However, this was necessary to obtain a 
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comprehensive understanding of the impact of pre-assault substance consumption on 
PTSD. Although the quality of studies was gauged, the author was the sole evaluator, 
which may have introduced bias.  
This review included community and college samples and samples from specific 
agencies with mostly large samples over multiple time points. Despite this breadth, 
there remained some variation in methodological strengths across the reviewed studies. 
Methodologically weaker studies, including those with lower quality and relevance 
ratings, smaller sample sizes and shorter follow-up periods, should be given less 
weight in this review. 
Similarly, there were variations in the use of different measures for assessing 
PTSD symptoms and sexual assault experiences, resulting in a lack of consistency in 
variable definitions. In addition, some studies took baseline measures shortly after the 
assault, whereas others collected the data long after the assault had occurred. This may 
lead to problems in comparing results across studies due to potential confounding 
variables.  
As shown in Jaffe et al.’s (2017) study, there may be a dose-dependent effect of 
acute substance intoxication. The levels of acute substance intoxication were not 
reported in most of the reviewed studies, and it was possible that they varied across 
studies, contributing to inconsistent findings that for instance, low levels of substances 
would impact PTSD symptoms differently from high levels. Furthermore, it is 
reasonable to hypothesise that the effects of chronic pre-assault problematic substance 
use may also be dose-dependent, possibly leading to different degrees of PTSD 
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symptoms depending on the severity of pre-assault substance problems. Therefore, 
further studies need to be conducted to explore this hypothesis.  
4.4. Clinical implications  
The findings reported in this review have a number of clinical implications. They 
suggest that lower initial PTSD symptoms following trauma exposure amongst 
substance consumers may not necessarily indicate reduced risk for PTSD over time. 
Given that early interventions for victims of sexual assault may not be offered to those 
who initially present with lower PTSD symptoms, it is possible that these particular 
individuals may be less likely to receive early interventions for PTSD (Roberts, 
Kitchiner, Kenardy, & Bisson, 2009). Moreover, because of shame, stigma and 
negative social reactions, including the tendency to “blame the victim”, even victims 
with severe PTSD symptoms may not receive early help as a result of their failure to 
seek it. Therefore, the findings from this review suggest a need for routinely assessing 
both pre-assault and post-assault substance consumption (Resnick, Acierno, Amstadter, 
Self-Brown, & Kilpatrick, 2007) in order to effectively detect potential victims who 
might develop chronic PTSD development and provide appropriate early interventions. 
In addition, previous research supports providing a brief PTSD intervention for 
trauma-exposed individuals who are also endorsing difficulties with drinking in order 
to facilitate natural recovery from drinking problems. Conversely, reducing the degree 
of problems associated with alcohol use could, in turn, encourage PTSD recovery over 
time (Zatzick et al., 2004). Therefore, interventions addressing one of the problems in 
an acute trauma-exposed sample could be helpful in alleviating the other.  
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Furthermore, the findings of the review help identify mediators for PTSD 
development following sexual assaults, which is key in appropriately targeting the 
focus of interventions and hence developing effective prevention programmes for the 
victims (Litz, Gray, Bryant, & Adler, 2002). Specifically, the findings suggested that 
early interventions should target and focus on areas of self-blame and the development 
of social support to help victims recover from the trauma effectively.  
4.5. Future directions  
This review highlights some gaps in this field of research. Little is known about 
the impact of substances other than alcohol on PTSD development amongst victims of 
sexual assault. In addition, very limited research has been conducted with male victims 
of sexual assault. Therefore, future research should be carried out in these areas. 
Additionally, since all studies were conducted in the US, this clearly limits 
generalisability to low- and middle-income countries. Given differences in attitudes 
towards sexual behaviour and the use of substances between the US and, for example, 
European countries (Karam, Kypros, & Salamoun, 2007; Kuntsche, Rehm, & Gmel, 
2004), the results might not be applicable for other high-income countries.  
Longitudinal studies with prolonged follow-up periods would also be helpful in 
understanding the development of post-assault PTSD symptoms and investigating the 
outcomes of different levels of acute substance intoxication and chronic pre-assault 
problematic substance use. More laboratory-based studies were recommended to 
establish the causal relationship between pre-assault substance consumption and PTSD.  
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Lastly, as PTSD and SUDs have been shown to be closely associated, it would be 
invaluable to design and evaluate intervention programmes that address these 
problems concurrently within the trauma-exposed population.  
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Effect of Hydrocortisone on Intrusive Memories in Healthy Volunteers 
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Abstract 
 
Aim  
Recent studies suggest that pharmacological strategies targeting the human stress 
system may play a role in modulating intrusive memories, a canonical symptom of 
post-traumatic stress disorder (PTSD). Hydrocortisone that is administered in the 
critical memory consolidation period shortly after the traumatic event seems to reduce 
the risk of PTSD. However, the findings of relevant clinical studies in this area have 
so far been inconsistent, thus requiring further investigation and clarification. 
Therefore, the current study aimed to examine the effects of a single dose of 
hydrocortisone administered shortly post-film on intrusive and declarative memories 
using the trauma film paradigm. 
Method  
Healthy female participants were randomly allocated to a hydrocortisone (oral, 
30mg) or matched placebo control group. Trait, state and psychophysiological 
measures (heart rate, blood pressure and salivary cortisol level) were taken before and 
after a film containing distressing content. Some of these measures were repeated after 
drug administration. Participants recorded film-related intrusive memories for the next 
7 days, before their declarative memory was assessed via free and cued recall tasks.  
Results  
Compared to the placebo group, the frequency and vividness (but not distress) of 
intrusive memories were significantly reduced in the hydrocortisone group. In contrast, 
indices of declarative memory were unaffected by hydrocortisone treatment.   
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Discussion  
The findings provide experimental evidence that hydrocortisone, when 
administered within a critical window of opportunity post-trauma, can reduce the 
occurrence of a clinically important memory-related symptom in a model of PTSD. 
Such findings suggest that a single dose of hydrocortisone can provide protective 
effects, and this is clinically important for the development of early preventive 
interventions for PTSD. 
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1. Introduction 
 
1.1. Emotional memories 
Emotional information and events have a privileged status in human cognition. 
Due to their salience, they enhance new learning and adaptive behaviours. The human 
brain has evolved to respond effectively to emotional stimuli for survival and 
reproductive benefits. Extensive research has suggested the significant yet inconsistent 
effects of emotion on the quality and durability of memory recall (Kensinger, 2009; 
Schaefer & Philippot, 2005).  
Emotional stimuli can have an important adaptive function for memory 
enhancement, making emotional events easier to recall and hence ensuring that one 
can identify and strive for rewarding events and avoid threatening events in the future. 
For instance, emotions can enhance the richness and vividness of subjective details of 
a memory. Experimental studies have shown that people are more likely to remember 
emotional than neutral pictures or words (Dewhurst & Parry, 2000; Ochsner, 2000). 
The emotional intensity of an autobiographical memory has also been shown as a 
predictor of how well these memories are recalled (Talarico, LaBar, & Rubin, 2004). 
Similarly, eyewitness research has demonstrated that people who attended to an 
emotional event report detailed and vivid memories for this event with more clarity 
than for neutral events (Christianson & Hubinette, 1993). 
On the other hand, intensely emotional events or chronic exposure to stressful 
experiences can result in maladaptive consequences for memory processes (McEwen, 
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2007; Sheline, 2003), ultimately leading to maladaptive memory, as shown in a wide 
range of emotional disorders (Williams, 1996; Wilhelm, McNally, Baer, & Florin, 
1997). For example, people who witness highly distressing events or have aversive 
experiences often have poor recall of the details (Christianson & Safer, 1996; Steblay, 
1992), with memories that are more general and autobiographical than memories with 
specific spatio-temporal details. 
1.2. Intrusive memories in PTSD 
Severe life stressors and emotional experiences can result in post-traumatic stress 
disorder (PTSD) in vulnerable individuals. Reviews suggest lifetime prevalence rates 
of PTSD in the population as approximately being between 5% and 12% (Breslau et 
al., 1998; Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995; World Health 
Organisation, 2003). PTSD symptoms include avoidance of reminders of the traumatic 
event, emotional numbing, high arousal, and the re-experiencing of the traumatic event 
in the form of intrusive memories, nightmares or repetitive flashbacks (American 
Psychiatric Association, 2013).  
Intrusive memories, one of the cardinal symptoms of PTSD, involve the 
fragmented involuntary recall of autobiographical information which is distorted in 
terms of contextual, spatial and temporal details. Therefore, individuals experiencing 
intrusive memories usually feel as if the traumatic event is happening again at their 
present time and location (Ehlers, Hackmann, & Michael, 2004; Hackmann, Ehlers, 
Speckens, & Clark, 2004). These memories can be easily triggered by sensory cues 
and re-experienced spontaneously without conscious recollections of the traumatic 
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event (Ehlers & Clark, 2000; Ehlers et al., 2010). Intrusive memories have been the 
focus for a variety of empirical and theoretical work over the past decades (reviewed 
in Marks, Franklin, & Zoellner, 2018), as such investigations may provide important 
insight into the study of emotional memories and the understanding of memory 
processes in the general population. 
1.3. Dual Representation Theory (DRT) 
The dual representation theory (DRT) was developed to account for the intrusive 
memories in PTSD (Brewin, Dalgleish, & Joseph, 1996) and subsequently expanded 
to describe the occurrence and neural mechanisms of intrusive memories in the general 
context of healthy episodic memory (Brewin, Gregory, Lipton, & Burgess, 2010). 
According to the DRT, an event is represented in two parallel systems, namely 
contextual representations (C-reps) and sensory representations (S-reps). C-reps 
involve a subset of sensory input that is voluntarily and deliberately retrieved and 
recorded into an abstract structural description, which is integrated with both 
contextual and spatial information and personal semantic memory over time. In 
contrast, S-reps are low-level representations including sensory and perceptual inputs 
and affective states that are mainly accessed involuntarily. 
The DRT also proposes the corresponding neural mechanisms underpinning these 
representations. Sensory association areas support the allocentric sensory information 
in C-reps, while the hippocampus and other areas in the medial temporal lobe (MTL) 
support the allocentric contextual and spatial information in C-reps. The insula 
supports internal autonomic markers of affective values in S-reps (Craig, 2002; 
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Critchley, Wiens, Rotshtein, Ohman, & Dolan, 2004), which, via the amygdala 
(LeDoux, 1996), become associated with the low-level sensory characteristics of the 
event, supported by early sensory cortical and subcortical areas. The required process 
of egocentric-allocentric translation is supported by the retrosplenial and posterior 
parietal cortices, with higher-level imagery incorporating S-reps with corresponding 
C-reps supported in the precuneus (Brewin et al., 2010). Finally, Papez’s circuit 
supports the viewpoint orientation for which the egocentric representation is generated 
(Bird, Bisby, & Burgess, 2012; Taube, 1998).  
In normal memory processing, although S-reps decay quickly and become 
relatively inaccessible (Brewin et al., 2010), they can be retrieved by their close 
association with corresponding C-reps via higher-level representations. This 
association allows the S-rep represented event to be correctly integrated with its 
semantic and autobiographical context, forming declarative memory and thereby 
preventing it from being re-experienced in the present. This association also allows for 
heightened conscious control over retrieval via the connections from prefrontal cortex 
to the MTL, such as directed attention, the provision of specific retrieval cues, 
verification of the products of retrieval (Burgess & Shallice, 1996; Fletcher & Henson, 
2001), strategies for disambiguating it from events with similar contexts (King et al., 
2005), and deliberate suppression of retrieval if required (Anderson et al., 2004). 
However, extreme stress, as in the case of traumatic events, can potentiate 
amygdala functioning while impairing hippocampal functioning, producing stronger 
S-reps but weaker or impoverished C-reps and poor connections between them 
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(Elzinga & Bremner, 2002; Metcalfe & Jacobs, 1998; Payne et al., 2006; Vyas, Mitra, 
Rao, & Chattarji, 2002). The over-encoding of S-reps with insufficient C-reps results 
in a memory that is not contextualised but instead experienced as happening again in 
the present, ultimately leading to intrusive memories.  
In addition, the extinction process of fear responses learned from a traumatic event 
occurs via top-down inhibitory control of the prefrontal cortex over the amygdala and 
the integration of now emotionally neutral contextual information via the hippocampal 
consolidation. Therefore, fear extinction becomes difficult due to the upregulated 
amygdala functioning in S-reps and downregulated hippocampal functioning in C-reps.  
1.4. The stress response 
Neuroendocrine research has also reported the role of the stress response in 
emotional memories, and this sheds light on the development of intrusive memories. 
In particular, exposures to emotionally arousing stimuli or occurrences activate two 
bodily stress systems releasing different types of adrenal hormones (Roozendaal, 
McEwen, & Chattarji, 2009). One is the sympathetic nervous system, which is 
involved in the release of noradrenaline and adrenaline from the adrenal medulla, 
leading to the rapid behavioural, metabolic and cognitive adaptation known as the 
fight-or-flight response. The other is the hypothalamic-pituitary-adrenal (HPA) axis, 
which mediates the release of glucocorticoids from the adrenal cortex, as a slower and 
longer-lasting process responsible for a return to physiological equilibrium and 
homeostasis.  
These hormones are implicated in the mechanism by which the privileged status 
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of emotional memories is maintained. They contribute to the stabilisation of memory 
traces and other memory functions by influencing limbic brain structures (Roozendaal, 
2002).  
1.5. The effect of glucocorticoids  
The current research focuses on the effects of glucocorticoids on various memory 
processes. Stress leads to enhanced activity of the HPA axis, resulting in an increased 
release of glucocorticoids from the adrenal cortex (McEwen, 2000). Cortisol 
(pharmaceutical form: hydrocortisone; rodent form: corticosterone) is the most 
important endogenous human glucocorticoid, also acting as a biomarker for stress. The 
effect of glucocorticoids on memory may be memory-phase-dependent, with 
enhancing effects on memory consolidation and impairing effects on memory retrieval 
(Dominique, Aerni, Schelling, & Roozendaal, 2009; Roozendaal, 2002; Wolf, 2009). 
1.5.1. Memory consolidation  
Following encoding, there is a period of consolidation during which memories are 
transferred into long-term storage and are subject to emotional effects and 
neurohormonal modulation (McGaugh, 2000). It has been posited that memory 
consolidation is reflected at a cellular level by the process of hippocampal long-term 
potentiation (LTP) as an enduring form of synaptic plasticity (Guzowski et al., 2000; 
Lynch, 2004). During this period, memories are malleable within a “window of 
opportunity” lasting up to approximately 6 hours, raising the possibility of various 
types of manipulation, including pharmacological interference of glucocorticoids 
(Zohar et al., 2011; Zohar, Sonnino, Juven-Wetzler, & Cohen, 2009). Evidence from 
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both human and animal studies indicates that glucocorticoids administered shortly 
post-learning enhances the consolidation of memories, especially emotional in 
comparison with neutral memories (Diamond, Campbell, Park, Halonen, & Zoladz, 
2007; Joels, Pu, Wiegert, Oitzl, & Krugers, 2006; Maheu, Joober, Beaulieu, & Lupien, 
2004; Roozendaal, Williams, & McGaugh, 1999; Smeets, Otgaar, Candel, & Wolf, 
2008). 
Glucocorticoid hormones modulate memory consolidation by entering the brain 
and binding to two intracellular types of adrenal steroid receptors (de Kloet, 1991; 
Reul & de Kloet, 1985;). Glucocorticoid receptors (GRs) have low affinity for 
corticosterone, whereas mineralocorticoid receptors (MRs) have a much higher 
affinity for glucocorticoids (Wolf, Atsak, de Quervain, Roozendaal, & Wingenfeld, 
2016). Most of the enhancing effects of glucocorticoid on memory consolidation have 
been attributed to GR function, but more recent studies have highlighted the 
importance of MR function (Cornelisse, Joel, & Smeets, 2011; Oitzl & de Kloet, 1992; 
Otte et al., 2007; Rimmele, Besedovky, Lange, & Born, 2013; Roozendaal, Portillo-
Marquez, & McGaugh, 1996). 
The hippocampus has a high density of GRs (Reul & de Kloet, 1985). Post-
training infusions of corticosterone or other GR agonists into the hippocampus 
enhance memory consolidation in animal studies involving various types of tasks and 
training (Roozendaal & McGaugh, 1997b; Roozendaal, 2002). Glucocorticoids also 
help activate the amygdala (Roozendaal, 2000) to receive and process affective stimuli, 
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and elevated cortisol levels in humans are associated with increased amygdala activity 
in response to emotional stimuli (van Stegeren et al., 2007; van Stegeren, Wolf, 
Everaerd, & Rombouts, 2007). Infusions of specific GR agonists into the basolateral 
complex of the amygdala (BLA) in rodents immediately after inhibitory avoidance 
training seem to enhance memory retention performance (Roozendaal & McGaugh, 
1997a). In addition, the BLA activation facilitates consolidation processes in other 
brain regions, including the hippocampus and medial prefrontal cortex (mPFC; 
McGaugh, Cahill, & Roozendaal, 1996; McGaugh, Ferry, Vazdarjanova, & 
Roozendaal, 2000). Researchers have examined these BLA-hippocampus interactions 
in mediating glucocorticoid effects on memory consolidation (Roozendaal, Okuda, 
van der Zee, McGaugh, 2006; van Stegeren, Wolf, Everaerd, Scheltens, et al., 2007; 
van Stegeren, Wolf, Everaerd, & Rombouts, 2007), and the stimulatory influence of 
mPFC on BLA activity via a loss of inhibitory control (McDonald, 1991; Rosenkranz 
& Grace, 2002; de Quervain et al., 2009).  
The effect of glucocorticoids on memory consolidation follows an inverted U-
shape dose-response relationship (de Kloet, Oitzl, & Joëls, 1999; Lupien, Maheu, Tu, 
Fiocco, & Schramek, 2007; Lupien & McEwen, 1997). Excessively high or low levels 
of glucocorticoids can negatively interfere with memory consolidation, while their 
optimal level at the peak of the Yerkes-Dodson curve can lead to memory enhancement 
(Kuhlmann & Wolf, 2006; Patel et al., 2000). For instance, in a study investigating the 
effect of administering 20mg and 40mg hydrocortisone, memory facilitation for both 
negative and neutral information was only observed in the 20mg group (Abercrombie, 
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Kalin, Thurow, Rosenkranz, & Davidson, 2003). Similarly, a 30mg dose of 
hydrocortisone produced memory enhancement for emotional stimuli (Kuhlmann & 
Wolf, 2006), whereas a 10 mg dose of hydrocortisone administration impaired recall 
and recognition for both neutral and pleasant words (Top et al., 2003). In animal studies, 
moreover, high doses of corticosteroids negatively affect memory consolidation 
following a stressful event, whereas low doses facilitate memory consolidation (Cohen, 
Matar, Buskila, Kaplan, & Zohar, 2008).  
In addition, glucocorticoid levels can vary with circadian rhythms, along with 
fluctuations in response to external stressors (Chung, Son, & Kim, 2011). Endogenous 
cortisol levels peak in the early morning and then fall to their lowest levels 
approximately 3-5 hours following sleep onset (Kalsbeek et al., 2012; Sahdev & 
Reznek, 2015). This pattern is in line with findings from a meta-analysis that 
exogenous hydrocortisone administration in the morning is associated with memory 
impairment due to excessive levels of circulating glucocorticoid, whereas its 
administration in the late afternoon is associated with memory enhancement as a result 
of mildly elevated level of glucocorticoids (Het, Ramlow, & Wolf, 2005). 
1.5.2. Memory retrieval  
Following successful encoding and consolidation, memories can be later retrieved. 
Evidence exists from animal and human studies employing traditional declarative and 
autobiographical memory tasks indicating that stress and stress-induced release of 
glucocorticoids impair memory retrieval (de Quervain, Roozendaal, & McGaugh, 
1998; de Quervain, Roozendaal, Nitsch, McGaugh, & Hock, 2000; Wolf, Schommer, 
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Hellhammer, McEwen, & Kirschbaum, 2001). The impairing effects of 
glucocorticoids on memory retrieval are especially pronounced for emotionally 
arousing materials independent of their valence (i.e., both positive and negative 
materials), compared to neutral materials (Kuhlmann, Piel, & Wolf, 2005). Patients 
with rheumatoid arthritis showed impaired memory retrieval after being treated with 
the synthetic glucocorticoid prednisone one hour before delayed retrieval testing of 
materials that they had learned one day prior. Impairment was observed although they 
had also learned the materials under prednisone treatment (Coluccia et al., 2008). In 
addition, the impairing effect of glucocorticoids has also been observed in studies 
testing memory recall shortly after learning or training. For example, in a study by 
Wolf and his colleagues (2001), participants learned a word list before 0.5mg/kg 
hydrocortisone administration and then were asked to recall this list 2 hours later. 
Compared to the placebo group, the hydrocortisone group showed poorer word list 
recall. 
Furthermore, studies have also demonstrated that this glucocorticoid-induced 
memory retrieval impairment depends largely on GR activation in the hippocampus. 
Infusion of GR agonists administered into the hippocampus of rats 1 hour before 
retention testing induces similar selective memory retrieval impairment in a water 
maze task (Roozendaal, Griffith, Buranday, Dominique, & McGaugh, 2003). 
Glucocorticoids block hippocampal-dependent influence on memory retrieval by 
reducing the hippocampal firing rate with a delay of approximately 30-60 minutes 
(Joels, 2001). Further studies in animals have indicated that the BLA interacts with the 
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hippocampus in mediating glucocorticoid effects on the retrieval of emotionally 
arousing information. Lesions of the BLA or the infusion of a β-adrenoceptor 
antagonist into the BLA block the impairing effect of a GR agonist infused into the 
hippocampus on memory retrieval of spatial information (Roozendaal et al., 2003; 
Roozendaal, Hahn, Nathan, Dominique, & McGaugh, 2004). In addition, it should be 
noted that ‘stress levels’ of glucocorticoids may impair short-term memory retrieval 
(i.e., working memory) via influences on the prefrontal cortex (Arnsten, 2000; Lupien, 
Gillin, & Hauger, 1999). A number of fMRI studies observed decreased activation in 
the prefrontal cortex after cortisol treatment (Oei et al., 2007). 
The effects of glucocorticoids on memory retrieval may be time-dependent, as 
they do not permanently block the memory (Roozendaal, 2002). Retention 
performance was not impaired when rats were tested either 2 minutes or 4 hours after 
exposure to stress, whereas stress doses of corticosterone injected 30 minutes before 
retention testing have been found to impair memory retrieval (Dominique, Roozendaal, 
& McGaugh, 1998). This time course for retention impairment is correlated with 
plasma corticosterone levels, which peak 30 minutes after stress exposure and return 
to baseline within four hours. Therefore, in order to experimentally separate different 
memory phases, an appropriate retrieval interval is needed so that the experimental 
manipulations can target a specific memory phase (Wolf, 2009). To observe 
glucocorticoid effects on memory consolidation, it is important to maintain a long 
interval (i.e., 24 or 48 hours) between drug treatment and retention testing to allow for 
memory consolidation and the clearance of glucocorticoids. On the other hand, to test 
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glucocorticoid effects on memory retrieval, a relatively shorter memory testing 
interval should be considered (Roozendaal, 2002). However, it should be noted that it 
is difficult to parse the separate effects of glucocorticoids on memory in relation to 
retrieval and consolidation. For instance, short-term impairment of retrieval following 
glucocorticoid administration would tend to reduce rehearsal during the consolidation 
period, thus indirectly affecting memory consolidation.  
1.5.3. Intrusive memories 
Fewer studies have focused on the effects of glucocorticoid specifically on 
intrusive memories. Limited laboratory studies have been conducted to investigate the 
relationship between glucocorticoid and intrusive memories in non-clinical human 
populations. Trauma film paradigms, recognised as a valid model (Bisby, King, 
Brewin, Burgess, & Curran, 2010; Brewin & Saunders, 2001; Holmes & Bourne, 2008; 
Soni, Curran, & Kamboj, 2013), are often used to examine the formation of intrusive 
memories by successfully inducing short-lasting intrusions and psychological distress 
associated with films with traumatic content in non-clinical participants (Holmes & 
Bourne, 2008; James et al., 2016).  
For instance, a study used trauma film paradigm to investigate the relationship 
between endogenous cortisol level, intrusive memories and sympathetic reactions 
(Chou, La Marca, Steptoe, & Brewin, 2014). A positive correlation was found between 
post-film salivary cortisol levels and intrusion frequency in healthy participants with 
increased saliva alpha-amylase (sAA) activity, an indicator of enhanced noradrenergic 
activation in the sympathetic nervous system (Sahu, Upadhyay, & Panna, 2014; van 
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Stegeren et al., 2006). In addition, some experimental studies examined the effects of 
hydrocortisone on modulating various stages of trauma memory processing by 
administering it before, during or after viewing the trauma film. Specifically, a recent 
study examined the influence of pharmacologically increased cortisol levels during 
encoding and consolidation of a trauma film on the consecutive development of 
intrusive memories (Rombold et al., 2016). Healthy female participants were 
administered 20mg hydrocortisone prior to film viewing and subsequently asked to 
record their intrusive memories in a paper diary for the following 7 days. Results 
showed a lack of significant effect of hydrocortisone on the number of intrusions, their 
vividness and the degree of distress evoked by the intrusions. Furthermore, another 
study examined the influence of repeated cortisol administration during memory 
retrieval on intrusive memories (Graebener, Michael, Holz, & Lass-Hennemann, 2017). 
In this study, 20mg hydrocortisone was administered twice a day for 3 days following 
the presentation of trauma film. Participants were asked to record the number of 
intrusive memories and rate the distress caused by each intrusive memory over these 
3 days. The findings showed that there was no significant effect of hydrocortisone on 
intrusion frequency or distress.  
There were also studies using clinical samples to examine the effect of 
hydrocortisone on intrusive memories during various memory processes. In a recent 
meta-analysis, hydrocortisone was the only early pharmacological intervention to have 
a large effect in reducing the risk of PTSD (Sijbrandij, Kleiboer, Bisson, Barbui, & 
Cuijpers, 2015). Clinical studies are limited in examining the effect of hydrocortisone 
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on intrusive memories during memory encoding as it is difficult to administer 
hydrocortisone prior to the occurrence of a traumatic event. There were, nevertheless, 
a number of studies examining the effect of hydrocortisone on intrusive memory 
during memory consolidation. For instance, trauma victims of work or traffic accidents 
who received 100–140mg hydrocortisone within 6 hours post-trauma showed a 
decreased risk for subsequent PTSD 3 months post-trauma (Zohar et al., 2011). In 
addition, compared to placebo, patients who received stress doses of hydrocortisone 
during various kinds of medical treatments within the period of memory consolidation 
showed reduced intrusive memories and other PTSD symptoms related to their 
medical procedures in the long run (Schelling et al., 1999, 2001, 2004, 2006). Similarly, 
patients who had received a loading dose of hydrocortisone intravenously during 
cardiac surgery reported fewer intrusive memories and other PTSD symptoms at 6-
month post-surgery follow-up assessments (Weis et al, 2006).  
With regards to the effect of hydrocortisone on intrusive memories during memory 
retrieval, Aerni and his colleagues (2004) conducted a study that required trauma 
victims to take 10mg hydrocortisone orally on a daily basis for 3 months, and to daily 
report their PTSD symptoms. The findings suggested that hydrocortisone could reduce 
the frequency and intensity of intrusive memories, effectively inhibiting retrieval of 
daily-rated traumatic memories. Furthermore, in Delahanty et al.’s (2013) study, 
patients with physical injuries following a traumatic event received 20mg 
hydrocortisone within 12 hours post-trauma (outside the critical period of memory 
consolidation) and every 12 hours for the following 10 days. The results suggested that 
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patients who had received hydrocortisone treatment reported fewer intrusive memories 
at 1-month and 3-month follow-ups. These findings suggested that hydrocortisone 
might lead to retrieval impairment that further impact on memory retention in the long 
term. In another recent study, nonetheless, PTSD patients were randomly assigned to 
one of two treatment conditions; they received either 1)1 week placebo followed by 1-
week hydrocortisone (10mg/day), followed by 1-week placebo, followed by 1-week 
hydrocortisone (30mg/day) or 2) 1-week hydrocortisone (30mg/day), followed by 1-
week placebo, followed by 1-week hydrocortisone (10 mg/day), followed by 1-week 
placebo (Ludäscher et al., 2015). Intrusive memories were assessed three times per 
day over the course of the treatment. The findings showed that overall, there was no 
significant difference in the frequency and intensity of intrusive memories between 
these two conditions.  
1.6.The current study 
As noted above, few studies have examined the effect of glucocorticoids 
specifically on the development of intrusive memories. Additionally, amongst the 
studies focusing on intrusive memories, there may also be some potential confounds 
arising from variations in patient and trauma characteristics that weakened the validity 
of the observational studies conducted with clinical populations. Recently, a number 
of laboratory studies were carried out in non-clinical human samples, but results were 
inconsistent. 
This current study, therefore, addresses these conceptual and methodological 
limitations by investigating the effect of a single dose of hydrocortisone following an 
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‘analogue trauma’ on Day 1 on intrusive memories in the following week (Day 1-7) 
and declarative memories (Day 8) in a healthy population using the trauma film 
paradigm. It focuses on the effect of hydrocortisone administered shortly after the 
trauma film (within the consolidation window) in the afternoon when there is a 
relatively lower level of endogenous cortisol. This mimics treatment of real-world 
PTSD more closely than pre-encoding administration. In addition, there has thus far 
been a lack of explanation for the distinct mechanisms of action of hydrocortisone on 
intrusive and declarative memories in terms of well-established theoretical models 
such as the DRT. This current study aims to fill this gap. Extensive research on the 
actions of sex hormones on brain structures has shown gender differences in response 
to acute and chronic stressors (Eiland, Ramroop, Hill, Manley, & McEwen, 2012; 
McEwen, Nasca, & Gray, 2016; Soni et al., 2013). This current study will therefore 
focus on the female population taking a hormone-based contraceptive in an effort to 
minimise confounding effects of gender and ovarian hormone fluctuations on memory 
processes.  
Hypotheses 
1) Given the enhancing effect of hydrocortisone on memory consolidation via the 
hippocampus, an important area supporting C-reps, participants who are 
administered hydrocortisone will perform better on declarative memory tasks than 
participants who are administered placebo.  
2) Due to the top-down effects of well-consolidated C-reps, participants who are 
administered hydrocortisone will experience fewer intrusive memories than 
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participants who are administered placebo. As such, declarative memory 
performance will be expected to be negatively correlated with the frequency of 
intrusive memories. 
3) Participants will show an increase in subjectively experienced distress and 
negative states immediately after the presentation of trauma film, indicating a 
successful induction of traumatic memories.  
4) Post-film salivary cortisol levels will be positively correlated with the frequency 
of intrusive memories, if there is an increase in mean heart rate as an indicator of 
sympathetic activation during film viewing. 
 
2. Method 
 
2.1. Design  
This current study was part of a larger project investigating stress-modulating 
drugs and memories, using three independent groups (hydrocortisone, propranolol and 
placebo). A randomised, double-blind, placebo-controlled and between-subject design 
was used to examine the effect of a single dose of hydrocortisone (30mg) and 
propranolol (80mg), compared to matched placebo, on intrusive and declarative 
memories following an analogue trauma. This study was carried out jointly with 
another trainee from University College London (UCL; Sim, 2018), who focused on 
the effects of propranolol (see appendix 2). In the current study, however, only the 
results from the placebo and hydrocortisone groups will be reported. All procedures 
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were approved by the UCL research ethics committee (see appendix 3). 
2.2. Participants  
A convenience sample was recruited from UCL and the surrounding locale via 
online research recruitment websites and posters and flyers put up around the campus. 
In the recruitment advertisement, participants were briefly informed about the process 
and purpose of the study and also cautioned regarding the intake and side effects of 
drugs and the graphic nature of the trauma film. Interested participants were provided 
with the study information sheet and consent form and subsequently underwent a 
telephone screening (approximately 15 minutes) to assess and confirm their eligibility 
for the study.  
Female participants aged 18-35 years old were recruited. In order to limit the 
potential effect of variations in circulating ovarian hormone levels at specific 
menstrual cycle stages on intrusive memories and to reduce the cortisol response to 
stressors (Roche, King, Cohoon, & Lovallo, 2013), they were required to have been 
taking an oral hormone-based contraceptive for more than one month (Bryant et al., 
2011; Kirschbaum, Kudielka, Gaab, Schommer, & Hellhammer, 1999; Soni et al., 
2013). Other inclusion criteria included fluency in English, normal physical health, 
normal or corrected-to-normal colour vision, normal blood pressure, body mass index 
(BMI) between 18.5 and 30 kg/m2, weekly alcohol consumption (i.e., ≤ 14 units/112g, 
the UK standard for women), daily reliable access to Internet to facilitate data 
collection, and ability and willingness to complete an online memory monitoring diary 
daily for 7 days.  
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Exclusion criteria included self-reported historical or current diagnosis of mental 
health issues requiring treatment, history of significant interpersonal violence or 
trauma such as being assaulted or witnessing violent assault, injury or death, known 
memory impairments, asthma, diabetes, chronic obstructive pulmonary disease 
(COPD), significant sleep problems, cardiac pacemaker implant or other 
cardiovascular conditions, history of epilepsy or neurosurgery, impaired liver or 
kidney function, history of severe anaphylactic reaction to a variety of allergens, and 
history of fainting. Medication-specific exclusion criteria include hypersensitivity to 
hydrocortisone, intolerance to lactose, inability to swallow capsules, pregnancy or 
breastfeeding, currently taking cardiovascular or psychiatric medication or beta-
blockers, and regular (≥twice per month) recreational or medical use of drugs other 
than alcohol and caffeine.  
Power analysis for this current study was informed by previous studies examining 
pharmacological and behavioural manipulations on intrusive memories (e.g. Holmes, 
James, Coode-Bate, & Deeprose, 2009; Soni et al., 2013; Das et al., 2016). A large 
effect (f = 0.04) was used with α = 0.05, and power 1-β = 0.8. Based on a power 
calculation performed using G*Power version 3.1.9.2 (Faul, Erdfelder, Buchner, & 
Lang, 2009), the total minimum sample size was estimated to be n = 66. 
In total, 186 participants were screened, and 111 met inclusion and exclusion 
criteria. Of these, 92 participants attended the study on Day 1. Two withdrew on Day 
1 due to their initial reactions to the trauma film and two were withdrawn either due to 
misreporting of oral contraceptive use (only 2-week continuous use rather than ≥1 
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month) and one due to undisclosed depressive symptom at screening. Therefore, the 
final sample constituted 88 participants (hydrocortisone n = 29; propranolol n = 30; 
placebo n = 29; see Figure 1). All participants provided written informed consent and 
received £25 remuneration for completing the study.  
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Participants excluded because they 
• were not on oral-based contraception 
(n = 60) 
• were unable to attend experiment 
sessions (n = 5) 
• were over the alcohol limit (n = 1) 
• had mental health issues (i.e., anxiety 
and eating disorders; n = 3) 
• had asthma (n = 2) 
• had diabetes (n =2)  
• did not want to watch film (n = 1) 
• did not want to take drug (n = 1) 
Participants eligible for the 
study after telephone 
screening (n = 111) 
Participants who withdrew before the study (n = 19) 
 
Withdrew due to reaction to the trauma film (n = 2) 
or were withdrawn because of misreporting of 
contraceptive use (n =1) or undisclosed depression 
(n = 1)  
Participants attended on 
Day 1 of the study (n = 92) 
hydrocortisone 
group (n = 29) 
Propranolol 
group (n = 30) 
Placebo group 
(n = 29) 
Participants completed the entire study 
protocol and included as the final sample in 
analysis (n = 88) 
Figure 1. Participant flowchart. 
Screened participants (n = 
186) 
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2.3. Materials 
Trauma Film. The emotional video consisted of two video clips taken from the 
film “Irreversible” (Studio Canal, France). The scenes included a violent rape of a 
female victim by a male perpetrator (scene one, 15 minutes long) and a man being 
beaten to death in a club (scene two, 4 minutes long). A voiceover preceded each scene 
to outline the characters and context of the scenes and link the two depicted events, 
which helped create a single coherent narrative. The use of these clips was based on 
pilot data showing a greater number of intrusions following these clips than previously 
used multiple short scenes (Soni et al., 2013). These clips had also been used 
successfully in previous relevant studies assessing intrusive memories (Das et al., 
2016). 
All participants were informed of the very graphic nature of the trauma film in the 
study advert, during the telephone screening and at the start of study on Day 1. They 
were informed that they could withdraw from the study at any point if they found the 
scenes too distressing (see appendix 4). Participants watched the film on a 15-inch 
laptop monitor in a darkened lab. The audio track was played through headphones. A 
chinrest was used to minimise head movement artefacts during eye movement 
recordings. An eye-tracker (GP3 eye-tracker, Gazepoint, Vancouver, Canada) was used 
to continuously monitor participants’ eye movements and measure their level of 
engagement and attention throughout the film (LaBar & Cadenza, 2006). Gaze 
duration and number of fixations on pre-defined areas of interest were recorded and 
analysed offline using Gazepoint software. This was to determine whether the groups 
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were equivalent at baseline on these attentional parameters.  
Drug administration. Participants took a single dose of hydrocortisone, 
propranolol or placebo orally. The 30mg hydrocortisone (1x10mg and 1x20mg; Auden 
Mckenzie Pharma Division Ltd, Ruislip, UK) tablets were re-formulated in-house. 
Pairs of tablets (10mg, 20mg) were mechanically crushed and re-encapsulated into two 
identical opaque gelatin capsules and filled with additional lactose powder. The 
placebo consisted of two identical capsules containing lactose powder only. One hour 
after drug administration (before the final physiological and subjective measures), 
participants and researchers were asked to independently guess which drug 
participants had received.                                 
2.4. Measures  
2.4.1. Trait measures 
Depression. Participants’ levels of depressed mood were measured using the Beck 
Depression Inventory-II (BDI-II; Beck, Steer, & Carbin, 1988). This is a 
psychometrically sound self-report inventory containing 21 multiple-choice questions 
measuring the severity of depression. It instructed participants to describe the way they 
have been feeling during the past 2 weeks. A total BDI-II score was calculated for each 
participant. 
Anxiety. The State-Trait Anxiety Inventory for adults (STAI; Spielberger, 1983) 
was used to measure participants’ trait levels of anxiety. The inventory includes 20 
items, and responses are made using a 4-point Likert scale (almost never, sometimes, 
often, almost always). For each participant, a total STAI score was calculated. 
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Dissociation. The Dissociative Experience Scale-II (DES-II; Carlson & Putnam, 
1993) was selected as a measure of participants’ naturalistic level of dissociative 
symptoms. This questionnaire consists of 28 questions about experiences that one may 
have in daily life. Participants were asked to estimate the percentage of time that they 
had the described experience. The sub-scores for amnesia, derealisation and absorption 
were calculated, together with a total DES-II score. 
2.4.2. State measures 
Acute emotional responses to the film. This set of six visual analogue scales (VASs; 
McCormack, David, & Sheather, 1988) was employed to capture participants’ levels 
of disgust, fear, anger, sadness, happiness and distress. They were asked to give their 
responses according to how they felt “right now”. Emotional responses were measured 
on 10-point numerical rating scales anchored with the descriptors “not at all” and 
“very”. This measure is used extensively in epidemiologic and clinical research to 
measure the intensity and frequency of various symptoms (Paul-Dauphin, Guillemin, 
Virion, & Briançon 1999). Responses to the negative items of the VASs (disgust, fear, 
anger, sadness, and distress) were highly correlated and loaded onto a single factor 
(average score) along with the positive VAS item (happiness). 
Positive and negative affects. To assess participants’ current positive and negative 
affective states, the Positive-Negative Affect Schedule (PANAS; Watson, Clark, & 
Tellegen, 1988) was used. This instrument includes 10 positive and 10 negative items 
rated on a 5-point Likert scale (very slightly or not at all, a little, moderately, quite a 
bit, extremely). The PANAS negative and positive subscales were calculated.  
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Bodily sensations. The Bodily Symptoms Scales (BSS; Bond & Lader, 1974) were 
used to gauge a series of bodily sensations, including anxiety, depression, memory 
impairment, palpitations or increased heart rate, nausea or sickness, emotional 
numbness, euphoria, drowsiness, muscular tension, headache, loss of concentration, 
shaking or trembling and confusion. Participants were asked to rate these sensations 
on a scale from 0-100%. 
Impact of the film. The revised Impact of Events Scale (IES-R; Weiss & Marmar, 
1997) measured the effect, if any, of the trauma film on participants. Participants were 
provided with a list of difficulties (e.g., poor sleep, emotional numbness, adverse 
physical reactions) that they might have experienced after watching the film on Day 1. 
They needed to indicate and rate how much they had been distressed or bothered by 
each of the listed difficulties for the following 7 days. Sub-scale scores were calculated 
for intrusion, avoidance and hyperarousal, together with a total IES-R score.  
2.4.3. Physiological measures 
Heart Rate. Participants’ heart rates were measured to capture the interplay 
between sympathetic and parasympathetic influences on the heart and the autonomic 
nervous system’s response to threat (Nikolin, Boonstra, Loo, & Martin, 2017; Porges, 
1997). Heart rate data were recorded using a BodyGuard 2 ECG device (FirstBeat 
Technologies, Jyvaskyla, Finland) at a sampling rate of 1000Hz and expressed as the 
mean heart rate for a targeted event. Ag/AgCl electrodes were attached below the right 
clavicle and left ribcage. On Day 1, a 5-minute period prior to viewing the trauma film 
served as pre-film (baseline) indices of autonomic arousal. The period between the 
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start and end of the film was used to determine heart rate during the film. A final 5-
minute period was used to determine heart rate 1-hour post-drug. On Day 8, similarly, 
the 5-minute period prior to the free recall task served as a baseline. The periods 
between the start and end of the free recall and of the cued recall tasks were used to 
determine heart rate during these two tasks.  
Blood Pressure. A portable blood pressure monitor (BM40 XL; Beurer UK 
Limited) was used to measure systolic and diastolic blood pressure. A cuff was placed 
around participants’ left wrist and readings taken.  
Saliva samples. Participants’ bodily cortisol levels were collected from their saliva 
samples. As stated in the Procedure section (see below), they were instructed not to 
consume any food or drinks containing caffeine for the 2 hours prior to the study and 
required to rinse their mouths with water at the beginning of the study. Passive drool 
(approximately 500 μl) was collected in cryovials via a truncated straw (Shirtcliff, 
Granger, Schwartz, & Curran, 2001). Saliva samples were frozen immediately and 
stored at -80℃ until further analysis. The enzyme-linked immunosorbent assay 
(ELISA) was used to analyse the saliva sample and measure the level of cortisol. 
2.4.4. Memory assessments 
Intrusive memories. Each day, participants were asked to record the number of 
intrusive memories related to the trauma film they had experienced in a diary via an 
online Qualtrics interface (Qualtrics; Provo, Utah, USA). At the end of the study on 
Day 1, they were provided with a detailed description of the nature of intrusive 
memories as follows (refer to Appendix 5.5 and 5.6 for full description):  
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“By ‘spontaneous’, what we mean is memories of the film that suddenly pop 
into your mind automatically. We do not mean times when you deliberately 
think about it or mull it over. The spontaneous memories may pop into your 
mind when you are doing or thinking about something completely unrelated. 
Or you may be reminded of the film by things that happen in your 
environment. The main thing is that you didn’t mean to think about the film, 
but recall something about it, out of the blue” 
Participants were sent email/smartphone prompts at 8pm daily for the 7 days of 
recording (Day 1 to Day 7) to remind them to record their intrusive memories on the 
Qualtrics device. The importance of daily completion of memory diary entries was 
emphasised and mentioned.  
Participants needed to report the frequency of intrusive memories each day and 
briefly describe their contents. They were then asked to classify the type of memory 
as “verbal” or “sensory” or “both”. In addition, they rated the memory vividness and 
distress caused by these memories on a 5-point Likert scale (1 = not at all; 5 = 
extremely).  
Declarative memory. Participants were asked to complete a free recall task on Day 
8. They were instructed to write about both scenes of the trauma film “[in as much 
detail] as possible, including information about where things happen, when they 
happen, who they happen to, what the people and scenes look like, etc.” Participants 
typed their responses directly into a text box (see appendix 5.3). Free recall 
performance was determined by counting the number of recalled idea units (the total 
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of gist and detail units) as a proportion of all possible accurately recalled units across 
the entire sample (i.e., maximum possible free recall performance). Participants’ 
written accounts were reviewed by two raters independently blind to drug allocation. 
Intraclass correlations (ICC) were calculated to evaluate inter-rater reliability (ICC(scene 
1 gist unit) = 0.945; ICC(scene 1 detail unit) =0.982; ICC(scene 2 gist unit) = 0.948; ICC(scene 2 detail unit) 
= 0.971).  
Subsequently, a cued recall task was used, involving 19 questions about the events 
in the trauma film (Das et al., 2016; see appendix 5.4). Participants received a score of 
1 for a correct answer, 0.5 for a partially correct answer, and 0 for an incorrect answer 
to each question, and then a total score was calculated for their recall of the content of 
the traumatic film after 7 days. Participants’ responses were reviewed by two raters 
independently blind to drug allocation to ensure inter-rater reliability (ICC = 0.925). 
Diary compliance. Participants were asked to self-rate how accurately they 
completed the online diary for the past 7 days on a scale of 0-10 (0 = not at all 
accurately, 10 = extremely accurately).  
2.4.5. Sleep measures 
Sleep habit. The Adapted Pittsburgh Sleep Quality Index (PSQI; Buysse, 
Reynolds, Monk, Berman, & Kupfer, 1989; see appendix 5.1) was used to measure 
participants’ usual sleep habits. Participants were asked to indicate the most accurate 
replies for the majority of days and nights in the month prior to Day 1. They needed to 
report the time that they usually went to bed and got up, average hours of actual sleep 
at night, and average minutes taken to fall asleep. They were also asked to subjectively 
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rate their sleep quality on a 4-point Likert scale (very good, fairly good, fairly bad, 
very bad). Sub-scores were calculated for sleep quality, latency, duration and efficiency.  
Sleep survey. Participants were asked to indicate their sleep quality for the night 
after Day 1 of the study. Some questions were adapted from the PSQI (see appendix 
5.1). Participants also needed to answer questions about their dreams retrospectively, 
including nightmares, night terrors, affectivity of dreams and dream contents relating 
to the trauma film. Participants reported this information via the online diary together 
with their reports on intrusive memories. 
2.5. Procedure  
Screening. Participants underwent a telephone screening interview to determine 
their eligibility for the study after expressing their interest over email (see appendix 4). 
Eligible participants were briefly informed about the study and reminded of the highly 
graphic nature of the film clips and involvement of drugs. They were assured that they 
had the right to withdraw from the study at any stage without needing to give a reason. 
In addition, prior to Day 1, participants were reminded via email and text message to 
avoid consuming food or any drinks containing caffeine for 2 hours before the study.  
Day 1. Following the telephone screening, all eligible participants were asked to 
attend Day 1 testing, which commenced between 2pm and 5pm. Participants who 
wished to proceed in the study were given time to read the information sheet and 
complete the informed consent form. They were then taken to rinse their months in 
preparation for saliva collection. The ECG device was fitted, allowing for a sufficient 
stabilisation period (≥ 10 minutes before the start of the film). Participants completed 
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a series of trait questionnaires (in this order: BDI-II, STAI, DES-II, PSQI), followed 
by pre-film (Time 1) state questionnaires (in this order: VASs, PANAS, BSS). Blood 
pressure was recorded, and saliva samples were collected immediately pre-film (Time 
1). The blood pressure monitor cuff remained on the participant’s arm to allow 
measures to be taken immediately post-film.  
Subsequently, participants were asked to rest their chins on a head mount and put 
on a set of headphones. They were instructed to not move and to try to attend to the 
film shown on the laptop as much as possible. The lights were turned off. Once the 
eyetracker was calibrated, participants were shown the trauma film.  
Heart rate was assessed continuously, with event markers identifying the 5-minute 
pre-film period as Time 1 and the period between the start and end of film viewing as 
Time 2. Blood pressure readings and saliva samples were taken again (Time 2) 
immediately after viewing the film. Participants were asked to complete post-film 
(Time 2) state measures (VASs, PANAS, BSS).  
According to their allocated group, participants then swallowed the two gelatin 
capsules with water. After drug administration, they sat quietly and completed ‘filler’ 
tasks for one hour. These included a demographic questionnaire (ethnicity, education 
level, employment status) and a music rating task. They listened to a standard sequence 
of 25 clips of classical music via headphones and rated their pleasantness after each 
clip (see appendix 5.2). This task was used to fill the time while the drug was absorbed, 
so the ratings were not analysed. Participants were asked to report any adverse effects 
during this hour.  
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After 1 hour, participants were asked to guess which drug they had received. 
Researcher also made a guess independently. Post-drug (Time 3) state measures (VASs, 
PANAS, BSS) were taken, following by blood pressure readings and the collection of 
saliva samples. Before the ECG device was removed, the end time was marked, 
identifying the final 5-minute period as Time 3. Lastly, written and verbal instructions 
on recording intrusive memories in the following week were provided. The time for 
Day 8 testing was scheduled as close as possible to the start time of Day 1 testing, 
before each participant left the laboratory.  
Day 1 to Day 7. Starting on the day of the trauma film (Day 1), participants were 
required to complete the memory diary on a daily basis from Day 1 to Day 7. The time 
of diary completion was recorded automatically on Day 1 via Qualtrics, enabling 
calculation of the potential consolidation or retrieval period (the period between film 
viewing and intrusive memory recording) on Day 1. Participants followed a link to a 
Qualtrics webpage to enter relevant information about intrusive memories. On Day 2 
only, they were also required to provide information about their sleep during the night 
after the film viewing.  
Day 8. One week later, participants returned to the laboratory. Upon arrival, the 
ECG was fitted, allowing for a stabilisation period of over ten minutes. They 
completed a series of state measures in the following order: IES-R, VASs, PANAS and 
BSS. This was followed by a free recall task and subsequently a cued recall task, before 
asking them to self-evaluate their compliance with completing the diary entries for the 
past 7 days. Similar to Day 1, heart rate was assessed continuously, with event markers 
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identifying the 5-minute period pre-free recall task as Time 1, the period between the 
start and end of the free recall task as Time 2, and the period between the start and end 
of the cued recall task as Time 3. The ECG device was removed. Upon completion, 
participants were debriefed and requested to refrain from discussing the study from 
others. Finally, they were reimbursed for their participation in the study. 
2.6. Statistical analysis  
Statistical analysis was carried out using IBM Statistical Package for the Social 
Sciences (SPSS) version 25. The hydrocortisone (n = 29) and placebo (n = 29) groups 
were included in the data analysis. Data were inspected for normality both visually and 
statistically using the Kolmogorov-Smirnov test. Equality of variance was examined 
using Levene’s test. The majority of data conformed to assumptions of the linear model, 
except the positively skewed data of cortisol levels, IES measures and the frequency 
of intrusive memories. Cortisol levels and IES measures were successfully log 
transformed, while the data of intrusive memories frequency were log+1 transformed.  
The state affect and physiological data (cortisol level, heart rate, blood pressure, 
and state measures) were analysed using repeated measures ANOVA with Time as the 
within-subject factor and Group as the between-subject data. Similarly, preliminary 
repeated measures analysis of the data of intrusive memories across seven days 
(frequency, vividness, and distress) was also conducted using a Repeated ANOVA with 
Day as the within-subject factor and Group as the between-subjects factor. No a priori 
covariates were specified for any analysis. Since intrusion data consisted of zero-
inflated counts, the effect of drug group was re-analysed using Negative Binomial 
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Regression with estimated values of parameter.  
2.7. Missing data and outliers 
There were no missing values for the declarative memory and IES measures. The 
data for frequency, vividness and distress of intrusive memories were virtually 
complete (0.7% missing; Little’s MCAR test: χ2(76) = 47.95, p = 0.995), with 
complete data on Days 1,4,5, and 6 for frequency and on Days 1,4, 5, 6 and 7 for 
vividness and distress. Given the declining pattern of frequency, vividness and distress 
across days, the small number of missing data points were replaced by the next day’s 
values (next observation carried back).  
 
3. Results 
3.1. Descriptive statistics 
In the final sample (n = 58), the mean age was 23.72 years old (SD = 3.37; range: 
18-32), with mean education of 16.28 years (SD = 1.83; range: 13-21). The majority 
of participants were students (n = 44, 75.9%) and 24.1% (n = 14) were currently 
employed. In terms of ethnicity, 51.7% (n = 30) identified as White, 19.0% (n = 11) 
East Asian, 6.9% (n = 4) South Asian, 5.2% (n = 3) Black African, 3.4% (n = 2) 
Southeast Asian, 1.7% (n =1) Black Caribbean, 8.6% (n = 5) Mixed, and 3.4% (n = 2) 
Other. The mean BMI was 22.41kg/m2 (SD = 2.36; median = 22.35; range: 17.47-
27.58). The mean duration on oral contraception was 35.68 months (SD = 36.29; range: 
1-144). Participant demographics, psychological trait variables, physiological 
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variables and baseline ratings of sleep quality are given in Table 1. Hydrocortisone and 
placebo groups did not differ significantly on these variables.  
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Table 1 
 
Participant Demographics, Trait Characteristics, Physiological Variables and Baseline Ratings of Sleep Quality by Drug Treatment Group  
 
Variables Hydrocortisone (n = 29) 
M (SD) 
Placebo (n = 29) M (SD) Statistics for group difference p-value Effect size (Cohen’s d) 
Demographics  
Age (years) 23.66 (3.12) 23.76 (3.64) t(56) = 0.116 0.908 -0.03 
BMI (kg/m2) 22.72 (2.09) 22.01 (2.60) t(56) = -1.135 0.261 0.30 
Education (years) 16.34 (1.37) 16.24 (2.20) t(46.9) = -0.215 0.83 0.05 
Duration of taking contraceptives 
continuously (months) 
31.06 (32.91) 39.90 (38.93) t(56) = 0.933 0.355 0.26 
Trait characteristics  
BDI-II 5.10 (4.56) 6.79 (4.09) t(56) = 1.485 0.143 -0.39 
STAI 36.34 (9.91) 38.62 (7.82) t(56) = 0.971 0.336 -0.26 
DES-II  
Amnesia  1.71 (4.22) 1.72 (2.10) t(55) = 0.011 0.991 <0.01 
Derealisation 2.24 (3.97) 1.90 (3.05) t(56) = -0.371 0.712 0.10 
Absorption  10.79 (8.86) 10.34 (6.98) t(56) = -0.214 0.831 0.06 
Total  9.57 (9.51) 9.37 (6.65) t(56) = -0.091 0.927 0.02 
Blood pressure       
Systolic (mmHg) 109.66 (13.58) 110.59 (10.80) t(56) = 0.289 0.774 -0.08 
Diastolic (mmHg) 68.45 (8.22) 71.52 (7.93) t(56) = 1.447 0.153 -0.38 
Baseline sleep quality   
Sleep quality 0.83 (0.60) 1.07 (0.59) χ2(2) = 2.360 0.307 -0.40 
Sleep latency  0.86 (0.69) 0.83 (0.76) χ2(2) = 0.624 0.732 0.04 
Sleep duration  0.55 (0.74) 0.63 (0.68) χ2(3) = 1.926, 0.588 -0.11 
Sleep efficiency  0.31 (0.54) 0.38 (0.68) χ2(2) = 1.333 0.513 -0.11 
Note. BMI = Body Mass Index; BDI-II = Beck Depression Inventory-II (Beck et al., 1988); STAI = State-Trait Anxiety Inventory (Spielberger, 1983); DES-II = Dissociative Experience Scale-II (Carlson & Putnam, 1993). 
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3.2. Manipulation checks: Response to the film  
The specific effects of the trauma film presented before the drug administration 
was isolated by examining the changes in participants’ subjective state and 
physiological responses between Time 1 and 2 (see Table 2). A significant increase in 
VAS-negative scale and decrease in VAS-happiness scale from Time 1 to 2 were 
observed. Likewise, there was a significant increase in PANAS-negative and decrease 
in PANAS-positive scales. The majority of BSS scores also significantly differed 
between Time 1 and 2, apart from the scores for memory impairment, loss of 
concentration and drowsiness. These consistent data with large effect sizes suggested 
a significant deterioration in positive mood and elevation in negative mood. In terms 
of physiological indices, systolic blood pressure showed a significant increase from 
Time 1 to 2. However, there were small but non-significant increase in cortisol levels 
and heart rate from Time 1 to 2. It should also be noted that in terms of attentional 
parameters during film viewing, the hydrocortisone and placebo groups did not differ 
in dwell time represented by average gaze duration and number of fixation (see Table 
4).  
 
  
128 
Table 2 
 
Physiological and Subjective State Responses at Time 1 and 2  
 
Measures  Time 1 (n = 58) M (SD) Time 2 (n = 58) M (SD) Time effect t(57) p-value  Effect size (Cohen’s d) 
VASs 
Negative scale 0.48 (0.73) 5.89 (2.07) -20.829 <0.001*** -3.49 
Happiness  5.29 (2.42) 1.67 (1.68) 12.067 <0.001*** 1.74 
PANAS 
Positive  27.90 (7.46) 19.45 (5.87) 11.850 <0.001*** 1.26 
Negative  12.71 (3.35) 25.72 (7.60) -13.385 <0.001*** -2.22 
BSS 
Anxiety  12.33 (14.73) 41.81 (23.71) -10.056 <0.001*** -1.49 
Depression  5.34 (6.94) 18.47 (18.95) -5.972 <0.001*** -0.92 
Memory impairment 3.95 (6.83) 7.31 (15.86) -1.639 0.107 -0.28 
Palpitation 3.41(7.54) 30.47 (25.52) -8.726 <0.001*** -1.44 
Nausea  2.21 (5.79) 20.90 (23.70) -6.550 <0.001*** -1.08 
Emotional numbness 9.62 (19.86) 23.09 (26.67) -3.740 <0.001*** -0.57 
Euphoria 8.57 (17.63) 1.17 (3.44) 3.342 0.001** 0.58 
Drowsiness  13.82 (18.77) 10.48 (19.44) 1.095 0.278 0.17 
Muscular tension  8.98 (14.24) 25.24 (23.29) -6.742 <0.001*** -0.84 
Headache 2.28 (5.77) 6.72 (11.56) -3.230 0.002** -0.49 
Loss of concentration  5.88 (9.26) 5.90 (10.66) -0.012 0.991 <0.01 
Shaking  2.00 (7.14) 16.84 (21.34) -5.436 <0.001*** -0.93 
Confusion  1.91 (5.47) 11.07 (19.50) -3.705 <0.001*** -0.64 
Physiological measures 
Systolic BP (mmHg) 110.12 (12.17) 116.12 (16.11) -3.580  0.001** -0.42 
Diastolic BP (mmHg) 69.98 (8.15) 71.47 (9.30) -1.838  0.071 -0.17 
Cortisol level (µg/dL) 0.14 (1.11) 1.15 (0.08) -1.051 0.298 -1.28 
Mean HR (beats/min) 78.49 (8.92) 90.10 (11.95) -1.236 0.222 -1.10 
Note. VASs = visual analogue scales (McCormack et al., 1988); PANAS = Postive-Negative Affect Schedule (Watson et al., 1988); BSS = Bodily Symptoms Scales (Bond & Lader, 1974); BP = blood pressure; HR = heart rate 
*** p < 0.001; **p < 0.01; *p < 0.05. 
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Correlations. There was no significant correlation between post-film cortisol 
level at Time 2 and the total frequency of intrusive memories in the following week 
(r(55) = 0.042, p = 0.760). Blood pressure change between Time 1 and 2 correlated 
with post-film PANAS-negative (r(58)=-0.265, p = 0.045), BSS heartbeat (r(58)=-
0.349, p = 0.007), BSS tension (r(58)=-0.341, p = 0.009), and BSS shaking (r(58)=-
0.384, p = 0.003), suggesting that the increase in blood pressure at Time 2 was due to 
the trauma film rather than spontaneous changes.  
3.3. Response to drug  
During the study, no participant reported any adverse effects. The specific effects 
of drugs administered after film viewing was isolated by examining the changes in 
participants’ physiological responses between Time 2 and 3. The bio-physiological 
index relevant to the hydrocortisone group indicated a clear increase in salivary 
cortisol levels (shown in Figure 2). Results from repeated measure ANOVA showed a 
robust Drug x Time interaction on cortisol level (F(1.6, 84.1) = 26.229, p<0.001, ηp2 
= 0.340), a main effect of Time (F(1.6, 84.1) = 48.794, p<0.001, ηp2 = 0.489), and a 
main effect of Drug (F(1, 51) = 13.179, p = 0.001, ηp2 = 0.205). As expected, follow-
up repeated measures at each level of the group showed that this effect was mainly 
driven by changes in the hydrocortisone group (F(1.3, 31.7) = 52.952), p<0.001, ηp2 
= 0.679). In the hydrocortisone group, there was a significant increase in salivary 
cortisol level between Time 2 and 3 (F(1, 25) = 52.078, p<0.001, ηp2 = 0.676), not 
between Time 1 and 2 (F(1, 25) = 1.808, p = 0.191, ηp2 = 0.067). There was a 
significant moderate change in cortisol level in the placebo group (F(1.5, 39.2) = 4.392, 
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p = 0.028, ηp2 = 0.145). However, repeated contrasts showed that there was no 
significant change between Time 1 and 2 (F(1, 26) = 3.370, p = 0.078, ηp2 = 0.115), 
or between Time 2 and 3 (F(1, 26) = 1.801, p = 0.191, ηp2 = 0.065). 
Table 3 outlines the summary statistics for physiological and subjective state 
measures on Day 1. Overall, no main effect of Drug or interaction effect of Drug and 
Time was found on other physiological measures and subjective state and bodily 
measures. The absence of detectable subjective bodily symptoms was in line with 
participants’ guess on the receipt of drug, indicating successful blinding (χ2(2) = 0.262, 
p = 0.877, V = 0.068). similarly, researchers remained blind (χ2(2) = 1.309, p = 0.520, 
V = 0.149). 
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Table 3 
 
Summary Statistics for Physiological and Subjective State Measures on Day 1 
 
 Time effect 
 
Drug effect 
 
Drug x Time interaction 
 
Measures  Statistics p-value ηp2 Statistics p-value ηp2 Statistics p-value ηp2 
Physiological measures 
Cortisol level 
(µg/dL)  
F(1.6, 84.1) = 48.794 <0.001 *** 0.489 F(1, 51) = 13.179 0.001 ** 0.205 F(1.6, 84.1) = 26.229 <0.001 *** 0.340 
Systolic BP 
(mmHg) 
F(1.8, 100.7) = 8.655 0.001 ** 0.134 F(1, 56) = 0.807 0.373 0.014 F(1.8, 100.7) = 0.721 0.475 0.013 
Diastolic BP 
(mmHg) 
F(2, 112) = 1.703 0.187 0.030 F(1, 56) = 1.141 0.290 0.020 F(2, 112) = 0.834 0.437 0.015 
Mean HR 
(beats/min) 
F(1.4, 77.6) = 3.507 0.033 * 0.061 F(1, 54) = 0.881 <0.001 *** <0.001 F(1.4, 77.6) = 0.105 0.835 0.002 
VASs 
Negative scale F(1.7, 94.6) = 317.726 <0.001 *** 0.850 F(1, 56) = 1.013 0.379 0.014 F(1.7, 94.6) = 1.460 0.238 0.025 
Happiness F(2, 112) = 67.813 <0.001 *** 0.548 F(1, 56) = 0.001 0.979 <0.001 F(2, 112) = 0.745 0.477 0.013 
PANAS 
Positive  F(1.8, 100.8) = 61.574 <0.001 *** 0.524 F(1, 56) = 0.315 0.577 0.006 F(1.8, 100.8) = 0.537 0.567 0.010 
Negative  F(1.6, 90.0) = 163.281 <0.001 *** 0.745 F(1, 56) = 0.020 0.888 <0.001 F(1.6, 90.0) = 1.261 0.282 0.022 
BSS 
Anxiety  F(1.7, 94.4) = 90.416 <0.001 *** 0.618 F(1, 56) = 0.502 0.482 0.009 F(1.7, 94.4) = 0.458 0.601 0.008 
Depression  F(2, 112) = 24.625 <0.001 *** 0.205 F(1, 56) = 0.178 0.675 0.003 F(2, 112) = 0.662 0.505 0.012 
Memory 
impairment 
F(1.6, 90.0) = 1.940 0.158 0.033 F(1, 56) = 0.014 0.907 <0.001 F(1.6, 90.0) = 0.386 0.635 0.007 
Palpitation F(1.3, 70.1) = 73.037 <0.001 *** 0.566 F(1, 56) = 0.126 0.723 0.002 F(1.3, 70.1) = 0.375 0.590 0.007 
Nausea  F(1.1, 61.2) = 40.535 <0.001 *** 0.420 F(1, 56) < 0.001 0.997 <0.001 F(1.1, 61.2) = 0.063 0.824 0.001 
Emotional 
numbness 
F(2, 112) = 8.703 <0.001 *** 0.135 F(1, 56) = 0.015 0.901 <0.001 F(2, 112) = 0.271 0.763 0.005 
Euphoria F(1.7, 95.8) = 6.037 0.005 * 0.097 F(1, 56) = 0.050 0.924 0.001 F(1.7, 95.8) = 0.685 0.485 0.012 
Drowsiness  F(1.7, 97.4) = 14.8 0.001 ** 0.209 F(1, 56) = 0.035 0.825 0.001 F(1.7, 97.4) = 0.861 0.425 0.015 
Muscular tension  F(1.2, 73.8) = 42.722 <0.001 *** 0.433 F(1, 56) = 0.777 0.382 0.014 F(1.2, 73.8) = 1.118 0.311 0.020 
Headache F(2, 112) = 5.138 0.007 ** 0.084 F(1, 56) = 0.068 0.796 0.001 F(2, 112) = 0.155 0.857 0.003 
Loss of 
concentration  
F(1.5, 81.2) = 10.555 <0.001 *** 0.159 F(1, 56) = 0.594 0.444 0.011 F(1.5, 81.2) = 0.902 0.381 0.016 
Shaking  F(1.5, 85.1) = 23.267 <0.001 *** 0.311 F(1, 56) = 0.011 0.915 <0.001 F(1.5, 85.1) = 0.459 0.580 0.008 
Confusion  F(1.5, 81.2) = 10.666 <0.001 *** 0.160 F(1, 56) = 0.008 0.929 <0.001 F(1.5, 81.2) = 0.375 0.620 0.007 
Note. BP = blood pressure; HR = heart rate; VASs = visual analogue scales (McCormack et al., 1988); PANAS = Positive-Negative Affect Schedule (Watson et al., 1988); BSS = Bodily Symptoms Scales (Bond & Lader, 1974); ηp2 = partial eta squared 
*** p < 0.001; **p < 0.01; *p < 0.05. 
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Figure 2. Salivary cortisol level on Day 1. Error bars represent standard errors. 
 
 
3.4. Intrusive memories Day 1 
Critically, the number of hours between film viewing and diary completion on Day 
1 did not differ significantly between groups (see table 4). Groups also did not differ 
in their ratings of sleep quality on Day 1. Therefore, any observed group differences 
on memory-related outcomes were not attributable to difference in these variables.  
As the drug group differences were evident on Day 1, the sub-acute effects of 
hydrocortisone versus placebo on the frequency, vividness and distress of intrusive 
memories on Day 1 were examined separately. There was a significant difference 
between drug groups in the frequency of intrusive memories on Day 1 (t(56) = 3.264, 
p = 0.002, d = -0.94), indicating higher frequency in the placebo than hydrocortisone 
group. Similarly, there was a significant difference in vividness on Day 1 (t(56) = 2.655, 
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p = 0.010, d = -0.64), suggesting higher level of vividness in the placebo than 
hydrocortisone group. However, there was no significant difference in distress on Day 
1 (t(55) = 1.686, p = 0.097, d = -0.45).  
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Table 4 
 
Diary Completion Time, Attentional Parameters, and Ratings of Sleep Quality on Day 1 by Drug Treatment Group 
 
Variables  Hydrocortisone (n = 29) 
M (SD) 
Placebo (n = 29) M (SD) Statistics for group difference p-value Effect size (Cohen’s d) 
Diary completion time 7.64 (5.47) 7.90 (4.79) t(56) = 0.046 0.963 -0.05 
Attentional parameters      
Average gaze duration 2.59 (2.35) 2.54 (1.89) t(54) = -0.078 0.938 0.02 
Number of fixation 7.72 (6.33) 8.61 (5.77) t(56) = -0.184 0.855 -0.15 
Ratings of sleep quality      
Sleep quality  0.89 (0.69) 1.24 (0.79) χ2(3) = 3.952 0.267 -0.47 
Sleep latency  0.89 (0.99) 1.17 (1.07) χ2(3) = 1.477 0.688 -0.27 
Sleep duration 0.82 (0.77) 0.72 (0.70) χ2(3) = 1.223 0.747 0.14 
Experience of dream 0.32 (0.48) 0.41 (0.50) χ2(1) = 0.522 0.470 -0.18 
Experience of nightmare 0.18 (0.39) 0.17 (0.38) χ2(1) = 0.004 0.951 0.03 
Experience of night terror <0.001* 0.03 (0.19) χ2(1) = 0.983 0.322 -0.22 
* Only one participant reported in the hydrocortisone group reported experience of night error on Day 1, resulting in a very small value of mean and standard deviation.  
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3.5. Intrusive memories on Day 1-7 
Intrusive memories across Day 1-7 were examined. Figure 3 shows the frequency 
of intrusive memories across Day 1-7, indicating a steady decline overall. This is 
consistent with the results of repeated measure ANOVA that there was a significant 
main effect of Drug on the frequency of intrusive memories (F(1, 56) = 8.073, p = 
0.006, ηp2 = 0.126). There was also a main effect of Time on the frequency of intrusive 
memories (F(5.0, 280.4) = 33.446, p <0.001, ηp2 = 0.374). However, there was a lack 
of significant interaction effect, showing that the rate of decline did not differ between 
drug groups (F(5.0, 280.4) = 0.825, p = 0.533, ηp2 = 0.015).  
In addition, Helmert contrasts were used to compare daily intrusive memories with 
the mean of intrusive memories on the subsequent days. They showed that for the 
placebo group, intrusive memories on Day 1, Day 2 and Day 3 were more frequent 
than subsequent days (Day 1: F(1, 28) = 52.689, p < 0.001, ηp2 = 0.657; Day 2: F(1, 
28) = 31.632, p < 0.001, ηp2 = 0.530; Day 3: F(1, 28) = 7.930, p = 0.009, ηp2 = 0.221). 
For the Hydrocortisone group, similarly, intrusive memories on Day 1, Day 2 and Day 
3 were more frequent than subsequent days (Day 1: F(1, 28) = 34.565, p < 0.001, ηp2 
= 0.552; Day 2: F(1, 28) = 17.273, p < 0.001, ηp2 = 0.382; Day 3: F(1, 28) = 11.231, 
p = 0.002, ηp2 = 0.286). 
Negative binomial regression, furthermore, confirmed the main effect of Drug and 
showed that across Day 1-7, relative to the hydrocortisone group, the placebo group 
experienced 2.25 times as many total number of intrusive memories (95% CI: 1.43-
3.55; p = 0.001). The incident rate ratio (IRR) remained virtually unchanged (Exp(B) 
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= 2.210; 95% CI: 1.40-3.50; p = 0.001) when baseline BDI, STAI and DES total scores 
were added to the model. The covariates did not significantly improve the model (BDI: 
Exp(B) = 0.983; 95% CI: 0.91-1.07; p = 0.685; STAI: Exp(B) = 1.021; 95% CI: 0.99-
1.06; p = 0.258; DES: Exp(B) = 0.990; 95% CI: 0.95-1.03; p = 0.585). 
 
 
Figure 3. The frequency of intrusive memories across Day 1-7. Error bars represent standard 
errors. 
 
Figure 4 shows a steady decline in the vividness of intrusive memories across Day 
1-7. There was a main effect of Drug (F(1, 54) = 5.905, p = 0.018, ηp2 = 0.099) and a 
main effect of Time (F(6, 324) = 29.862, p <0.001, ηp2 = 0.356) on the frequency of 
intrusive memories. However, there was a lack of significant interaction effect, 
showing that the rate of decline did not differ between drug groups (F(6, 324) = 0.653, 
p = 0.687, ηp2 = 0.012).  
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Helmert contrasts showed that for the placebo group, intrusive memories on each 
of Day 1, Day 2 and Day 3 were more vivid than subsequent days (Day 1: F(1, 28) = 
87.730, p < 0.001, ηp2 = 0.758; Day 2: F(1, 28) = 32.088, p < 0.001, ηp2 = 0.534; Day 
3: F(1, 28) = 11.440, p = 0.002, ηp2 = 0.290). For the Hydrocortisone group, intrusive 
memories on each of Day 1, Day 2 and Day 3 were also more vivid than subsequent 
days (Day 1: F(1, 26) = 26.757, p < 0.001, ηp2 = 0.507; Day 2: F(1, 26) = 9.577, p = 
0.005, ηp2 = 0.269; Day 1: F(1, 26) = 7.021, p = 0.014, ηp2 = 0.213). 
 
 
 
Figure 4. The vividness of intrusive memories across Day 1-7. Error bars represent standard 
errors. 
 
Figure 5 shows a steady decline in the distress of intrusive memories across Day 
1-7. There was a main effect of Time (F(6, 324) = 31.294, p <0.001, ηp2 = 0.367) and 
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no significant main effect of Drug (F(1, 54) = 3.613, p = 0.063, ηp2 = 0.063) or 
interaction effect (F(6, 324) = 0.578, p = 0.722, ηp2 = 0.011) on the distress of 
intrusive memories. Therefore, the distress of intrusive memories and the rate of 
decline in distress did not differ between drug groups. 
Helmert contrasts showed that for the placebo group, intrusive memories on each 
of Day 1, Day 2 and Day 3 were more distressing than subsequent days (Day 1: F(1, 
28) = 65.445, p < 0.001, ηp2 = 0.700; Day 2: F(1, 28) = 40.488, p < 0.001, ηp2 = 
0.591; Day 3: F(1, 28) = 9.375, p = 0.005, ηp2 = 0.251). For the Hydrocortisone group, 
intrusive memories on each of Day 1, Day 2 and Day 3 were also more distressing than 
subsequent days (Day 1: F(1, 26) = 31.176, p < 0.001, ηp2 = 0.545; Day 2: F(1, 26) = 
13.741, p = 0.001, ηp2 = 0.346; Day 1: F(1, 26) = 6.608, p = 0.016, ηp2 = 0.203). 
 
 
 
 
Figure 5. The distress of intrusive memories across Day 1-7. Error bars represent standard errors. 
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3.6. Declarative memory on Day 8 
There were no group differences in subjective state measures and IES-R on Day 
8 (see Table 5). In addition, there was no group difference in self-reported diary 
compliance ratings. Participants’ performance on free and cued recall tasks on Day 8 
is given in Table 6. Overall, there were no drug group differences in any measure of 
free or cued recall performance. Considering declarative memories for both scenes of 
the trauma film together, there was no significant difference in free recall (gist: t(56) 
= -0.695, p = 0.490, d = 0.21); detail: t(56) = -0.952, p = 0.345, d = 0.25; idea 
information: t(56) = -0.891, p = 0.377, d = 0.22) or cued recall (t(56) = -0.172, p = 
0.864, d = 0.04).  
Correlations. In the placebo group, there was a strong positive correlation between 
the number of intrusive memories on Day 1 and all measures of free recall (average of 
both scenes) on Day 8 (gist: r = 0.679, p <0.001; detail: r = 0.460, p = 0.012; total: r 
= 0.534, p = 0.003). However, there was no significant correlation between Day 1 
frequency and Day 8 cued recall (average of both scenes; r = 0.038, p = 0.843). 
Similarly, there was a positive correlation between total number of intrusive memories 
across 7 days and all measures of free recall (gist: r = 0.615, p <0.001; detail: r = 0.391, 
p = 0.036; total: r = 0.467, p = 0.011), but not on cued recall on Day 8 (r = -0.038, p = 
0.845). In the hydrocortisone group, however, there was no significant correlation 
between the frequency of intrusive memories on Day 1 and cued recall (r = 0.168, p = 
0.384) or all measures of free recall (gist: r = 0.196, p = 0.307; details: r = 0.251, p = 
0.189; total: r = 0.240, p = 0.211). In addition, there was no correlation between the 
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total number of intrusive memories across 7 days and free recall of gist units (r = 0.263, 
p = 0.168) or cued recall on Day 8 (r = 0.201, p = 0.295). Nonetheless, there was a 
positive correlation between the total number of intrusive memories across 7 days and 
free recall of detail units (r = 0.441, p = 0.017) and total units (r = 0.395, p = 0.034). 
Therefore, in the placebo group, a higher number of intrusive memories was associated 
with better declarative memories, suggesting frequent intrusive memories supporting 
long-term declarative memory. In the hydrocortisone group, nonetheless, the lack of 
correlations suggested that declarative memory performance was not associated with 
the frequency of intrusive memories on Day 1 but might be associated with overall 
frequency of intrusive memories.  
In addition, there was a general decrease in mean heart rate from Time 1 (M = 
83.4, SD = 10.8) to Time 2 (M = 80.6, SD = 10.8) to Time 3 (M = 78.0, SD = 10.9) on 
Day 8. There was a main effect of Time on mean heart rate (F(1.5, 79.7) = 21.302, p < 
0.001, ηp2 = 0.287), but no main effect of Drug (F(1, 53) = 1.074, p = 0.305, ηp2 = 
0.020), or interaction of Drug and Time (F(1.5, 79.7) = 0.499, p = 0.556, ηp2 = 0.009). 
Therefore, there was no evidence of increased sympathetic arousal during free or cued 
recall tasks on Day 8.  
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Table 5 
  
Diary Compliance Rating, Subjective State Measures and IES-R Scores by Drug Treatment Group 
 
Measures Hydrocortisone (n = 29) M (SD) Placebo (n = 29) M (SD) Statistics  p-value Effect size (Cohen’s d) 
Diary compliance rating 8.72 (1.13) 8.48 (1.70) t(56) = -0.636 0.527 0.17 
IES-R  
Intrusion  6.27 (4.62) 8.52 (6.13) t(56) = 1.573 0.121 -0.41 
Avoidance  7.28 (6.16) 8.17(6.30) t(56) = 0.548 0.586 -0.16 
Hyperarousal  1.93 (2.28) 3.10 (3.63) t(47.2) = 1.473 0.147 -0.39 
Total  15.48 (10.93) 19.93 (15.0) t(56) = 1.292 0.202 -0.34 
VASs  
Negative scale 0.48 (0.77) 0.32 (0.42) t(43.6) = -1.019 0.314 0.26 
Happiness 5.21 (1.84) 5.10 (2.43) t(56) = -0.183 0.855 0.05 
PANAS  
Positive  24.59 (6.58) 25.45 (7.50) t(56) = 0.465 0.644 -0.12 
Negative  11.72 (1.75) 12.0 (2.28) t(56) = -0.453 0.652 -0.14 
BSS  
Anxiety  12.52 (14.89) 8.93 (9.42) t(56) = -1.096 0.278 0.29 
Depression  3.86 (6.47) 4.14 (5.44) t(56) = 0.176 0.861 -0.05 
Memory impairment 1.86 (4.18) 4.34 (11.18) t(56) = 1.120 0.267 -0.29 
Palpitation 4.03 (7.45) 3.07 (4.30) t(44.8) = -0.604 0.549 0.16 
Nausea  2.21 (5.58) 5.72 (14.51) t(36.1) = 1.218 0.231 -0.32 
Emotional numbness 5.66 (11.56) 5.48 (9.01) t(56) = -0.063 0.950 0.02 
Euphoria 9.45 (18.43) 11.10 (19.78) t(56) = 0.330 0.743 -0.09 
Drowsiness  11.14 (16.41) 11.9 (14.41) t(56) = 0.179 0.859 -0.05 
Muscular tension  5.10 (11.01) 5.07 (7.27) t(56) = -0.014 0.989 <0.01 
Headache 2.79 (6.73) 5.52 (9.91) t(56) = 1.225 0.226 -0.32 
Loss of concentration  4.55 (9.13) 5.79 (8.63) t(56) = 0.532 0.597 -0.14 
Shaking  2.24 (6.84) 1.41 (3.51) t(56) = -0.580 0.564 0.15 
Confusion  1.38 (4.25) 2.52 (4.15) t(56) = 1.033 0.306 -0.27 
Note. IES-R = The revised impact of Events Scale (Weiss & Marmar, 1997); VASs = visual analogue scales (McCormack et al., 1988); PANAS = Postive-Negative Affect Schedule (Watson et al., 1988); BSS = Bodily Symptoms 
Scales (Bond & Lader, 1974). 
*** p < 0.001; **p < 0.01; *p < 0.05. 
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Table 6 
 
Free Recall and Cued Recall Scores by Drug Treatment Group 
 
 Hydrocortisone (n = 29) M (SD) 
 
Placebo (n = 29) M (SD) 
 
Memory scores Scene 1 Scene 2 Average  Scene 1 Scene 2 Average  
FR gist (%) 23.85 (9.17) 28.08 (11.12) 25.96 (8.52) 23.92 (9.89) 24.63 (12.60) 24.28 (9.93) 
FR detail (%) 5.78 (2.95) 12.10 (5.22) 8.94 (3.70) 6.45 (3.56) 9.53 (4.70) 7.99 (3.91) 
FR total (%) 9.59 (4.16) 13.85 (5.59) 11.72 (4.37) 10.13 (4.72) 11.18 (5.27) 10.66 (4.70) 
CR total  4.43 (1.53) 3.43 (1.60) 3.93 (1.30) 4.53 (1.08) 3.22 (1.52) 3.88 (0.95) 
Note. FR = free recall; CR = cued recall.  
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4. Discussion 
 
4.1. Findings of the current study 
This study examined the effect of administering hydrocortisone shortly after an 
experimentally induced trauma on subsequent intrusive memories in healthy women 
using a trauma film paradigm. The findings provided partial support for the proposed 
hypotheses. Participants showed an increase in subjectively experienced negative 
states post-film and hydrocortisone and placebo groups differed in their cortisol levels 
after drug intake, indicating a successful induction of traumatic memories and 
hydrocortisone administration. Moreover, the frequency and vividness of intrusive 
memories throughout the course of the week after the trauma film significantly differed 
between the hydrocortisone and placebo groups. As predicted, the administration of a 
single dose of hydrocortisone within the memory consolidation window reduced 
intrusive memories, with a sub-acute effect on the day of film viewing. However, 
contrary to predictions, after one week, performance on free- and cued-recall tasks 
related to the trauma film did not differ between these two groups. Furthermore, 
declarative memory performance was not negatively correlated with the frequency of 
intrusive memories. 
Consistent with the hypothesis, there was a significant reduction in the frequency 
and vividness of intrusive memories in the hydrocortisone group. One explanation for 
such a reduction could be the improved consolidation of C-reps via hydrocortisone 
treatment during the critical period of memory consolidation and hence top-down, 
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down-regulation of intrusive memories (S-reps) that ultimately led to the overall lower 
rate of intrusive memories in the hydrocortisone condition. Alternatively, another 
explanation for the decrease in intrusive memories could be the initially impaired 
retrieval of trauma memory via hydrocortisone administration that further impeded 
subsequent memory retention as there was less information to be rehearsed during the 
consolidation period, resulting in a continuously lower number of intrusive memories 
for the rest of the week (Day 2-7).  
In this study, there was a short time interval between drug administration and 
memory recording (approximately 8 hours on average). On the one hand, it was 
possible that hydrocortisone disrupted the formation of intrusive memories by 
weakening the memory retrieval process while the consolidation process was not yet 
completed and the cortisol level was still elevated. This explanation could be supported 
by the finding that there was a sub-acute difference between drug groups on Day 1 that 
the hydrocortisone group showed significantly lower frequency and vividness of 
intrusive memories than the placebo group. Past research suggested that PTSD 
symptoms develop over time after trauma because of positive feedback mechanisms 
in which the traumatic memories are constantly retrieved and restored (Pitman, Orr, & 
Shalev, 1993). Hydrocortisone might prevent chronic stress symptoms and incidence 
of PTSD in patients with traumatic memories through interference with memory 
retrieval. On the other hand, the effect of hydrocortisone on retrieval impairment is 
related to plasma corticosterone levels that can return to baseline within a few hours 
(i.e., fewer than 8 hours) post-administration due to its short duration of action 
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(Dominique et al., 1998). It was possible that plasma corticosterone levels have 
returned to the baseline by the time of intrusion recording, limiting its effect on 
memory retrieval. Therefore, both explanations for the reduction in intrusive memories 
need to be explored further, given that the timescale of this study did not permit testing 
the difference between memory consolidation and retrieval.  
Contrary to predictions, the findings of the current study only showed a reduction 
in intrusive memories but not in declarative memories. Although a number of studies 
showed that stress and stress-induced elevations of cortisol can improve declarative 
memories, it should be noted that these studies differ from the current one in that they 
administered mostly psychosocial stressors (Domes, Heinrichs, Reichwald, & 
Hautzinger, 2002; Smeets et al., 2008) and/or administered exogenous hydrocortisone 
prior to stimulus presentation, usually at the time of encoding (Abercrombie et al., 
2003; Buchanan & Lovallo, 2001; Kirschbaum, Wolf, May, Wippich, & Hellhammer, 
1996; Maheu et al., 2004). Therefore, the findings of the aforementioned studies may 
have been affected by other factors as a result of differences in design from the current 
study.  
Additionally, in the previous study demonstrating that induced stress and/or 
hydrocortisone administered shortly after learning negatively affected memory 
retention, declarative memory was tested within a relatively short period of time (i.e., 
< 24 hours; Diamont, Fleshner, Ingersoll, & Rose, 1996; Wolf et al., 2001). However, 
in the current study, declarative memory was tested after one week, so that there was 
a relatively long interval between learning and recall. During this long interval, a 
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number of events might have happened to interfere with memory of the trauma film 
and natural forgetting from Day 1 to Day 8 might have occurred in both groups, which 
hence contributed to the lack of significant difference between drug groups in 
declarative memory performance.  
Alternatively, the lack of enhancing effect on declarative memory performance 
might be linked to stress at the time of retrieval on Day 8. Stress might have been 
created as a result of the demand of the surprise memory tasks, which in turn impaired 
memory performance (de Quervain et al., 2009). However, there was no indication of 
increased heart rate as an indicator of sympathetic arousal during memory tasks, 
making this alternative explanation unlikely.  
In addition, inconsistent with the hypothesis that declarative memory performance 
is negatively correlated with intrusive memories, a significant positive correlation 
between total frequency of intrusive memories across 7 days and free recall of the 
trauma film (especially its detail units) was found in the hydrocortisone group. There 
seemed to be a positive relationship between intrusive and declarative memory, 
suggesting that a lower number of intrusive memories (possibly as a result of initially 
impaired retrieval via hydrocortisone administration) might be associated with worse 
declarative long-term memories.  
Despite a reduction in frequency and vividness, there was no significant impact of 
hydrocortisone on the degree of distress evoked by intrusive memories. In addition, 
there was a lack of significant differences between the hydrocortisone and placebo 
groups on IES-R measures, so that, similar to the findings in Rombold et al.’s (2016) 
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study, post-film hydrocortisone treatment did not seem to influence emotional 
responses or subjective interpretations of the impact of trauma (Brewin, 2001). The 
lack of effect on intrusion distress was inconsistent with some of the previous studies 
suggesting that emotional aspects of PTSD, such as anxiety and depression, could be 
improved by the administration of hydrocortisone (Delahanty et al., 2013; Zohar et al., 
2011). It might have been that the current study was underpowered to detect effects on 
distress, as the effect sizes for frequency (ηp2 = 0.126), vividness (ηp2 = 0.099), and 
distress (ηp2 = 0.063) were not too dissimilar and when examining the difference 
between drug groups in the degree of distress, the calculated p-value was equal to 
0.063.  
In this study, the lack of significant change in heart rate during the trauma film 
seemed to indicate no noradrenergic activation in the sympathetic nervous system 
amongst participants (Sahu, Upadhyay, & Panna, 2014; van Stegeren et al., 2006). In 
addition, there was no correlation between total frequency of intrusive memories and 
participants’ post-film salivary cortisol levels. These findings were consistent with the 
hypothesis that a positive correlation between post-film salivary cortisol level and 
frequency of intrusive memories only in participants with increased sympathetic 
activation, which also concurred with Chou et al.’s (2014) research findings. 
Furthermore, endogenous cortisol level increase and sympathetic activation had 
previously been considered essential for inducing an emotional effect on intrusive 
memories (Chou et al., 2014; Keyan & Bryant, 2017; Winter et al., 2007). The lack of 
change in these physiological reactions suggests that the non-significant reduction in 
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distress might be related to the absence of sufficient emotional effects on intrusive 
memories in the first place. Interestingly, the reduction of intrusive memories in the 
hydrocortisone group was still found in spite of a lack of increase in these 
physiological reactions, indicating that the effect of hydrocortisone administered 
shortly after the trauma film might be independent of emotional influences. 
4.2. Limitations 
Some limitations of the current study should be recognised. Intrusive memories 
were examined in healthy participants following a relatively mild stressor, which lacks 
the intensity of real-life traumatic events that potentially lead to PTSD. Therefore, it is 
uncertain whether these effects on reducing intrusive memories would be applicable 
to the intrusive memories in patients with PTSD. In addition, vulnerable populations, 
such as individuals with previous traumatic experiences, might respond differently to 
hydrocortisone during consolidation and retrieval of traumatic events (de Quervain et 
al., 2009; Rombold et al. 2016; Yehuda, 2002).  
It has also been suggested in past studies that patients with established PTSD can 
show low endogenous cortisol levels, depending on trauma type (Meewisse, Reitsma, 
Vries, Gersons, & Olff, 2007; Pitman & Orr, 1990; Young & Breslau, 2004). Different 
at-risk groups may have distinctly different physiological reactions to trauma despite 
being classified under a single diagnosis of PTSD (Aerni et al., 2004). The lack of 
universal patterns makes the findings less generalisable. Therefore, patients with 
previous traumatic experiences of various types may have different baseline 
endogenous cortisol levels and other physiological responses, affecting the formation 
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of intrusive memories and resulting in responses to hydrocortisone treatment that differ 
from those in this current study using healthy participants.  
In addition, emotional memory consolidation differs between men and women 
(Felmingham, Tran, Fong, & Bryant, 2012), and female sex hormones have an impact 
on the formation of intrusive memories (Ferree, Kamat, & Cahill, 2011). For instance, 
salivary estrogen in women is associated with increased intrusive memories (Cheung, 
Chervonsky, Felmingham, & Bryant, 2013). As a result, the results from a female 
sample might not be transferable to men. Emotional memory consolidation also differs 
between women with a natural cycle and women taking oral contraception (Nielsen, 
Barber, Chai, Clewett, & Mather, 2015). Research has suggested that changes in sex 
hormones as a result of taking oral contraception might also affect sleep and hence 
memory (Baker et al., 2017). In addition, past research has also indicated that 
hydrocortisone has differential impacts on memory consolidation and retrieval in 
young and old samples (Wolf et al., 2001). Therefore, this sample, consisting solely of 
young females taking oral contraceptives, may limit generalisability. 
In this study, drug was administered within the window of opportunity for memory 
consolidation, but the intrusive memories on Day 1 were retrieved within a short post-
drug time interval. Orally administered hydrocortisone is highly bioavailable, but it is 
short-acting in terms of the duration of action and time of maximum concentration. 
For example, 20mg hydrocortisone has a plasma and biological half-life of 
approximately 100 minutes and 8-12 hours respectively (Cevc & Blume, 2004; Liapi 
& Chrousos, 1992; Meikle & Tyler, 1977; Webb & Singer, 2005). Therefore, the 
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duration of action and the time of administration of hydrocortisone in the current study 
did not allow for discrimination between the effects on the formation of intrusive 
memories of hydrocortisone during consolidation and retrieval of the trauma film. This 
also made it difficult to interpret the findings in terms of the mechanisms by which the 
drug has an impact. Future studies would benefit from ensuring a long interval (i.e., 
24 hours) post-drug before the recording of intrusive memories in order to examine 
the effect of hydrocortisone on memory consolidation alone.  
In addition, the filler task used in this current study consisted of 1-hour classical 
music clips, which may have had differential effects on individuals depending on their 
appraisal of the music. Research has supported the association between relaxing music 
and lower post-stressor cortisol levels, so participants who particularly enjoyed or were 
aroused by the music may have experienced different changes in their cortisol levels 
(Khalfa, Bella, Roy, Peretz, & Lupien, 2003). Future studies should include subjective 
ratings of how relaxing or arousing participants found the music clips in order to 
control for endogenous cortisol changes.  
Lastly, the 1-hour post-oral hydrocortisone assessment of cortisol levels might not 
have given an accurate indication of peak concentrations as these occur closer to 2 
hours post-administration (Jung et al., 2014). However, it might be difficult to have 
participants remained at the study centre for a longer time period. In addition, although 
BDI-II was used in this current study to measure participants’ trait levels of depressed 
mood, it may not represent trait depression generally as it only asked participants to 
report their mood over the past 2 weeks. It might be a good idea to use other trait 
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measures such as the State-Trait Depression Scales (STDS; Spielberger, 1995; Krohne, 
Schmukle, Spaderna & Spielberger, 2002), in which some items instruct people to 
report how they feel generally. 
4.3. Clinical implications and future directions 
A strength of this current study lies in the use of the trauma film paradigm that can 
induce intrusive memories within a randomised controlled design. The study ensured 
equivalent baseline characteristics, attentional parameters during film viewing, and 
timestamped recording of intrusive memories across participants to minimise the effect 
of confounding variables. Even though the induced intrusive memories are discrepant 
from real-life trauma, the findings of the current study shed an important light on the 
effect of hydrocortisone administered shortly after trauma on intrusive and declarative 
memories in a young female sample. This study adds to a wealth of literature that 
reports the relationship between emotional memories and glucocorticoid. In addition, 
although floor-level results have often been a concern when investigating subclinical 
symptoms, the current study found that the use of online diaries is a feasible method 
of collecting data of intrusive memories in healthy individuals. This was reflected in 
the 0% drop-out rate and low levels of missing data, showing participants’ good 
compliance with the study.  
Furthermore, this study involves the administration of hydrocortisone post-
learning within the window of memory consolidation. This is an important step to 
identifying possible preventative treatment for emotional disorders such as PTSD, as 
it is very unlikely that the practitioners would have the opportunity to administer 
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hydrocortisone prior to a traumatic event. Moreover, a pharmacological treatment that 
can be administered immediately as a single dose rather than repeatedly following a 
traumatic event (Graebener et al., 2017) may help to impede the formation of intrusive 
memories in the first place, thus alleviating the potentiated suffering of an individual 
who not only experienced a traumatic event, but who may also potentially be forced 
to relive it via intrusions and flashbacks. Future advances in screening methods may 
also allow practitioners to identify risk factors and ascertain a patient’s baseline 
cortisol response to a traumatic event, then to subsequently make decisions as to 
whether or not the individual requires further pharmacological interventions. 
In terms of future directions, research should focus on the time-dependent effects 
of hydrocortisone to clarify its effect at each stage of the memory process, namely 
encoding, consolidation, retrieval and reconsolidation. It may be useful to conduct 
studies in which hydrocortisone is given after a delay (e.g., 30 minutes - 1 hour) which 
is more clinically realistic as most people cannot be treated directly after traumatic 
events. In addition, studies should be carried out to examine both genomic and non-
genomic effects of hydrocortisone on the formation of intrusive memories. The 
endocannabinoid system, along with genetic and epigenetic mechanisms within the 
HPA axis, have all been suggested to be involved in the formation and development of 
intrusive memories, hence requiring more explorations and investigations. The 
interactional influence of the HPA axis and noradrenergic systems should be examined 
by blocking or activating one system while conversely activating or blocking the other. 
Lastly, neuroimaging techniques may be helpful in uncovering neural mechanisms of 
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S-reps and C-reps consolidation with theoretical reference to DRT, as researchers may 
be able to discover differences in activation of the hippocampus and amygdala in 
response to emotional stimuli following hydrocortisone administration.  
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Part 3: Critical Appraisal 
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Introduction 
 
This critical appraisal considers conceptual and practical issues raised during the 
process of the current research project. Firstly, this appraisal comprises my personal 
assumptions and how they have been challenged and modified throughout the project. 
Next, it will reflect on the methodological and analytical choices and the feelings of 
anxiety and frustration that have raised in me. Lastly, this critical appraisal will set out 
insights gained from research results and their implications for future work. The 
strengths, limitations and implications of the current research project that were 
discussed in the empirical paper in Part 2 will not be repeated in this critical appraisal.  
 
1. Personal assumptions 
Researchers usually carry their own assumptions during the process of research 
that reflect their experiences, values and beliefs, which in turn inevitably influence 
their research (Willig, 2013). The consideration and presentation of a researcher’s 
influences upon their work, known as the process of reflexivity, generates richer 
findings that the reader can more easily assess in relation to their own settings (Finlay, 
1998; Mantzoukas, 2005; Willig, 2013). It is impossible to exclude bias in research 
studies (Kaptchuk, 2003; Mantzoukas, 2005; Norris, 1997; Soeken & Sripusanapan, 
2003), and bias is not by definition counterproductive for research studies. It has been 
argued that biased studies do not necessarily constitute invalid research, and 
acknowledging and reflecting on one’s biases and assumptions can improve the 
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validity of research findings and lead to more objective evaluations of one’s research 
(Endacott, 1994; Mays & Pope, 2000; Moseley & Mead, 2004; Whittemore, Chase, & 
Mandle, 2001). During the process of this current research, I held several assumptions 
that might have emerged from my personal as well as professional experiences. These 
assumptions were challenged and modified as my research progressed.  
Firstly, before conducting this research, I believed that stress is disadvantageous 
and always brings about negative consequences in our daily lives. This assumption 
emerged from a range of personal experiences; for example, stress can negatively 
affect my concentration and performance in work and study. However, while reading 
relevant literature on the relationship between stress hormones and memory, I realised 
that a number of studies have suggested that either extremely high or low levels of 
stress can lead to harmful effects on memory, whereas a reasonable level of stress 
actually has a beneficial effect on memory (Kuhlmann & Wolf, 2006; Patel et al., 2000). 
In addition, the impact of stress on memory is also dependent on memory phase 
(Dominique, Aerni, Schelling, & Roozendaal, 2009; Roozendaal, 2002; Wolf, 2009). 
The supporting evidence from this current research also consolidated these findings. I 
then reflected on this information in relation to my daily experiences. For instance, an 
appropriate amount of stress during exam revision can help me remember and revise 
more efficiently, while stress prior to an exam can harm my memory of study materials. 
Therefore, my negative view of stress was shifted, and this research helped me update 
my knowledge and have a neutral view of the functions of stress.  
In addition, I began my research with an assumption that psychological 
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interventions outweigh pharmacological interventions in the treatment of trauma-
related symptoms. This assumption stemmed from my professional experience as a 
trainee clinical psychologist, where I was equipped with more knowledge of trauma-
related therapies, such as trauma-focused cognitive-behavioural therapy (CBT; 
Fitzgerald & Cohen, 2012), compassion-focused therapy (CFT; Gilbert, 2010), and 
eye movement desensitization and reprocessing (EMDR; Shapiro & Solomon, 1995) 
than pharmacological treatments. The significant findings from the current research 
allowed me to gain more knowledge of the impact of pharmacological interventions 
on the treatment of psychological trauma and realise the importance of both types of 
interventions and their complementary effects in the treatment of trauma. These 
findings helped me have greater awareness that pharmacological and psychological 
interventions for trauma are not mutually exclusive and that using them 
complementarily can be more effective in reducing trauma-related symptoms (Hetrick, 
Purcell, Garner, & Parslow, 2010; Jonas et al., 2013; McHugh, Whitton, Peckham, 
Welge, & Otto, 2013). 
 
2. Reflections on the research process 
On reflection, I experienced feelings of anxiety and frustration at various stages of 
my research. Firstly, although I found myself interested in the field of trauma and 
trauma-related symptoms, I was relatively unfamiliar with research studies in the area 
of psycho-pharmacology and brain functions that are important parts of the current 
research project. Therefore, I was initially not confident and did not believe that I had 
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a sufficient body of knowledge for carrying out this research. Furthermore, most of my 
previous research experiences had involved the use of retrospective questionnaires and 
surveys, whereas the current research project is experiment-based, involving the use 
of various research and technical equipment (e.g., eye-tracker, BodyGuard 2 ECG 
device and the collection and analysis of saliva sample) in a laboratory setting. My 
lack of relevant experience or knowledge created many challenges for me, and much 
time was spent familiarising myself with the research equipment before the start of 
testing. These self-doubts fostered anxiety and made me question whether it was wise 
to have chosen this research project. In addition, as this was a joint project in which I 
worked with a colleague who was another trainee from the same doctoral course at 
University College London (UCL; Sim, 2018), I was concerned that my lack of 
knowledge and confidence would impede the overall progress of the project and hence 
affect the progress of my colleague’s work. However, my supervisors and colleagues 
from the same research project offered me support and demonstrated patience while 
helping me make sense of new and complicated ideas. I also received encouragement 
from my supervisors in the process of writing my research proposal, which set a good 
direction for my research project. In addition, I realised that my lack of previous 
experience in these areas of research actually helped me become more open and 
curious about different ideas and more able to generate new and creative ideas. 
Therefore, as my research project progressed, I gained more confidence, certainty and 
interest in my research.      
Due to the graphic nature of the trauma film and the use of medications in this 
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current research, I was initially concerned about potential negative effects on healthy 
participants involved in the study. I discussed my concerns with my supervisors, who 
directed me to some relevant papers in which the effects of hydrocortisone were 
elicited, a similar study design was used, and the trauma film paradigm was validated 
(e.g., Holmes & Bourne, 2008; Rombold et al., 2016; Soni, Curran, & Kamboj, 2013; 
Zohar et al., 2011; Zohar, Sonnino, Juven-Wetzler, & Cohen, 2009). As I became more 
familiar with the literature, I began to realise that my initial concerns were mainly 
related to my lack of relevant knowledge, so that it was important to ensure that I 
gained a good understanding of this area of research. In addition, my anxiety led me 
to become warier when explaining the study process to the research participants, 
highlighting to them their right to withdraw from the study at any point and gaining 
their consent before they started the experiment. During the experiment, furthermore, 
no participants reported any negative drug effects. After they were debriefed, many 
participants were interested in the research findings and asked to be updated about our 
findings after our project is finalised. Participants’ interests were rewarding and 
encouraging.  
In addition, as part of the inclusion criteria, participants needed to be taking oral-
based contraceptives for at least one month in order to be eligible for the current study. 
This brought about challenges for our recruitment, as many participants expressed 
interest in the study but later realised that they were ineligible because they did not 
take oral-based contraceptives. As a result, our recruitment was slowed, creating much 
anxiety in me and my colleague, thinking that we might not be able to recruit enough 
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participants on time and hence not have sufficient power for the result analysis. The 
current study was advertised on various research platforms, and I constantly explored 
different types of online and offline platforms in order to promote our research. This 
was an opportunity to learn which platforms were more efficient. Eventually, our 
recruitment was a success, and we managed to recruit more participants than we 
originally planned. After we had recruited enough participants, they were still a 
number of participants getting in touch with us and would like to take part. Participants 
who were interested but unable to take part in our research project were informed that 
if they were interested, they would be kept on our contact list and would be contacted 
for similar research studies in the future. Recruitment strategies were also shared with 
other researchers. As noted in the empirical paper in Part 2, this current study only 
involved young female participants, limiting the research findings. Research has 
suggested that although approximately 74% of reproductive age women use some form 
of contraception on a regular basis (Alkema, Kantorova, Menozzi, & Biddlecom, 2013; 
Rowlands, 2007; Taylor, Keyse, & Bryant, 2006), only a small proportion of women 
in some non-western cultures use contraception (Gueye, Speizer, Corroon, & Okigbo, 
2015; Joshi, Khadilkar, & Patel, 2015). As a result, the sample diversity was limited, 
making it difficult to generalise the current findings to other cultural contexts. The 
current research findings need to replicate in other cultural contexts in order to 
examine their generalisability.  
This current research was designed as a joint study divided between me and my 
colleague. I focused on the effects of hydrocortisone, while my colleague focused on 
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the effects of propranolol. We worked collaboratively in designing the study, recruiting 
participants, running the experiments and analysing the data, which increased the 
efficiency of our work via consistent mutual support. By working in pairs, inter-rater 
reliability can be reinforced. However, there was some confusion about how we should 
present the research findings in our respective research dissertations. We determined 
that there were two ways of presenting our work, but we were not sure which would 
be most suitable. Specifically, as we shared the same placebo group, we could compare 
the hydrocortisone, propranolol and placebo groups altogether, or, alternatively, we 
could compare our respective drug groups with the placebo group individually. After 
evaluating the pros and cons of each method and consulting our supervisors, we 
decided to resort to the latter as the former might lead to our research dissertations 
being similar to each other and lacking in originality, although it would be more 
scientifically valid and consistent with the study design. We also decided to combine 
and present our overall research findings in a published paper in the future, comparing 
all three groups with each other as a whole.  
 
3. Implications for future work 
More work is required to understand the effect of hydrocortisone on intrusive and 
declarative memories following the experience of trauma. The empirical paper in Part 
2 discussed the implications of the current research for future work. This critical 
appraisal will instead focus on its implications for my personal clinical and 
professional work and its implications beyond clinical psychology.  
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Firstly, the findings from the current research project have implications for my 
clinical work. Although the current research examined intrusive memories relating to 
sexual assault, these findings may shed important light on intrusive memories relating 
to other types of traumatic experiences. For instance, I am currently working as a 
trainee clinical psychologist at a clinical health setting with cancer patients. Many of 
my patients have reported that they experience intrusive memories, images and 
thoughts after their cancer treatment. Research has suggested that cancer patients may 
experience intrusive imagery and thoughts post-surgery, which negatively affect their 
psychological well-being and quality of life and result in mental health issues during 
remission (Chan et al., 2001; Kazak, & Noll, 2015; Monti et al., 2017; Vickberg, 
Bovbjerg, DuHamel, Currie, & Redd, 2000). It is important to take into consideration 
patients’ physical as well as psychological well-being in the treatment of cancer (de 
Vibe, Bell, Merrick, Omar, & Ventegodt, 2009; Epstein, Fiscella, Lesser, & Stange, 
2010). As shown by the current research findings, the beneficial effects of 
administering hydrocortisone within the memory consolidation window on reducing 
the frequency and vividness of intrusive memories suggested that pharmacological 
treatment following cancer treatment may potentially be an effective intervention for 
alleviating intrusive memories and hence reducing mental health issues after cancer 
treatment in these patients. Therefore, future work is needed to replicate these results 
in this clinical population in order to consolidate the research findings.  
Furthermore, some intrusive memories in cancer patients are verbal, presented in 
the form of thoughts and statements. These experiences are sometimes known as 
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intrusive thoughts, which are considered different phenomena from intrusive images 
as they are produced by separate memory systems according to the dual representation 
theory of PTSD (Brewin, Gregory, Lipton, & Burgess, 2010; Hagenaars, Brewin, van 
Minnen, Holmes, & Hoogduin, 2010). In the current study, although participants were 
asked to report whether their intrusive memories were verbal or sensory or both, the 
number of intrusive memories was recorded and calculated without any differentiation. 
It might be helpful to ensure verbal and sensory intrusive memories are analysed 
separately in future work in an attempt to examine the effects of hydrocortisone on 
intrusive images and thoughts respectively as well as to determine whether 
hydrocortisone has a differential effect on these distinct types of intrusive memories.  
In addition, this current research project showed that trauma memory can be 
modulated immediately and shortly following the experience of trauma, usually within 
6 hours (Diamond, Campbell, Park, Halonen, & Zoladz, 2007; Zohar et al., 2011). This 
finding suggests the importance of timing in the treatment of trauma. Intervention 
needs to be implemented soon after trauma and within the appropriate time frame. In 
regard to cancer patients, it might be prudent to implement interventions soon after 
cancer treatment in order to prevent the occurrence of intrusive memories over time.  
Moreover, the findings from the current research have implications for other areas 
as well as for clinical psychology. Through this research project, I have observed that 
the reduction in trauma-related symptoms extends well beyond the traditional 
boundaries of clinical psychology into fields such as social psychology, health 
psychology, sociology and politics. Real progress will emerge only from holistic, 
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multi-disciplinary work that targets not only the individual level but also community 
and societal levels. In addition, any efforts to improve the wellbeing of trauma victims 
(e.g., female victims of sexual assault) depends on the reduction of stereotyping and 
prejudice in both local communities and wider society (Allport, 1954; Buddie & Miller, 
2001; George & Martínez, 2002; McKimmie, Masser, & Bongiorno, 2014). At the 
community level, specifically, such work might include interventions based on 
principles of social psychology, which seek to increase positive social reactions to 
assault victims and reduce relevant stereotyping via encouraging meaningful social 
interactions and support from families, friends and the community as well as from 
virtual social interactions online (Allport, 1954; Crisp & Turner, 2009; Kraut et al., 
1998; Pettigrew, 1998; Pettigrew & Tropp, 2008; Rutland & Killen, 2015). On a 
societal level, efforts might include national publicity campaigns to tackle prejudice 
and discrimination and to support the feminist movement (Donat & D'Emilio, 1992; 
Franiuk, Seefelt, Cepress, & Vandello, 2008; Johnson, Olivo, Gibson, Reed, & 
Ashburn-Nardo, 2009; Mardorossian, 2002; Matthews, 2005).  
Additionally, assault victims need to be encouraged to voice their opinions in order 
to increase awareness in the general public (Houston & Kramarae, 1991; Thompson, 
2000). Moreover, in some societies where sexual assault victims are stigmatised and 
blamed, non-discriminatory and destigmatising campaigns should be encouraged 
(Barnett, Sligar, & Wang, 2016; Deitz, Williams, Rife, & Cantrell, 2015; Lefley, Scott, 
Llabre, & Hicks, 1993; Trenholm, Olsson, Blomqvist, & Ahlberg, 2016). Research 
indicates that a non-blaming environment plays a significant role in improving post-
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trauma well-being and reducing trauma-related symptoms (Peter-Hagene & Ullman, 
2015, 2016; Relyea & Ullman, 2013; van der Bruggen, & Grubb, 2014). Real progress 
will also depend on the continuation of governmental work to provide social support 
to trauma victims under the scheme of social welfare via implementing support groups 
and appropriate services for acute interventions and long-term follow-up (Hazelwood 
& Burgess, 2016; Neville & Heppner, 1999; Staggs, Long, Mason, Krishnan, & Riger, 
2007). Publicity about these available services and support is needed to help victims 
become aware of them. Self-help guidelines also need to be made available and 
accessible to the general public (Herbert, 2017; Litz, Williams, Wang, Bryant, & Engel, 
2004; McCann & Pearlman, 2015). Finally, police investigation and appropriate legal 
consequences for perpetrators are essential to provide social justice for the victim 
(Carbone-Lopez, Slocum, & Kruttschnitt, 2016; Martin & Powell, 1994; Mennicke, 
Anderson, & Kennedy, 2014). 
 
Conclusion 
Through the process of carrying out this research project, I have been struck by 
the complexity of memory processes, brain areas and the effect of hydrocortisone on 
memory. There were some challenges in terms of study design, participant 
recruitments, and result analyses and presentation. Through collaboration with my 
supervisors and my colleague, however, these dilemmas have been resolved via active 
discussions. Carrying out the current research project has been a powerful learning 
experience about pharmacological interventions and brain mechanisms with which I 
was initially unfamiliar but later became profoundly interested. I have also gained 
189 
knowledge regarding how to use a range of research equipment, which is certainly 
valuable for me in terms of conducting other experiments in the future. Some of my 
previous assumptions have been challenged and modified through the process of this 
current research. Conducting this research project has given me a greater awareness of 
the importance of collaboration and group discussion that can often generate new ideas 
and insights into the research. Furthermore, the current research findings clarify the 
effect of hydrocortisone on intrusive memories and have important implications, not 
only for my personal clinical work as a trainee clinical psychologist, but also for work 
beyond clinical psychology into areas of social psychology, politics, crime justice, 
gender equality and social welfare. Overall, I was very pleased to see that this current 
research experience consolidates my passion and hope of pursuing further research in 
the realm of trauma.  
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Appendix 1: Quality and relevant assessment scales 
 
  
202 
Adapted from Newcastle-Ottawa Quality Assessment Scale  
(cohort study) 
Italics represent changes from original assessment scale 
 
Note: A study can be awarded a maximum of one star for each numbered item within 
the Selection and Outcome categories. A maximum of two stars can be given for 
Comparability. 
 
Selection (Maximum 4 stars) 
1) Representativeness of the exposed cohort 
a) truly representative of the average victims of SA in the community * 
b) somewhat representative of the average victims of SA in the community * 
c) selected group of users (e.g. using specialist service or with a particular need) 
d) no description of the derivation of the cohort 
 
2) Selection of the non-exposed cohort 
a) drawn from the same community as the exposed cohort * 
b) drawn from a different source 
c) no description of the derivation of the non-exposed cohort  
 
3) Ascertainment of exposure 
a) secure record (e.g. police record or report) * 
b) structured interview * 
c) written self-report 
d) no description 
 
4) Demonstration that outcome of interest was not present at start of study 
a) yes * 
b) no 
 
Comparability (Maximum 2 stars) 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for baseline mental health condition (except for SUDs) * 
b) study controls for demographics (e.g. age, race/ethnicity, sexuality, education 
background, marital status, employment status, income level etc.) * 
 
Outcome (Maximum 4 stars) 
1) Assessment of outcome  
a) independent blind assessment *  
b) record linkage * 
c) self-report  
d) no description 
 
2) Was follow-up long enough for outcomes to occur 
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a) yes (follow up >/= 6 months) * 
b) no (follow up < 6 months) 
 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for * 
b) subjects lost to follow up unlikely to introduce bias - small number lost - </= 20% 
follow up, or description provided of those lost * 
c) follow up rate < 80% and no description of those lost 
d) no statement 
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Adapted from Newcastle-Ottawa Quality Assessment Scale  
(adapted for cross-sectional studies) 
Italics represent changes from original assessment scale 
 
Note: A study can be awarded a maximum of one star for each numbered item within 
the Selection and Outcome categories. A maximum of two stars can be given for 
Comparability. 
 
  
Selection: (Maximum 4 stars) 
1) Representativeness of the sample 
a) truly representative of the average victims of SA in the community * 
b) somewhat representative of the average victims of SA in the community * 
c) selected group of users (e.g. using specialist service or with a particular need) 
d) no description of the derivation of the cohort 
 
2) Sample size 
a) Justified and satisfactory * 
b) Not justified  
 
3) Non-respondents 
a) Comparability between respondents ‘  and non-respondents’ characteristics is 
established, and the response rate is satisfactory. * 
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
 
4) Ascertainment of the exposure (risk factor): 
a) Validated measurement tool * 
b) Non-validated measurement tool, but the tool is available or described 
c) No description of the measurement tool 
  
Comparability (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design 
or analysis. Confounding factors are controlled. 
a) study controls for baseline mental health condition (except for SUDs) * 
b) study controls for demographics (e.g. age, race/ethnicity, sexuality, education 
background, marital status, employment status, income level etc.) * 
 
Outcome:(Maximum 2 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment * 
205 
b) Record linkage * 
c) Self-report   
d) No description 
 
2) Statistical test: 
a) The statistical test used to analyse the data is clearly described and appropriate, 
and the measurement of the association is presented, including confidence intervals 
and the probability level (p value). * 
b) The statistical test is not appropriate, not described or incomplete. 
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Appendix 2: Trainee contribution to the project 
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This project was conducted jointly with another Trainee Clinical Psychologist at 
University College Long (UCL). We generated ideas together and designed experiment 
protocols under the supervision of Dr. Sunjeev Kamboj and Professor Val Curran. We 
worked collaboratively to recruit participants, and conduct telephone screening and 
experiments during testing sessions, initially in pairs and subsequently independently 
after we became more familiar and confident with the experiment protocols and testing 
materials and equipment. Two Masters students also helped us recruit participants and 
carry out experiments. We attended research meetings together and contributed to 
group discussions.  
Data for hydrocortisone, propranolol and placebo groups were collected altogether. 
I focused on the hydrocortisone group, while the other trainee focused on the 
propranolol group. We shared the placebo group and compared our drug groups with 
the placebo group respectively. The data analysis was carried out independently. We 
coded participants’ free recall performance independently and subsequently compared 
our coding in order to ensure inter-rater reliability.    
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4.1. Information sheet for participants involved in memory consolidation 
research study using cortisol and propranolol 
 
                                                            
You will be given a copy of this information sheet. 
Title of Project: Examining the effects of stress hormones on emotional 
memory using cortisol and propranolol 
This study has been approved by the UCL Research Ethics Committee (Project ID 
Number): 5583/002 
Names of Researchers An Tong Gong; Zhihui Sim; Adrihani Abd Rashid; Ami Baba 
Work Address Research Department of Clinical, Educational and Health 
Psychology, UCL, 1-19 Torrington Place, London WC1E 7HB 
Institute of Cognitive Neuroscience, UCL, Alexandra 
House, 17 Queen Square, London WC1N 3AZ 
Contact Details  Email: an.gong.10@ucl.ac.uk;  zhihui.sim.15@ucl.ac.uk; 
adrihani.rashid.16@ucl.ac.uk; ami.baba.16@ucl.ac.uk  
Tel:  075 1088 7575; 075 1089 1591 
We would like to invite women aged between 18 and 35 to take part in this study. 
You will need to be in good physical and mental health, have average weight (i.e. 
body mass index or ‘BMI’ - between 18.5-30.0), with normal or corrected to 
normal colour vision, taking oral contraception, and fluent in English. Because 
the study involves taking a medication, you cannot take part if you have any of 
the following: a historical or current diagnosis of a mental health issue that 
required/requires treatment, if you have been the victim of interpersonal 
violence or trauma, have known memory problems, serious sleep difficulties, 
diabetes, asthma, breathing problems like Chronic Obstructive Pulmonary 
Disease (COPD), a cardiac pacemaker implant or other cardiovascular 
conditions, a history of epilepsy or neurosurgery, impaired liver or kidney 
function, or a history of anaphylactic reaction.  
This study involves receiving one of two active medications or placebo. Thus, 
you will not be able to take part if you are sensitive to propranolol or cortisol 
and are intolerant of lactose or unable to swallow capsules. In addition, you will 
not be able to take part if you are currently taking cardiovascular or psychiatric 
medication, are pregnant or breastfeeding, or using psychoactive drugs (other 
than alcohol, nicotine and caffeine) regularly (i.e. more than twice a month). To 
take part, you should not be consuming excessive alcohol (i.e. > 14 units per 
week). 
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Details of Study: You should only participate in this study if you want to; 
choosing not to take part will not disadvantage you in any way. Before you 
decide whether you want to take part, it is important for you to read the 
following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. This 
study is being conducted by researchers from the Department of Clinical, 
Educational and Health Psychology at UCL. 
Why are we doing this study?  
Emotional events have a privileged status in our daily lives. However, intensely 
emotional events or chronic exposure to stressful experiences can create 
unwanted memories which are distressing. Therefore, it is important to learn 
about the brain mechanisms involved in the formation of unpleasant emotional 
memories. Some medications might be helpful in helping us understand 
emotional memories, particularly medications that affect the ‘stress response’ 
– such as the steroid drug hydrocortisone and the beta-blocker propranolol – 
which can affect processing of emotional information. Participants in this study 
will therefore receive cortisol or propranolol or a placebo to see how this affects 
their subsequent memories of unpleasant events. By taking part in this study 
you will contribute to the scientific knowledge of the effect of these two drugs 
on ‘memory consolidation,’ which may inform future treatments for 
psychological disorders such as post-traumatic stress disorder (PTSD).  
 
Do I have to take part? 
Your participation in the study is entirely voluntary and you are free to withdraw 
from the study at any time without giving a reason, even if you have previously 
given your written consent. If you do agree to take part, you will be asked to sign 
a consent form and will be given this information sheet to keep. 
What are these drugs and are they safe? 
Depending on which group you are randomly allocated to, you will receive a 
capsule containing hydrocortisone, propranolol or placebo. Hydrocortisone (or 
cortisol) is an important stress hormone in humans. Propranolol, a ‘beta 
blocker,’ is a drug typically used to treat conditions such as high blood pressure 
and anxiety. You will stay in the department for about 1 hr after you take the 
capsule.  
Note that, like all medications, cortisol and propranolol can have side effects 
(e.g. fatigue, sleep difficulties, nausea, drowsiness/weakness, exacerbation of 
existing breathing problems). Therefore, there are strict criteria for inclusion in 
the study.  
 
What will I have to do? 
If you agree to participate in this study, you should contact the experimenter by 
email with contact information and a convenient time to call. You will then 
receive a call from us, and we will ask you a series of questions to check your 
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eligibility for the study. Please note that based on your answers to these 
questions you may not be eligible to take part in the study.  
If you fulfill our study criteria, we will arrange for you to attend 2 appointments 
at UCL which will take place 1 week apart. During Session 1, you will be asked to 
complete some questionnaires about your current mood and usual emotional 
state. You will be asked to provide a saliva sample so we can measure stress 
hormones in your body. You will also be asked to place some sticky probes on 
your body to allow us to measure you heart rate and blood pressure. This is 
completely safe. You will then watch a short film (~15 minutes). You should be 
aware that the film contains highly graphic scenes of interpersonal and sexual 
violence, injury and death which are designed to be distressing. Please do not 
take part if you are likely to become very distressed by such scenes. This will 
be followed by some more questionnaires. After this, you will be given a 
capsules (hydrocortisone, propranolol or placebo) to swallow with water. You 
will then be required to remain in the Department for one hour and provide 
another saliva sample before you leave.  
Between Sessions 1 and 2, you will fill in a simple app-based online diary of 
spontaneous thoughts/memories about the film every evening. You will be 
reminded to do this daily by email.  The daily information provided between 
sessions is absolutely crucial for our experiment. If you are unable or unwilling 
to complete the brief daily diaries on the first three days and on at least five out 
of the seven days between sessions, we will not be able to invite you back for 
the second session and cannot compensate you for your time.  
Please bear in mind that the aim of our research is to develop new ideas for 
treating psychological problems, and we can only do this effectively if you help 
us by following the requirements of the study as carefully as possible. If we get 
bad data from participants, we could end up with the wrong conclusions, and 
that could ultimately be harmful for the people we hope to help with this 
research. You can contact the researchers at any time during or after the study 
if you experience any difficulties with this requirement. 
Seven days after Session 1, you will be asked to return to the Department for 
Session 2, in which you will complete some final tasks. This will last 
approximately 30 minutes, at the end of which, we will provide you with some 
more information about the study and you will receive reimbursement for 
participation in the study.  We will ask if you would like to participate in future 
research. 
 
What are the possible risks of taking part? 
You should be aware that the film contains graphic scenes of sexual assault, 
interpersonal violence, injury and death which are designed to be distressing. 
After the film, people often have spontaneous thoughts and images from the 
film. These are usually short-lasting. In previous research which used this 
procedure with hundreds of participants, no one experienced longstanding 
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intrusive thoughts or emotional problems in response to the film. Any clips you 
see are in the public domain. However, it is not possible to guarantee zero risk 
to you. You should therefore not take part if you have personally experienced 
interpersonal violence/trauma, have concerns about your mental health, or 
think that you may be strongly psychologically affected by the film. 
The medications involved in the study are routinely used in medical practice. 
They are generally very safe. However, like all medicines hydrocortisone and 
propranolol can cause side effects. For hydrocortisone, these include increased 
risk of infection. In particular, if you have never had them, you should keep away 
from people who have chicken pox or shingles. You should not take part if you 
have an infection of any kind.  Other side effects of cortisol can be nausea, 
heartburn, headache, dizziness, menstrual period changes, trouble sleeping, 
increased sweating, changes in eyesight and muscle weakness. If affected, you 
should not drive or operate machinery. Propranolol can cause tiredness, cold 
extremities, difficulties sleeping or disturbed sleep, and slow or irregular 
heartbeat. Other side effects of these drugs are uncommon. If you are 
concerned, you should talk to your doctor.  
How will I be paid? 
You will receive payment for participation upon completion of the whole study. 
In total, the basic testing and study follow-up in your own time should take ~2.5 
hours. You will be compensated £25 for your time.  
How will my data be stored? 
All information which is collected about you during the course of the research 
will be kept strictly confidential and will be securely stored electronically, using 
a numbered code so that you cannot be identified. Only researchers directly 
involved in the study will have access to the data. All data will be stored in 
accordance with the Data Protection Act 1998. The data will be used only for 
informing the research question in this study and the results of the research will 
be disseminated in peer-reviewed scientific journals, but you will in no way be 
identifiable from such publications. You will receive feedback when the study is 
completed. Any biological samples we collect from you will also be anonymised. 
These samples will be destroyed once they are analysed.  
 
Note – if you have any further questions regarding this study please do not 
hesitate to contact any of the researchers above. 
 
This study has been approved by the UCL ethics committee 
It is up to you to decide whether or not to take part. If you choose not to 
participate, it will involve no penalty or loss of benefits to which you are 
otherwise entitled. If you decide to take part, you will be given this information 
sheet to keep and be asked to sign a consent form. If you decide to take part, 
you are still free to withdraw at any time and without giving a reason.  
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Please discuss the information above with others if you wish or ask us if there is 
anything that is not clear or if you would like more information. 
 
Study Registration Details: 
All data will be collected and stored in accordance with the Data Protection Act 
1998. This study has been registered with UCL Data Protection; Number: 
Z6364106/2016/10/28 
This study has been approved by the UCL Research Ethics Committee (Project ID 
Number): 5583/002 
 
If you have any questions regarding the study, please contact the researchers: 
Research Department of Clinical, Educational and Health Psychology, UCL, 1-19 
Torrington Place, London WC1E 7HB 
Email: an.gong.10@ucl.ac.uk 
Tel: 075 1089 1591 
 
________________________________________________________________
________ 
Please discuss the information above with others if you wish or ask us if there is 
anything that is not clear or if you would like more information.  
It is up to you to decide whether to take part or not; choosing not to take part 
will not disadvantage you in any way. If you do decide to take part you are still 
free to withdraw at any time and without giving a reason.   
All data will be collected and stored in accordance with the Data Protection 
Act 1998. 
 
Thank you for reading this information sheet and for considering taking part 
in this research.  
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4.2. Informed consent for participants involved in memory consolidation 
research study using cortisol and propranolol 
 
Please complete this form after you have read the Information Sheet and/or 
listened to an explanation about the research.  
Title of Project:  
Examining the consolidation of emotional memory using cortisol and 
propranolol  
This study has been approved by the UCL Research Ethics Committee (Project ID 
Number): 5583/002 
Thank you for your interest in taking part in this research. Before you agree to take 
part, the person organising the research must explain the project to you. 
If you have any questions arising from the Information Sheet or explanation 
already given to you, please ask the researcher before you to decide whether to 
join.  You will be given a copy of this consent form to keep and refer to at any 
time.  
Participant’s Statement  
I, __________________________________________________ (print name 
clearly) 
 
• have read the notes written above and the Information Sheet, and 
understand what the study involves. 
• understand that if I decide at any time that I no longer wish to take part in 
this project, I can notify the researchers involved and withdraw immediately.  
• consent to the processing of my personal information for the purposes of 
this research study. 
• understand that such information will be treated as strictly confidential and 
handled in accordance with the provisions of the Data Protection Act 1998. 
• agree that the research project named above has been explained to me to 
my satisfaction and I agree to take part in this study.  
• agree to be contacted after my participation to be asked some quick follow-
up questions by the researchers. 
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• understand that I am being paid for my assistance in this research and that 
some of my personal details will be passed to UCL Finance for administration 
purposes. 
• understand that I must not take part if I am pregnant or breast feeding. 
• understand that my anonymity will be maintained and it will not be possible 
to identify me from any publications. 
Signed:         Date:  
 
Email:                                         Tel. No.:                                                                                                                     
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4.3. Study Advertisment  
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4.4. Telephone Screening Questions and Protocol 
 
NB, if in doubt about an inclusion/exclusion criterion, call/email participant back after 
clarifying with Sunjeev or Georges. 
  
Hi ________, my name is……… I am calling because you expressed your interest in 
our research study (to do with emotional memory of distressing events). Are you still 
interested in taking part? 
Is it ok to speak for five minutes now? 
Thank you, I just need to ask you a few screening questions to see if you are eligible to 
participate in the experiment. We ask these questions to everyone who expresses 
interest. I will let you know whether or not you are eligible and if you are not eligible 
I will explain why. Okay? 
So firstly can I check 
the spelling of your 
name? 
  
…Thank you. 
________   
How old are you? ________ (If under 18yrs or over 35yrs SAY: I’m 
sorry but we are only testing people who 
are aged 18-35 so I am afraid you are 
not eligible. Sorry about that.....) 
May I know your height 
and weight? 
_____cm 
_____kg 
(if BMI not within 18.5-30, SAY: I’m 
sorry but we are only testing people who 
have a Body Mass Index within 18.5-30) 
Just to explain a little 
bit about the study… we 
will need you to 
complete a brief online 
diary each evening 
between Session 1 and 
Session 2. 
Do you have reliable 
access to the internet 
every day, even if it’s 
from your mobile 
phone? 
YES / NO (If No, exclude) 
Do you read, write and 
speak English fluently? 
  
Please can you tell me 
YES / NO 
  
________ 
  
(If No, exclude) 
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your profession? 
Are you on an oral-
based contraceptive 
pill? 
YES / NO (If No, exclude) 
Can you please tell me 
the name of oral 
contraceptive pill you 
use? 
  Write down the brand name of the pill 
How long have you 
been using the oral 
contraceptive pill 
continuously? 
  Write down the duration 
When was your last 
period? 
  
  Write down the time 
What is the reason for 
you to take the oral 
contraceptive pill, or 
would you prefer not to 
say? 
  
  (They can choose not to answer) 
  
 
 
Have you ever been a 
victim of interpersonal 
violence or trauma, 
such as being 
assaulted or 
witnessing violent 
injury or death? 
YES / NO (If yes SAY: I’m sorry, as the study contains 
graphic content in a film, we cannot 
ethically include people who have a 
personal history of such events. We’re 
sorry that you cannot take part in this study 
at this time.) 
Have you ever 
experienced any 
mental health 
problems that required 
or requires treatment? 
YES / NO (If yes SAY: I'm sorry, but due to the nature 
of the experiment, we can only include 
people who have no history of mental 
health problems.) 
An important part of 
this experiment is to 
look at emotional 
YES / NO (CAN’T TELL YOU TOO MUCH BUT IT 
IS VERY GRAPHIC AND 
DISTURBING) 
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memory. The way in 
which we do this in this 
experiment is to show 
participants an 
extremely graphic and 
unpleasant video 
during Session 1. The 
video depicts scenes of 
extreme interpersonal 
violence, injury, death 
and sexual assault. 
Although the scenes 
are freely accessible to 
the public, I must 
iterate that they are 
very graphic. Would 
you agree to watch this 
video? 
  
(If no SAY: I’m sorry then you cannot take 
part, as this is a crucial part of the study.) 
  
  
 
As far as you know: 
Are you sensitive to 
cortisol? 
YES / 
NO 
(If Yes, exclude) 
  
Are you intolerant to 
lactose? 
YES / 
NO 
(if Yes, exclude) 
Are you able to swallow 
capsule? 
YES / 
NO 
(if No, exclude) 
Are you taking any 
cardiovascular or 
psychiatric medication? 
YES / 
NO 
(If Yes, exclude) 
  
Are you currently using a 
beta-blocker? 
YES / 
NO 
(If Yes, exclude) 
Do you have any of the 
following: 
-     Asthma or other 
breathing problems? 
-     Cardiovascular 
conditions or a cardiac 
pacemaker? 
YES / 
NO 
(If Yes, exclude) 
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-     Diabetes? 
-     Liver or kidney 
problems? 
-     Problems 
sleeping? 
-     Any diagnosed 
memory problems? 
-     Colour blindness? 
Have you ever had: 
-     A severe 
anaphylactic reaction? 
-     Epilepsy? 
-     Neurosurgery? 
YES / 
NO 
(If Yes, exclude) 
  
Do you have a history of 
fainting? 
YES / 
NO 
(If Yes, exclude) 
  
Do you have low blood 
pressure? (Systolic blood 
pressure of <100 mmHg) 
YES / 
NO 
(If Yes, exclude) 
Are you pregnant or likely 
to become pregnant in the 
coming weeks? 
YES / 
NO 
(If Yes, exclude) 
  
Are you breastfeeding or 
likely to breastfeed in the 
coming weeks? 
YES / 
NO 
(If Yes, exclude) 
  
Aside from caffeine, 
nicotine or alcohol, do you 
currently use any 
recreational drugs more 
than twice per month? 
YES / 
NO 
(If yes SAY: I’m sorry we are only testing 
people who do not use any recreational 
drugs, as this will interfere with the 
drugs we are using in the study.) 
How much alcohol do you 
take in a week? 
_______
_ 
(If over 14 units or ‘standard drinks’ 
SAY: I’m sorry but we are only testing 
people who consume alcohol at a 
moderate level, as this will interfere with 
the drugs we are using in the study.) 
The study may involve 
taking cortisol or 
propranolol on Day 1 of 
the study. Would you be 
YES / 
NO 
(If no SAY: I’m sorry then you cannot 
take part, as this is a crucial part of the 
study.) 
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happy to do this? 
  
Cortisol is an important 
stress hormone in humans. 
Propranolol is a drug 
typically used to treat 
conditions such as high 
blood pressure and 
anxiety. These drugs can 
have side effects (e.g. 
fatigue, nausea, 
drowsiness/weakness). 
Therefore, you will be 
asked to remain in the 
Dept till the effects wear 
off. 
Do you wear any visual 
aids such as glasses or 
contact lenses?  
Do you wear any hearing 
aids?            
YES / 
NO 
  
YES / 
NO 
(If yes to either SAY: please remember to 
bring any visual or hearing aids with you 
on both of your testing sessions, 
otherwise you will not be able to 
participate.) 
  
That’s the end of the screening questions and it seems you are eligible for participating 
in our study. Before I ask you whether you would like to take part or not, I’d like to 
remind you what will be expected of you if you do take part. 
  
If you agree to take part in the study you will be asked to: 
●   Attend UCL on TWO different occasions spaced one week apart. That means 
that if you attend the first session on a Wednesday you will be asked to return the 
following Wednesday for the second session. The first session will take about an 
hour and a half and the second one will take about thirty minutes. 
●   As part of the experiment we’ll be measuring your heart rate – 2 sticky probes, 
one below the right collar bone, one below the left rib cage. This is a completely 
harmless procedure which we’ll show you how to do. 
●   We will ask you to complete some questionnaires and tasks. 
●   We will ask you to watch a short film which contains some graphic scenes 
including interpersonal violence, injury and death which you may involuntarily 
remember afterwards. 
●   We will monitor your eye movements while you watch the film, which is 
completely non-invasive. 
●   We will ask you to take a pill which might be cortisol or propranolol. 
●   We will also ask you to fill in a brief online diary every day during the week 
between the two sessions. This is essential for our study and we can only invite 
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you back for the second part of the study if you complete the diary on the 7 days 
between sessions. Are you sure you can do this? 
●   At the end of the second session you will be paid £25. 
  
So would you like to take part?                                          
YES / NO 
(If YES SAY: Great, thank you! Let’s book your sessions. (Book sessions)) 
Phone number? 
  
It would be helpful if you could read the information sheet carefully before the first 
session, but we'll ask you to read this at the beginning of the session before you sign 
the consent form. 
  
For the experiment on Day 1, we also require you not to have any food or any drinks 
containing caffeine two hours prior to the experiment. Because we’re looking at your 
eye movements we also ask that you wear glasses rather than contacts on the first 
session.  
 
For your own comfort, we want to inform you that it may be of your best interest to 
refrain from wearing a dress or a jumpsuit on Day 1 of the experiment, as it may be 
difficult to attach the heart rate monitor on with these articles of clothing.  
  
Do you have any other questions about the study? 
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4.5. Debrief 
 
This study was an investigation into people’s intrusive memories of unpleasant events. 
Intensely emotional events can cause maladaptive consequences in the memory 
process. For example, you may have heard about Post-Traumatic Stress Disorder 
(PTSD), which visually involves 're-experiencing' the stressful event through 
nightmares, repetitive flashbacks and other distressing involuntary memory 
phenomena (known as intrusive memories). The pharmacological effects on memory 
of two different drugs, cortisol and propranolol, can be used to investigate intrusive 
memories. This in turn can often provide important insight into the nature of emotional 
memories and memory processes, and aid the development of methods to reduce such 
memories.  
 
Therefore, we measured the effects of cortisol and propranolol (alongside a placebo 
control) on the frequency of intrusive memories resulting from watching disturbing 
video clips, over the course of a week. We assessed two types of memory: the intrusive 
memories and voluntary memory (the memory tasks you completed today). The sleep 
survey was used to assess sleep quality, which is known to have an impact on memory 
consolidation. Questionnaires were used to measure participants’ general and event-
specific moods/emotions.  
 
We anticipate that participants who received the active drugs would have less frequent 
intrusive memories and possibly worse declarative memory compared to participants 
who received a placebo. We won’t know who received what until the end of the study, 
which is common in these kind of experiments.  
 
Please contact the experimenters, An Tong Gong, Zhihui Sim, Adrihani Rashid, or Ami 
Baba, at the following e-mail addresses: an.gong.10@ucl.ac.uk; 
zhihui.sim.15@ucl.ac.uk; adrihani.rashid.16@ucl.ac.uk; ami.baba.16@ucl.ac.uk, if 
you have any questions regarding this study. 
 
Thank you again for your participation and cooperation.  
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Appendix 5: Questionnaires and measures 
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5.1. Adapted Pittsburgh Sleep Quality Index 
 
1) What time did you go to bed last night? ____pm 
2) How long did it take you to fall asleep? _____ minutes 
3) How many hours of sleep did you get last night? _____ hours 
4) How would you rate your sleep quality overall? 
a. Very good 
b. Fairly good 
c. Fairly bad 
d. Very bad 
 
 
Retrospective Dream Questionnaire 
 
1) Do you remember having had any dreams last night? 
2) Yes___ 
3) No___ 
 
4) Could any of these dreams have been described as nightmares? (Nightmares are 
defined as ‘a vivid dream that is frightening or disturbing, the events of which 
you can remember clearly and in detail on awakening’.  
Yes ___ 
No___ 
 
5) Did you have any night terrors? A night terror is a ‘sudden awakening in fear, 
possibly accompanied by a scream, but where you do not remember a dream’.  
Yes___ 
No___ 
 
6) Please rate the affectivity of your dreams last night on a scale of 1 – 10, with 1 
being more negative, and 10 more positive 
 
7) Would you say the dream you had last night was more positive or negative than 
usual? 
i. More positive 
ii. More negative 
iii. About the same 
 
8) Did you dream about anything you saw in the video yesterday? 
 
9) If yes, please describe 
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5.2. Filter Task 
 
DEMOGRAPHIC INFORMATION 
 
Participant No.: _____________________ 
Group No:   _____________________ 
D.O.B (incl. year):  _____________________ 
Email address:  _____________________ 
 
Please circle the most appropriate answer for each question. 
 
Handedness: RIGHT LEFT 
 
Ethnicity:  
 
 White: 
• British 
• Irish 
• Any other White background 
 Mixed: 
• White and Black Caribbean 
• White and Black African 
• White and Asian 
• Any other mixed background 
 Asian or Asian British 
• Indian 
• Pakistani 
• Bangladeshi 
• Any other Asian Background 
 Black or Black British 
• Caribbean 
• African 
• Any other Black background 
 Other ethnic groups 
• Chinese 
• Other 
 Not stated 
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Highest academic qualification:  
 
 11 years schooling (GSCE) 
 13 years schooling (A levels) 
 14 years schooling (Bachelors degree 1st year completed)  
 15 years schooling (Bachelors degree 2nd year completed) 
 16 years schooling (Bachelors degree 3rd year completed) 
 17 years schooling (Masters/Bachelors degree 4th year completed) 
 18 years schooling (depending on number of post grad years) 
 19 years schooling (depending on number of post grad years) 
 20 years schooling (depending on number of post grad years) 
 
 
Height (cm): __________ 
Weight (kg): ___________ 
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Participant Number:  ________________ 
Group Number:  ________________ 
 
Music Task     
For each section of music, please rate how pleasant you find it on a scale of 1 to 9, where 
1 2 3 4 5 6. 7 8 9 
(1 = extremely unpleasant)             (5 = midway)          (9 = extremely pleasant) 
It should be easy to tell where one section ends and the next begins. 
 
Set 1: 
section 1 =  
section 2 = 
section 3 = 
section 4 = 
section 5 = 
section 6 = 
section 7 =  
section 8 =  
section 9 =  
section 10 = 
section 11 = 
section 12 =  
section 13 = 
Set 2: 
section 1 =  
section 2 = 
section 3 = 
section 4 = 
section 5 = 
section 6 = 
section 7 =  
section 8 =  
section 9 =  
section 10 = 
section 11 = 
section 12 =  
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5.3. Free recall task 
 
Think back to the video clips from last week.  
 
Please write down everything you can remember about the video clips.  
 
Be as detailed as possible, including information about WHERE things happen, 
WHEN they happen, WHO they happen to, WHAT the people and scenes look like, 
etc.  
 
Take your time. The main thing is to recall as much information and detail as you 
possibly can. Please write about both scenes. 
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5.4. Cued recall task 
 
The next set of questions relate to the first scene in the video. Even if you are not 
sure about the answer, just make your best guess. 
 
Q1: What is colour of the walls in the passageway that the woman walks through? 
 
Q2: What two things was the woman carrying? 
 
Q3: What does the woman see when she walks down the passageway? 
 
Q4: What is the woman who is first being attacked wearing? 
 
Q5: What does the man do with his knife while he's threatening the second woman? 
 
Q6: What is the attacker wearing? 
 
Q7: What happens in the background in the passageway while the man is raping the 
woman? 
 
Q8: What is lying on the floor next to the woman? 
 
Q9: What does the man do while he's lying next to the woman after he rapes her? 
 
Q10: What happens after the man has kicked the woman, at the very end of the 
video? 
 
The next set of questions relate to the second scene in the video. Even if you are 
not sure about the answer, just make your best guess. 
 
Q11: Where does the fight take place in the second scene? 
 
Q12: How many men are fighting in the beginning of the scene? 
 
Q13: While the two men are fighting, one man falls or is thrown to the ground. What 
happens next? 
 
Q14: Which arm (left or right) of the man on the floor does the other man break? 
 
Q15: After he breaks the man's arm, what does the attacker do next? 
Q16: As he attempts to rape the man on the floor, what is going on in the 
background? 
 
Q17: What is the man with the fire extinguisher wearing? 
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Q18: What is the colour of the lighting in the room? 
 
Q19: The camera turns to one of the onlookers at the end of the scene - describe his 
facial expression. 
 
On a scale of 0-10, how accurately did you complete the diary? 
 
0 - Not at all accurately 
10 - Extremely accurately  
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5.5. Verbal instructions for recoding intrusive memories Day 1-7 
  
I will now give you the instructions on what you need to do over the next seven 
days before you come to the study center again. You’ll need to fill in an online diary 
over the next seven days, including tonight, to record some of your experiences after 
you leave today. You can do it on your phone but we recommend you do in on your 
laptop.  
  It's really important that you understand what we need you to do in terms of 
recording your experiences in the online diary, and also that you understand what 
spontaneous, involuntary memories are, which is what we'll be asking you to record. 
So, let me explain about spontaneous, involuntary memories, which is what we'll be 
asking you to record. 
Over the next week, you will likely experience some spontaneously occurring 
memories about the film you watched. By ‘spontaneous’, what we mean is memories 
of the film that suddenly pop into your mind automatically. We do not mean times 
when you deliberately think about it or mull it over. The spontaneous memories may 
pop into your mind when you are doing or thinking about something completely 
unrelated. Or you may be reminded of the film by things that happen in your 
environment. The main thing is that you didn't mean to think about the film, but recall 
something about it, 'out of the blue.' 
Spontaneous memories may take the form of 'mental pictures' of the film you saw. 
They can be visual, but they can also be in any other sensory modality, so you might 
have memories of the sounds you heard. They can also take a verbal form – that is, 
words or sentences, statements or questions. Or they could be a mixture of sensory and 
verbal forms. The key thing is that they should be related to the film and they should 
occur out of the blue, without you trying to think about them. 
  In addition, for tomorrow morning only, you will need to complete some 
additional questions on sleep quality of the night before, which is tonight. This will 
also be on the app that you are recording intrusive memories on. 
  You will receive text reminders from us everyday evening, around 8pm, for the 
next seven days, including today, to remind you to complete the online diary and the 
questionnaires on sleep quality.  
Here is a detailed set of instructions (write down participant number on the paper 
instructions, give them to the participant and ask them to use this number to fill in the 
diary and survey in the next seven days), please read it carefully. Do you have any 
questions at this point? 
Thank you so much for your time! Would it be okay if we scheduled your 
appointment next week after seven days, for the same time? 
Once again, thank you so much for your time and see you in seven days.  
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5.6. Written instructions for recording intrusive memories Day 1-7 
 
You’ll need to fill in an online diary over the next seven days (including in the 
evening today) to record some of your experiences after you leave today.  
It's really important that you understand what we need you to do in terms of 
recording your experiences in the online diary. So, let me explain about spontaneous, 
involuntary memories, which is what we'll be asking you to record. 
Over the next week, you will likely experience some spontaneously occurring 
memories about the film you watched. By ‘spontaneous’, what we mean is memories 
of the film that suddenly pop into your mind automatically. We do not mean times 
when you deliberately think about it or mull it over. The spontaneous memories may 
pop into your mind when you are doing or thinking about something completely 
unrelated. Or you may be reminded of the film by things that happen in your 
environment. The main thing is that you didn't mean to think about the film, but recall 
something about it, 'out of the blue.' 
Spontaneous memories may take the form of 'mental pictures' of the film you saw. 
They can be visual, but they can also be in any other sensory modality, so you might 
have memories of the sounds you heard. They can also take a verbal form – that is, 
words or sentences, statements or questions. Or they could be a mixture of sensory and 
verbal forms. The key thing is that they should be related to the film and they should 
occur out of the blue, without you trying to think about them. 
You will be sent a reminder text message at 8pm everyday for the next seven days 
(including today) to complete the online diary about any memories you might 
have had on that day related to the video. Try to complete the diary as close as 
possible to bedtime. To complete the diary, do the following: 
 
1. Follow the link on the reminder text or email：  
https://uclpsych.eu.qualtrics.com/jfe/form/SV_6xuXgWEpplB6VGR 
 
2. Once you're on the diary site, you will see this screen:  
Mobile/Smart device screen: 
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Computer Screen: 
 
You will need to provide your DoB and participant number – this is your participant 
number (give them their card) - so that we can link your responses to the ones you 
provided today. Then click the “>>” button. 
 
3. You will be taken to the main diary page, which looks like this: 
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The purpose of this page is to record the unwanted involuntary memories I just 
mentioned. Before explaining how to fill this out, I’d just want to remind you that the 
aim of our research is to look at involuntary memories because they seem to be 
important in many psychological disorders, especially PTSD. So it’s also really 
important that I explain instructions on how to complete the diary as clearly as possible, 
because if we get bad data it’s potentially harmful to the people who we’re hoping to 
help with this research. So please ask me to repeat anything that isn’t clear.  
OK, so you'll notice that there are several columns.  
In the first column, I’d like you to record anything you recall involuntarily about 
the film you just saw every day for the next 7 days (including today). Record different 
involuntary memories on different rows. For example, if at the end of the day you 
recall having a memory in the morning about the men fighting and the same memory 
again a few minutes later, record that as two separate memories, for example as 
Memory 1 and memory 2 in these boxes. Just write a brief description of what came 
to your mind, but be specific (for example, “men fighting” is fine). It might be that in 
one memory you remember one  particular aspect of the men fighting, like the look 
on one of their faces, whereas the next time you recall what one of the men did to one 
of the others. It’s very helpful for us to know that you had two separate memories in 
that case. Alternatively, you might have exactly the same memory about the same thing 
several times in the day, in which case, please record the number of times you had the 
memory in this second row, with an appropriate brief description. It is common to have 
multiple occurrences of the same intrusion. We are interested in the number of 
intrusions you have. If you recall a particular thing several times in the same day, 
please indicate the number of times you recalled it in the second column on the same 
row. If you recalled it only once, also indicate this.   
The main thing is that you try to be as accurate as possible when you’re recording 
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the memories, both in terms of the number of memories you had, what they were about 
and how you felt while remembering.  
In the third column, please indicate whether the memory was generally verbal (e.g., 
words, sentences), sensory (e.g., visual, auditory), or both, by selecting the appropriate 
option. 
In the fourth and fifth columns, indicate respectively how distressing and how 
vivid the memory was for you by selecting the most appropriate number on a scale of 
1-5 (1=not at all, 5=extremely). If the same memory was experienced more than once, 
indicate the maximum level of distress the memory caused. 
When you have completed the diary, click the “>>” button. 
You may find it useful to set aside a certain time/time(s) near the end of each day 
to fill in the diary. The end of the day would be good.  
 
Sleep Survey – Instructions 
 
In addition, for tomorrow only, you will need to complete some additional 
questions on sleep quality of the night before (i.e. tonight). This will also be on the app 
that you are recording intrusive memories on. 
 
The link to the survey is as follows:  
https://uclpsych.eu.qualtrics.com/jfe/form/SV_1N5z2ikRVNXIWrz  
Mobile/Smart Device Screen: 
 
 
 
Computer Screen: 
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Should you experience any problems filling in the diary or sleep survey, please contact 
the researchers at an.gong.10@ucl.ac.uk.  
 
 
 
 
 
 
 
 
